 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Molecular Function	GO:0015403	thiamine uptake transmembrane transporter activity	1	1.015605e-4	3.745551e-1	3.745551e-1	9.846350e+3	1.015605e-4	1	1.015605e-4	1.000000e+0	1	2.217111e-4	8.176705e-1	8.176705e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	SLC19A2
GO Molecular Function	GO:0015563	uptake transmembrane transporter activity	2	1.138134e-4	4.197438e-1	2.098719e-1	8.786308e+3	1.138134e-4	1	1.138134e-4	1.000000e+0	2	3.325574e-4	1.000000e+0	6.132358e-1	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	SLC19A2
GO Molecular Function	GO:0008517	folic acid transporter activity	3	1.955116e-4	7.210468e-1	2.403489e-1	5.114786e+3	1.955116e-4	1	1.955116e-4	1.000000e+0	5	6.650594e-4	1.000000e+0	4.905478e-1	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	SLC19A2
GO Molecular Function	GO:0090482	vitamin transmembrane transporter activity	4	2.186084e-4	8.062278e-1	2.015569e-1	4.574389e+3	2.186084e-4	1	2.186084e-4	1.000000e+0	3	5.542315e-4	1.000000e+0	6.813353e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	SLC19A2
GO Molecular Function	GO:1901474	azole transmembrane transporter activity	5	4.422672e-4	1.000000e+0	3.262163e-1	2.261076e+3	4.422672e-4	1	4.422672e-4	1.000000e+0	3	5.542315e-4	1.000000e+0	6.813353e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	SLC19A2
GO Molecular Function	GO:0051184	cofactor transporter activity	6	8.259258e-4	1.000000e+0	5.076691e-1	1.210763e+3	8.259258e-4	1	8.259258e-4	1.000000e+0	7	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	SLC19A2
GO Molecular Function	GO:0015238	drug transmembrane transporter activity	7	1.036883e-3	1.000000e+0	5.462892e-1	9.644294e+2	1.036883e-3	1	1.036883e-3	1.000000e+0	6	1.662234e-3	1.000000e+0	1.000000e+0	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	SLC19A2
GO Molecular Function	GO:0051183	vitamin transporter activity	8	1.084612e-3	1.000000e+0	5.000061e-1	9.219889e+2	1.084612e-3	1	1.084612e-3	1.000000e+0	7	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	SLC19A2
GO Molecular Function	GO:0090484	drug transporter activity	9	1.203657e-3	1.000000e+0	4.932319e-1	8.308012e+2	1.203657e-3	1	1.203657e-3	1.000000e+0	7	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	SLC19A2
GO Molecular Function	GO:1901682	sulfur compound transmembrane transporter activity	10	2.334460e-3	1.000000e+0	8.609488e-1	4.283645e+2	2.334460e-3	1	2.334460e-3	1.000000e+0	10	2.769621e-3	1.000000e+0	1.000000e+0	3.608200e+2	2.771465e-3	1	25	5.000000e-1	4.000000e-2	unnamed	SLC19A2
GO Molecular Function	GO:0005507	copper ion binding	11	4.052119e-3	1.000000e+0	1.000000e+0	2.467845e+2	4.052119e-3	1	4.052119e-3	1.000000e+0	11	6.309133e-3	1.000000e+0	1.000000e+0	1.582544e+2	6.318940e-3	1	57	5.000000e-1	1.754386e-2	unnamed	F5
GO Molecular Function	GO:0022891	substrate-specific transmembrane transporter activity	12	8.482288e-2	1.000000e+0	1.000000e+0	1.178927e+1	8.482288e-2	1	8.482288e-2	1.000000e+0	12	8.926381e-2	1.000000e+0	1.000000e+0	1.094721e+1	9.134749e-2	1	824	5.000000e-1	1.213592e-3	unnamed	SLC19A2
GO Molecular Function	GO:0022857	transmembrane transporter activity	13	9.170810e-2	1.000000e+0	1.000000e+0	1.090416e+1	9.170810e-2	1	9.170810e-2	1.000000e+0	13	9.802388e-2	1.000000e+0	1.000000e+0	9.945424e+0	1.005488e-1	1	907	5.000000e-1	1.102536e-3	unnamed	SLC19A2
GO Molecular Function	GO:0022892	substrate-specific transporter activity	14	9.245642e-2	1.000000e+0	1.000000e+0	1.081591e+1	9.245642e-2	1	9.245642e-2	1.000000e+0	14	1.030706e-1	1.000000e+0	1.000000e+0	9.445550e+0	1.058700e-1	1	955	5.000000e-1	1.047120e-3	unnamed	SLC19A2
GO Molecular Function	GO:0005215	transporter activity	15	1.089898e-1	1.000000e+0	1.000000e+0	9.175171e+0	1.089898e-1	1	1.089898e-1	1.000000e+0	15	1.269529e-1	1.000000e+0	1.000000e+0	7.618666e+0	1.312566e-1	1	1184	5.000000e-1	8.445946e-4	unnamed	SLC19A2
GO Molecular Function	GO:0046914	transition metal ion binding	16	1.321251e-1	1.000000e+0	1.000000e+0	7.568583e+0	1.321251e-1	1	1.321251e-1	1.000000e+0	16	1.516365e-1	1.000000e+0	1.000000e+0	6.334621e+0	1.578626e-1	1	1424	5.000000e-1	7.022472e-4	unnamed	F5
GO Molecular Function	GO:0046872	metal ion binding	17	3.527991e-1	1.000000e+0	1.000000e+0	2.834474e+0	3.527991e-1	1	3.527991e-1	1.000000e+0	17	3.911753e-1	1.000000e+0	1.000000e+0	2.275605e+0	4.394435e-1	1	3964	5.000000e-1	2.522704e-4	unnamed	F5
GO Molecular Function	GO:0043169	cation binding	18	3.606111e-1	1.000000e+0	1.000000e+0	2.773071e+0	3.606111e-1	1	3.606111e-1	1.000000e+0	18	3.968711e-1	1.000000e+0	1.000000e+0	2.238337e+0	4.467602e-1	1	4030	5.000000e-1	2.481390e-4	unnamed	F5
GO Molecular Function	GO:0043167	ion binding	19	5.095070e-1	1.000000e+0	1.000000e+0	1.962682e+0	5.095070e-1	1	5.095070e-1	1.000000e+0	19	5.570694e-1	1.000000e+0	1.000000e+0	1.494945e+0	6.689208e-1	1	6034	5.000000e-1	1.657275e-4	unnamed	F5
GO Molecular Function	GO:0005515	protein binding	20	6.181781e-1	1.000000e+0	1.000000e+0	1.617657e+0	6.181781e-1	1	6.181781e-1	1.000000e+0	20	6.900633e-1	1.000000e+0	1.000000e+0	1.127985e+0	8.865362e-1	1	7997	5.000000e-1	1.250469e-4	unnamed	F5
GO Molecular Function	GO:0005488	binding	21	8.171102e-1	1.000000e+0	1.000000e+0	1.223825e+0	8.171102e-1	1	8.171102e-1	1.000000e+0	21	8.942547e-1	1.000000e+0	1.000000e+0	7.409644e-1	1.349593e+0	1	12174	5.000000e-1	8.214227e-5	unnamed	F5
GO Biological Process	GO:0015888	thiamine transport	1	1.015605e-4	1.000000e+0	1.000000e+0	9.846350e+3	1.015605e-4	1	1.015605e-4	1.000000e+0	1	2.217111e-4	1.000000e+0	1.000000e+0	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	SLC19A2
GO Biological Process	GO:0015884	folic acid transport	2	2.021323e-4	1.000000e+0	1.000000e+0	4.947256e+3	2.021323e-4	1	2.021323e-4	1.000000e+0	3	7.758812e-4	1.000000e+0	1.000000e+0	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	SLC19A2
GO Biological Process	GO:0042723	thiamine-containing compound metabolic process	3	6.327246e-4	1.000000e+0	1.000000e+0	1.580466e+3	6.327246e-4	1	6.327246e-4	1.000000e+0	2	5.542315e-4	1.000000e+0	1.000000e+0	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	SLC19A2
GO Biological Process	GO:0072337	modified amino acid transport	4	8.901594e-4	1.000000e+0	1.000000e+0	1.123394e+3	8.901594e-4	1	8.901594e-4	1.000000e+0	5	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	SLC19A2
GO Biological Process	GO:0051181	cofactor transport	5	9.443147e-4	1.000000e+0	1.000000e+0	1.058969e+3	9.443147e-4	1	9.443147e-4	1.000000e+0	6	2.437470e-3	1.000000e+0	1.000000e+0	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	SLC19A2
GO Biological Process	GO:0051180	vitamin transport	6	1.367860e-3	1.000000e+0	1.000000e+0	7.310690e+2	1.367860e-3	1	1.367860e-3	1.000000e+0	7	2.658910e-3	1.000000e+0	1.000000e+0	3.758542e+2	2.660606e-3	1	24	5.000000e-1	4.166667e-2	unnamed	SLC19A2
GO Biological Process	GO:0072348	sulfur compound transport	7	1.880044e-3	1.000000e+0	1.000000e+0	5.319024e+2	1.880044e-3	1	1.880044e-3	1.000000e+0	8	2.991025e-3	1.000000e+0	1.000000e+0	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	SLC19A2
GO Biological Process	GO:0045117	azole transport	8	1.976932e-3	1.000000e+0	1.000000e+0	5.058343e+2	1.976932e-3	1	1.976932e-3	1.000000e+0	4	1.551461e-3	1.000000e+0	1.000000e+0	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	SLC19A2
GO Biological Process	GO:0015893	drug transport	9	3.117582e-3	1.000000e+0	1.000000e+0	3.207614e+2	3.117582e-3	1	3.117582e-3	1.000000e+0	9	3.433759e-3	1.000000e+0	1.000000e+0	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	SLC19A2
GO Biological Process	GO:0006835	dicarboxylic acid transport	10	5.360935e-3	1.000000e+0	1.000000e+0	1.865346e+2	5.360935e-3	1	5.360935e-3	1.000000e+0	10	6.088097e-3	1.000000e+0	1.000000e+0	1.640091e+2	6.097223e-3	1	55	5.000000e-1	1.818182e-2	unnamed	SLC19A2
GO Biological Process	GO:0072527	pyrimidine-containing compound metabolic process	11	6.706757e-3	1.000000e+0	1.000000e+0	1.491033e+2	6.706757e-3	1	6.706757e-3	1.000000e+0	11	8.297342e-3	1.000000e+0	1.000000e+0	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	SLC19A2
GO Biological Process	GO:0002576	platelet degranulation	12	7.826832e-3	1.000000e+0	1.000000e+0	1.277656e+2	7.826832e-3	1	7.826832e-3	1.000000e+0	12	9.401043e-3	1.000000e+0	1.000000e+0	1.061235e+2	9.422981e-3	1	85	5.000000e-1	1.176471e-2	unnamed	F5
GO Biological Process	GO:0006767	water-soluble vitamin metabolic process	13	8.493979e-3	1.000000e+0	1.000000e+0	1.177305e+2	8.493979e-3	1	8.493979e-3	1.000000e+0	13	9.732033e-3	1.000000e+0	1.000000e+0	1.025057e+2	9.755557e-3	1	88	5.000000e-1	1.136364e-2	unnamed	SLC19A2
GO Biological Process	GO:0006766	vitamin metabolic process	14	1.089445e-2	1.000000e+0	1.000000e+0	9.178985e+1	1.089445e-2	1	1.089445e-2	1.000000e+0	14	1.281861e-2	1.000000e+0	1.000000e+0	7.776293e+1	1.285960e-2	1	116	5.000000e-1	8.620690e-3	unnamed	SLC19A2
GO Biological Process	GO:0006865	amino acid transport	15	1.137929e-2	1.000000e+0	1.000000e+0	8.787896e+1	1.137929e-2	1	1.137929e-2	1.000000e+0	15	1.325916e-2	1.000000e+0	1.000000e+0	7.517083e+1	1.330303e-2	1	120	5.000000e-1	8.333333e-3	unnamed	SLC19A2
GO Biological Process	GO:0046942	carboxylic acid transport	16	1.899186e-2	1.000000e+0	1.000000e+0	5.265415e+1	1.899186e-2	1	1.899186e-2	1.000000e+0	17	2.248791e-2	1.000000e+0	1.000000e+0	4.421814e+1	2.261515e-2	1	204	5.000000e-1	4.901961e-3	unnamed	SLC19A2
GO Biological Process	GO:0030168	platelet activation	17	2.162078e-2	1.000000e+0	1.000000e+0	4.625181e+1	2.162078e-2	1	2.162078e-2	1.000000e+0	18	2.358369e-2	1.000000e+0	1.000000e+0	4.215187e+1	2.372374e-2	1	214	5.000000e-1	4.672897e-3	unnamed	F5
GO Biological Process	GO:0006887	exocytosis	18	2.478047e-2	1.000000e+0	1.000000e+0	4.035436e+1	2.478047e-2	1	2.478047e-2	1.000000e+0	20	2.686732e-2	1.000000e+0	1.000000e+0	3.696926e+1	2.704950e-2	1	244	5.000000e-1	4.098361e-3	unnamed	F5
GO Biological Process	GO:0006790	sulfur compound metabolic process	19	2.820341e-2	1.000000e+0	1.000000e+0	3.545671e+1	2.820341e-2	1	2.820341e-2	1.000000e+0	19	2.675795e-2	1.000000e+0	1.000000e+0	3.712140e+1	2.693864e-2	1	243	5.000000e-1	4.115226e-3	unnamed	SLC19A2
GO Biological Process	GO:0015711	organic anion transport	20	2.827900e-2	1.000000e+0	1.000000e+0	3.536193e+1	2.827900e-2	1	2.827900e-2	1.000000e+0	24	3.319999e-2	1.000000e+0	1.000000e+0	2.986921e+1	3.347930e-2	1	302	5.000000e-1	3.311258e-3	unnamed	SLC19A2
GO Biological Process	GO:0008015	blood circulation	21	3.353044e-2	1.000000e+0	1.000000e+0	2.982364e+1	3.353044e-2	1	3.353044e-2	1.000000e+0	21	3.058208e-2	1.000000e+0	1.000000e+0	3.244784e+1	3.081869e-2	1	278	5.000000e-1	3.597122e-3	unnamed	F5
GO Biological Process	GO:0003013	circulatory system process	22	3.378328e-2	1.000000e+0	1.000000e+0	2.960044e+1	3.378328e-2	1	3.378328e-2	1.000000e+0	22	3.080038e-2	1.000000e+0	1.000000e+0	3.221607e+1	3.104041e-2	1	280	5.000000e-1	3.571429e-3	unnamed	F5
GO Biological Process	GO:0006820	anion transport	23	3.528482e-2	1.000000e+0	1.000000e+0	2.834080e+1	3.528482e-2	1	3.528482e-2	1.000000e+0	27	4.320252e-2	1.000000e+0	1.000000e+0	2.289467e+1	4.367829e-2	1	394	5.000000e-1	2.538071e-3	unnamed	SLC19A2
GO Biological Process	GO:0071705	nitrogen compound transport	24	3.671157e-2	1.000000e+0	1.000000e+0	2.723937e+1	3.671157e-2	1	3.671157e-2	1.000000e+0	29	4.666947e-2	1.000000e+0	1.000000e+0	2.117488e+1	4.722576e-2	1	426	5.000000e-1	2.347418e-3	unnamed	SLC19A2
GO Biological Process	GO:0042493	response to drug	25	4.125969e-2	1.000000e+0	1.000000e+0	2.423673e+1	4.125969e-2	1	4.125969e-2	1.000000e+0	26	3.929468e-2	1.000000e+0	1.000000e+0	2.519693e+1	3.968738e-2	1	358	5.000000e-1	2.793296e-3	unnamed	SLC19A2
GO Biological Process	GO:0032940	secretion by cell	26	4.352339e-2	1.000000e+0	1.000000e+0	2.297615e+1	4.352339e-2	1	4.352339e-2	1.000000e+0	28	4.428662e-2	1.000000e+0	1.000000e+0	2.232797e+1	4.478687e-2	1	404	5.000000e-1	2.475248e-3	unnamed	F5
GO Biological Process	GO:0007596	blood coagulation	27	4.808184e-2	1.000000e+0	1.000000e+0	2.079787e+1	4.808184e-2	1	4.808184e-2	1.000000e+0	32	5.477048e-2	1.000000e+0	1.000000e+0	1.800499e+1	5.554016e-2	1	501	5.000000e-1	1.996008e-3	unnamed	F5
GO Biological Process	GO:0007599	hemostasis	28	4.832719e-2	1.000000e+0	1.000000e+0	2.069229e+1	4.832719e-2	1	4.832719e-2	1.000000e+0	33	5.530932e-2	1.000000e+0	1.000000e+0	1.782708e+1	5.609445e-2	1	506	5.000000e-1	1.976285e-3	unnamed	F5
GO Biological Process	GO:0046903	secretion	29	5.307229e-2	1.000000e+0	1.000000e+0	1.884223e+1	5.307229e-2	1	5.307229e-2	1.000000e+0	31	5.444710e-2	1.000000e+0	1.000000e+0	1.811345e+1	5.520758e-2	1	498	5.000000e-1	2.008032e-3	unnamed	F5
GO Biological Process	GO:0050878	regulation of body fluid levels	30	5.804318e-2	1.000000e+0	1.000000e+0	1.722855e+1	5.804318e-2	1	5.804318e-2	1.000000e+0	35	6.573237e-2	1.000000e+0	1.000000e+0	1.495937e+1	6.684774e-2	1	603	5.000000e-1	1.658375e-3	unnamed	F5
GO Biological Process	GO:0001775	cell activation	31	5.914753e-2	1.000000e+0	1.000000e+0	1.690688e+1	5.914753e-2	1	5.914753e-2	1.000000e+0	34	6.176339e-2	1.000000e+0	1.000000e+0	1.593728e+1	6.274597e-2	1	566	5.000000e-1	1.766784e-3	unnamed	F5
GO Biological Process	GO:0042060	wound healing	32	6.218622e-2	1.000000e+0	1.000000e+0	1.608073e+1	6.218622e-2	1	6.218622e-2	1.000000e+0	36	6.658942e-2	1.000000e+0	1.000000e+0	1.476350e+1	6.773460e-2	1	611	5.000000e-1	1.636661e-3	unnamed	F5
GO Biological Process	GO:0016192	vesicle-mediated transport	33	8.338200e-2	1.000000e+0	1.000000e+0	1.199300e+1	8.338200e-2	1	8.338200e-2	1.000000e+0	39	9.623310e-2	1.000000e+0	1.000000e+0	1.013539e+1	9.866415e-2	1	890	5.000000e-1	1.123596e-3	unnamed	F5
GO Biological Process	GO:0009611	response to wounding	34	9.491742e-2	1.000000e+0	1.000000e+0	1.053547e+1	9.491742e-2	1	9.491742e-2	1.000000e+0	40	1.086266e-1	1.000000e+0	1.000000e+0	8.948909e+0	1.117455e-1	1	1008	5.000000e-1	9.920635e-4	unnamed	F5
GO Biological Process	GO:0006811	ion transport	35	1.070764e-1	1.000000e+0	1.000000e+0	9.339125e+0	1.070764e-1	1	1.070764e-1	1.000000e+0	41	1.160425e-1	1.000000e+0	1.000000e+0	8.360056e+0	1.196164e-1	1	1079	5.000000e-1	9.267841e-4	unnamed	SLC19A2
GO Biological Process	GO:0007155	cell adhesion	36	1.119169e-1	1.000000e+0	1.000000e+0	8.935198e+0	1.119169e-1	1	1.119169e-1	1.000000e+0	37	8.778204e-2	1.000000e+0	1.000000e+0	1.113642e+1	8.979547e-2	1	810	5.000000e-1	1.234568e-3	unnamed	F5
GO Biological Process	GO:0022610	biological adhesion	37	1.120241e-1	1.000000e+0	1.000000e+0	8.926651e+0	1.120241e-1	1	1.120241e-1	1.000000e+0	38	8.809966e-2	1.000000e+0	1.000000e+0	1.109533e+1	9.012804e-2	1	813	5.000000e-1	1.230012e-3	unnamed	F5
GO Biological Process	GO:0051649	establishment of localization in cell	38	1.284678e-1	1.000000e+0	1.000000e+0	7.784051e+0	1.284678e-1	1	1.284678e-1	1.000000e+0	43	1.571416e-1	1.000000e+0	1.000000e+0	6.103180e+0	1.638490e-1	1	1478	5.000000e-1	6.765900e-4	unnamed	F5
GO Biological Process	GO:1901564	organonitrogen compound metabolic process	39	1.379740e-1	1.000000e+0	1.000000e+0	7.247740e+0	1.379740e-1	1	1.379740e-1	1.000000e+0	44	1.637442e-1	1.000000e+0	1.000000e+0	5.846079e+0	1.710548e-1	1	1543	5.000000e-1	6.480881e-4	unnamed	SLC19A2
GO Biological Process	GO:0071702	organic substance transport	40	1.396970e-1	1.000000e+0	1.000000e+0	7.158351e+0	1.396970e-1	1	1.396970e-1	1.000000e+0	45	1.786811e-1	1.000000e+0	1.000000e+0	5.334418e+0	1.874619e-1	1	1691	5.000000e-1	5.913661e-4	unnamed	SLC19A2
GO Biological Process	GO:0051641	cellular localization	41	1.548748e-1	1.000000e+0	1.000000e+0	6.456828e+0	1.548748e-1	1	1.548748e-1	1.000000e+0	46	1.828954e-1	1.000000e+0	1.000000e+0	5.205136e+0	1.921180e-1	1	1733	5.000000e-1	5.770340e-4	unnamed	F5
GO Biological Process	GO:0003008	system process	42	1.967197e-1	1.000000e+0	1.000000e+0	5.083376e+0	1.967197e-1	1	1.967197e-1	1.000000e+0	47	2.046945e-1	1.000000e+0	1.000000e+0	4.621158e+0	2.163960e-1	1	1952	5.000000e-1	5.122951e-4	unnamed	F5
GO Biological Process	GO:0044281	small molecule metabolic process	43	2.001784e-1	1.000000e+0	1.000000e+0	4.995545e+0	2.001784e-1	1	2.001784e-1	1.000000e+0	48	2.509628e-1	1.000000e+0	1.000000e+0	3.716728e+0	2.690538e-1	1	2427	5.000000e-1	4.120313e-4	unnamed	SLC19A2
GO Biological Process	GO:0044765	single-organism transport	44	2.288177e-1	1.000000e+0	1.000000e+0	4.370291e+0	2.288177e-1	1	2.288177e-1	1.000000e+0	16	2.085859e-2	1.000000e+0	1.000000e+0	6.922870e+0	2.888975e-1	2	2606	1.000000e+0	7.674597e-4	unnamed	F5,SLC19A2
GO Biological Process	GO:0006950	response to stress	45	2.428193e-1	1.000000e+0	1.000000e+0	4.118289e+0	2.428193e-1	1	2.428193e-1	1.000000e+0	50	3.014152e-1	1.000000e+0	1.000000e+0	3.045409e+0	3.283632e-1	1	2962	5.000000e-1	3.376097e-4	unnamed	F5
GO Biological Process	GO:0044710	single-organism metabolic process	46	2.517961e-1	1.000000e+0	1.000000e+0	3.971468e+0	2.517961e-1	1	2.517961e-1	1.000000e+0	51	3.105584e-1	1.000000e+0	1.000000e+0	2.946913e+0	3.393382e-1	1	3061	5.000000e-1	3.266906e-4	unnamed	SLC19A2
GO Biological Process	GO:0065008	regulation of biological quality	47	2.713082e-1	1.000000e+0	1.000000e+0	3.685845e+0	2.713082e-1	1	2.713082e-1	1.000000e+0	49	2.887566e-1	1.000000e+0	1.000000e+0	3.191967e+0	3.132864e-1	1	2826	5.000000e-1	3.538570e-4	unnamed	F5
GO Biological Process	GO:0006810	transport	48	2.770578e-1	1.000000e+0	1.000000e+0	3.609355e+0	2.770578e-1	1	2.770578e-1	1.000000e+0	23	3.272428e-2	1.000000e+0	1.000000e+0	5.527267e+0	3.618425e-1	2	3264	1.000000e+0	6.127451e-4	unnamed	F5,SLC19A2
GO Biological Process	GO:0051234	establishment of localization	49	2.827781e-1	1.000000e+0	1.000000e+0	3.536342e+0	2.827781e-1	1	2.827781e-1	1.000000e+0	25	3.373470e-2	1.000000e+0	1.000000e+0	5.443874e+0	3.673854e-1	2	3314	1.000000e+0	6.035003e-4	unnamed	F5,SLC19A2
GO Biological Process	GO:0042221	response to chemical stimulus	50	2.954524e-1	1.000000e+0	1.000000e+0	3.384640e+0	2.954524e-1	1	2.954524e-1	1.000000e+0	52	3.326549e-1	1.000000e+0	1.000000e+0	2.731002e+0	3.661660e-1	1	3303	5.000000e-1	3.027551e-4	unnamed	SLC19A2
GO Biological Process	GO:0051179	localization	51	3.597525e-1	1.000000e+0	1.000000e+0	2.779689e+0	3.597525e-1	1	3.597525e-1	1.000000e+0	30	4.993858e-2	1.000000e+0	1.000000e+0	4.474454e+0	4.469819e-1	2	4032	1.000000e+0	4.960317e-4	unnamed	F5,SLC19A2
GO Biological Process	GO:0046483	heterocycle metabolic process	52	3.657512e-1	1.000000e+0	1.000000e+0	2.734099e+0	3.657512e-1	1	3.657512e-1	1.000000e+0	54	4.495636e-1	1.000000e+0	1.000000e+0	1.937393e+0	5.161576e-1	1	4656	5.000000e-1	2.147766e-4	unnamed	SLC19A2
GO Biological Process	GO:0006725	cellular aromatic compound metabolic process	53	3.683046e-1	1.000000e+0	1.000000e+0	2.715144e+0	3.683046e-1	1	3.683046e-1	1.000000e+0	55	4.506323e-1	1.000000e+0	1.000000e+0	1.931998e+0	5.175988e-1	1	4669	5.000000e-1	2.141786e-4	unnamed	SLC19A2
GO Biological Process	GO:0034641	cellular nitrogen compound metabolic process	54	3.768107e-1	1.000000e+0	1.000000e+0	2.653853e+0	3.768107e-1	1	3.768107e-1	1.000000e+0	56	4.663767e-1	1.000000e+0	1.000000e+0	1.855306e+0	5.389945e-1	1	4862	5.000000e-1	2.056767e-4	unnamed	SLC19A2
GO Biological Process	GO:1901360	organic cyclic compound metabolic process	55	3.827617e-1	1.000000e+0	1.000000e+0	2.612592e+0	3.827617e-1	1	3.827617e-1	1.000000e+0	57	4.683993e-1	1.000000e+0	1.000000e+0	1.845815e+0	5.417660e-1	1	4887	5.000000e-1	2.046245e-4	unnamed	SLC19A2
GO Biological Process	GO:0006807	nitrogen compound metabolic process	56	4.138051e-1	1.000000e+0	1.000000e+0	2.416597e+0	4.138051e-1	1	4.138051e-1	1.000000e+0	58	4.994558e-1	1.000000e+0	1.000000e+0	1.709399e+0	5.850008e-1	1	5277	5.000000e-1	1.895016e-4	unnamed	SLC19A2
GO Biological Process	GO:0044707	single-multicellular organism process	57	5.372858e-1	1.000000e+0	1.000000e+0	1.861207e+0	5.372858e-1	1	5.372858e-1	1.000000e+0	59	5.291973e-1	1.000000e+0	1.000000e+0	1.593165e+0	6.276814e-1	1	5662	5.000000e-1	1.766160e-4	unnamed	F5
GO Biological Process	GO:0050896	response to stimulus	58	5.533212e-1	1.000000e+0	1.000000e+0	1.807268e+0	5.533212e-1	1	5.533212e-1	1.000000e+0	42	1.457136e-1	1.000000e+0	1.000000e+0	2.619573e+0	7.634832e-1	2	6887	1.000000e+0	2.904022e-4	unnamed	F5,SLC19A2
GO Biological Process	GO:0032501	multicellular organismal process	59	5.539872e-1	1.000000e+0	1.000000e+0	1.805096e+0	5.539872e-1	1	5.539872e-1	1.000000e+0	60	5.461571e-1	1.000000e+0	1.000000e+0	1.532275e+0	6.526246e-1	1	5887	5.000000e-1	1.698658e-4	unnamed	F5
GO Biological Process	GO:0044237	cellular metabolic process	60	6.001923e-1	1.000000e+0	1.000000e+0	1.666133e+0	6.001923e-1	1	6.001923e-1	1.000000e+0	62	7.045181e-1	1.000000e+0	1.000000e+0	1.095519e+0	9.128097e-1	1	8234	5.000000e-1	1.214477e-4	unnamed	SLC19A2
GO Biological Process	GO:0071704	organic substance metabolic process	61	6.199145e-1	1.000000e+0	1.000000e+0	1.613126e+0	6.199145e-1	1	6.199145e-1	1.000000e+0	63	7.239536e-1	1.000000e+0	1.000000e+0	1.053551e+0	9.491713e-1	1	8562	5.000000e-1	1.167951e-4	unnamed	SLC19A2
GO Biological Process	GO:0008152	metabolic process	62	6.507895e-1	1.000000e+0	1.000000e+0	1.536595e+0	6.507895e-1	1	6.507895e-1	1.000000e+0	64	7.596471e-1	1.000000e+0	1.000000e+0	9.809156e-1	1.019456e+0	1	9196	5.000000e-1	1.087429e-4	unnamed	SLC19A2
GO Biological Process	GO:0065007	biological regulation	63	7.151977e-1	1.000000e+0	1.000000e+0	1.398215e+0	7.151977e-1	1	7.151977e-1	1.000000e+0	65	7.940293e-1	1.000000e+0	1.000000e+0	9.155080e-1	1.092290e+0	1	9853	5.000000e-1	1.014919e-4	unnamed	F5
GO Biological Process	GO:0044763	single-organism cellular process	64	7.497126e-1	1.000000e+0	1.000000e+0	1.333844e+0	7.497126e-1	1	7.497126e-1	1.000000e+0	66	8.068544e-1	1.000000e+0	1.000000e+0	8.920589e-1	1.121002e+0	1	10112	5.000000e-1	9.889241e-5	unnamed	F5
GO Biological Process	GO:0044699	single-organism process	65	7.935590e-1	1.000000e+0	1.000000e+0	1.260146e+0	7.935590e-1	1	7.935590e-1	1.000000e+0	53	3.800402e-1	1.000000e+0	1.000000e+0	1.622100e+0	1.232969e+0	2	11122	1.000000e+0	1.798238e-4	unnamed	F5,SLC19A2
GO Biological Process	GO:0009987	cellular process	66	8.656787e-1	1.000000e+0	1.000000e+0	1.155163e+0	8.656787e-1	1	8.656787e-1	1.000000e+0	61	5.606826e-1	1.000000e+0	1.000000e+0	1.335480e+0	1.497589e+0	2	13509	1.000000e+0	1.480494e-4	unnamed	F5,SLC19A2
GO Cellular Component	GO:0031093	platelet alpha granule lumen	1	5.166153e-3	1.000000e+0	1.000000e+0	1.935676e+2	5.166153e-3	1	5.166153e-3	1.000000e+0	1	5.314281e-3	1.000000e+0	1.000000e+0	1.879271e+2	5.321213e-3	1	48	5.000000e-1	2.083333e-2	unnamed	F5
GO Cellular Component	GO:0031091	platelet alpha granule	2	6.017186e-3	1.000000e+0	1.000000e+0	1.661907e+2	6.017186e-3	1	6.017186e-3	1.000000e+0	2	6.640639e-3	1.000000e+0	1.000000e+0	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	F5
GO Cellular Component	GO:0034774	secretory granule lumen	3	6.282318e-3	1.000000e+0	1.000000e+0	1.591769e+2	6.282318e-3	1	6.282318e-3	1.000000e+0	3	6.972090e-3	1.000000e+0	1.000000e+0	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	F5
GO Cellular Component	GO:0060205	cytoplasmic membrane-bounded vesicle lumen	4	7.112970e-3	1.000000e+0	1.000000e+0	1.405882e+2	7.112970e-3	1	7.112970e-3	1.000000e+0	4	8.959636e-3	1.000000e+0	1.000000e+0	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	F5
GO Cellular Component	GO:0030141	secretory granule	5	2.369213e-2	1.000000e+0	1.000000e+0	4.220811e+1	2.369213e-2	1	2.369213e-2	1.000000e+0	5	2.992705e-2	1.000000e+0	1.000000e+0	3.316360e+1	3.015354e-2	1	272	5.000000e-1	3.676471e-3	unnamed	F5
GO Cellular Component	GO:0044433	cytoplasmic vesicle part	6	4.819948e-2	1.000000e+0	1.000000e+0	2.074711e+1	4.819948e-2	1	4.819948e-2	1.000000e+0	6	5.218192e-2	1.000000e+0	1.000000e+0	1.891090e+1	5.287955e-2	1	477	5.000000e-1	2.096436e-3	unnamed	F5
GO Cellular Component	GO:0005615	extracellular space	7	8.028245e-2	1.000000e+0	1.000000e+0	1.245602e+1	8.028245e-2	1	8.028245e-2	1.000000e+0	9	9.517887e-2	1.000000e+0	1.000000e+0	1.025057e+1	9.755557e-2	1	880	5.000000e-1	1.136364e-3	unnamed	F5
GO Cellular Component	GO:0016023	cytoplasmic membrane-bounded vesicle	8	8.772555e-2	1.000000e+0	1.000000e+0	1.139919e+1	8.772555e-2	1	8.772555e-2	1.000000e+0	10	9.949731e-2	1.000000e+0	1.000000e+0	9.794245e+0	1.021008e-1	1	921	5.000000e-1	1.085776e-3	unnamed	F5
GO Cellular Component	GO:0031988	membrane-bounded vesicle	9	9.310199e-2	1.000000e+0	1.000000e+0	1.074091e+1	9.310199e-2	1	9.310199e-2	1.000000e+0	11	1.061128e-1	1.000000e+0	1.000000e+0	9.167175e+0	1.090849e-1	1	984	5.000000e-1	1.016260e-3	unnamed	F5
GO Cellular Component	GO:0031410	cytoplasmic vesicle	10	9.330829e-2	1.000000e+0	1.000000e+0	1.071716e+1	9.330829e-2	1	9.330829e-2	1.000000e+0	12	1.070559e-1	1.000000e+0	1.000000e+0	9.084089e+0	1.100826e-1	1	993	5.000000e-1	1.007049e-3	unnamed	F5
GO Cellular Component	GO:0031982	vesicle	11	1.007261e-1	1.000000e+0	1.000000e+0	9.927917e+0	1.007261e-1	1	1.007261e-1	1.000000e+0	13	1.159383e-1	1.000000e+0	1.000000e+0	8.367811e+0	1.195056e-1	1	1078	5.000000e-1	9.276438e-4	unnamed	F5
GO Cellular Component	GO:0044421	extracellular region part	12	1.147157e-1	1.000000e+0	1.000000e+0	8.717204e+0	1.147157e-1	1	1.147157e-1	1.000000e+0	14	1.270565e-1	1.000000e+0	1.000000e+0	7.612236e+0	1.313674e-1	1	1185	5.000000e-1	8.438819e-4	unnamed	F5
GO Cellular Component	GO:0005576	extracellular region	13	1.896595e-1	1.000000e+0	1.000000e+0	5.272606e+0	1.896595e-1	1	1.896595e-1	1.000000e+0	16	2.281481e-1	1.000000e+0	1.000000e+0	4.117070e+0	2.428912e-1	1	2191	5.000000e-1	4.564126e-4	unnamed	F5
GO Cellular Component	GO:0043233	organelle lumen	14	2.231770e-1	1.000000e+0	1.000000e+0	4.480748e+0	2.231770e-1	1	2.231770e-1	1.000000e+0	17	2.816332e-1	1.000000e+0	1.000000e+0	3.280182e+0	3.048611e-1	1	2750	5.000000e-1	3.636364e-4	unnamed	F5
GO Cellular Component	GO:0031974	membrane-enclosed lumen	15	2.255118e-1	1.000000e+0	1.000000e+0	4.434357e+0	2.255118e-1	1	2.255118e-1	1.000000e+0	18	2.863237e-1	1.000000e+0	1.000000e+0	3.221607e+0	3.104041e-1	1	2800	5.000000e-1	3.571429e-4	unnamed	F5
GO Cellular Component	GO:0005886	plasma membrane	16	4.126577e-1	1.000000e+0	1.000000e+0	2.423316e+0	4.126577e-1	1	4.126577e-1	1.000000e+0	7	5.887829e-2	1.000000e+0	1.000000e+0	4.120831e+0	4.853390e-1	2	4378	1.000000e+0	4.568296e-4	unnamed	F5,SLC19A2
GO Cellular Component	GO:0071944	cell periphery	17	4.194602e-1	1.000000e+0	1.000000e+0	2.384017e+0	4.194602e-1	1	4.194602e-1	1.000000e+0	8	6.157154e-2	1.000000e+0	1.000000e+0	4.029707e+0	4.963140e-1	2	4477	1.000000e+0	4.467277e-4	unnamed	F5,SLC19A2
GO Cellular Component	GO:0016021	integral to membrane	18	4.578656e-1	1.000000e+0	1.000000e+0	2.184047e+0	4.578656e-1	1	4.578656e-1	1.000000e+0	19	4.982001e-1	1.000000e+0	1.000000e+0	1.714598e+0	5.832271e-1	1	5261	5.000000e-1	1.900779e-4	unnamed	SLC19A2
GO Cellular Component	GO:0031224	intrinsic to membrane	19	4.694206e-1	1.000000e+0	1.000000e+0	2.130286e+0	4.694206e-1	1	4.694206e-1	1.000000e+0	20	5.070350e-1	1.000000e+0	1.000000e+0	1.678545e+0	5.957541e-1	1	5374	5.000000e-1	1.860811e-4	unnamed	SLC19A2
GO Cellular Component	GO:0044446	intracellular organelle part	20	4.732075e-1	1.000000e+0	1.000000e+0	2.113238e+0	4.732075e-1	1	4.732075e-1	1.000000e+0	22	5.897910e-1	1.000000e+0	1.000000e+0	1.390765e+0	7.190289e-1	1	6486	5.000000e-1	1.541782e-4	unnamed	F5
GO Cellular Component	GO:0044422	organelle part	21	4.814989e-1	1.000000e+0	1.000000e+0	2.076848e+0	4.814989e-1	1	4.814989e-1	1.000000e+0	23	5.977049e-1	1.000000e+0	1.000000e+0	1.367157e+0	7.314450e-1	1	6598	5.000000e-1	1.515611e-4	unnamed	F5
GO Cellular Component	GO:0044444	cytoplasmic part	22	5.199381e-1	1.000000e+0	1.000000e+0	1.923306e+0	5.199381e-1	1	5.199381e-1	1.000000e+0	24	6.277110e-1	1.000000e+0	1.000000e+0	1.282596e+0	7.796685e-1	1	7033	5.000000e-1	1.421868e-4	unnamed	F5
GO Cellular Component	GO:0044425	membrane part	23	5.293034e-1	1.000000e+0	1.000000e+0	1.889276e+0	5.293034e-1	1	5.293034e-1	1.000000e+0	21	5.687230e-1	1.000000e+0	1.000000e+0	1.456564e+0	6.865473e-1	1	6193	5.000000e-1	1.614726e-4	unnamed	SLC19A2
GO Cellular Component	GO:0016020	membrane	24	6.308744e-1	1.000000e+0	1.000000e+0	1.585102e+0	6.308744e-1	1	6.308744e-1	1.000000e+0	15	1.895088e-1	1.000000e+0	1.000000e+0	2.297046e+0	8.706834e-1	2	7854	1.000000e+0	2.546473e-4	unnamed	F5,SLC19A2
GO Cellular Component	GO:0005737	cytoplasm	25	6.734732e-1	1.000000e+0	1.000000e+0	1.484840e+0	6.734732e-1	1	6.734732e-1	1.000000e+0	27	7.735178e-1	1.000000e+0	1.000000e+0	9.540455e-1	1.048168e+0	1	9455	5.000000e-1	1.057641e-4	unnamed	F5
GO Cellular Component	GO:0043231	intracellular membrane-bounded organelle	26	6.973299e-1	1.000000e+0	1.000000e+0	1.434041e+0	6.973299e-1	1	6.973299e-1	1.000000e+0	28	8.019514e-1	1.000000e+0	1.000000e+0	9.009688e-1	1.109916e+0	1	10012	5.000000e-1	9.988014e-5	unnamed	F5
GO Cellular Component	GO:0043227	membrane-bounded organelle	27	6.992039e-1	1.000000e+0	1.000000e+0	1.430198e+0	6.992039e-1	1	6.992039e-1	1.000000e+0	29	8.036253e-1	1.000000e+0	1.000000e+0	8.979196e-1	1.113685e+0	1	10046	5.000000e-1	9.954211e-5	unnamed	F5
GO Cellular Component	GO:0043229	intracellular organelle	28	7.399473e-1	1.000000e+0	1.000000e+0	1.351448e+0	7.399473e-1	1	7.399473e-1	1.000000e+0	30	8.473502e-1	1.000000e+0	1.000000e+0	8.206423e-1	1.218558e+0	1	10992	5.000000e-1	9.097525e-5	unnamed	F5
GO Cellular Component	GO:0043226	organelle	29	7.415866e-1	1.000000e+0	1.000000e+0	1.348460e+0	7.415866e-1	1	7.415866e-1	1.000000e+0	31	8.487331e-1	1.000000e+0	1.000000e+0	8.182602e-1	1.222105e+0	1	11024	5.000000e-1	9.071118e-5	unnamed	F5
GO Cellular Component	GO:0044424	intracellular part	30	8.017695e-1	1.000000e+0	1.000000e+0	1.247241e+0	8.017695e-1	1	8.017695e-1	1.000000e+0	32	9.083176e-1	1.000000e+0	1.000000e+0	7.171649e-1	1.394379e+0	1	12578	5.000000e-1	7.950390e-5	unnamed	F5
GO Cellular Component	GO:0005622	intracellular	31	8.064789e-1	1.000000e+0	1.000000e+0	1.239958e+0	8.064789e-1	1	8.064789e-1	1.000000e+0	33	9.139354e-1	1.000000e+0	1.000000e+0	7.076012e-1	1.413225e+0	1	12748	5.000000e-1	7.844368e-5	unnamed	F5
GO Cellular Component	GO:0044464	cell part	32	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	25	6.728810e-1	1.000000e+0	1.000000e+0	1.219069e+0	1.640596e+0	2	14799	1.000000e+0	1.351443e-4	unnamed	F5,SLC19A2
GO Cellular Component	GO:0005623	cell	33	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	26	6.729719e-1	1.000000e+0	1.000000e+0	1.218986e+0	1.640707e+0	2	14800	1.000000e+0	1.351351e-4	unnamed	F5,SLC19A2
Mouse Phenotype	MP:0005435	hemoperitoneum	1	1.926772e-3	1.000000e+0	1.000000e+0	5.190028e+2	1.926772e-3	1	1.926772e-3	1.000000e+0	2	2.437470e-3	1.000000e+0	1.000000e+0	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	F5
Mouse Phenotype	MP:0001721	absent visceral yolk sac blood islands	2	2.120282e-3	1.000000e+0	1.000000e+0	4.716354e+2	2.120282e-3	1	2.120282e-3	1.000000e+0	1	1.883760e-3	1.000000e+0	1.000000e+0	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	F5
Mouse Phenotype	MP:0003333	liver fibrosis	3	5.027206e-3	1.000000e+0	1.000000e+0	1.989176e+2	5.027206e-3	1	5.027206e-3	1.000000e+0	6	4.871965e-3	1.000000e+0	1.000000e+0	2.050114e+2	4.877778e-3	1	44	5.000000e-1	2.272727e-2	unnamed	F5
Mouse Phenotype	MP:0011204	abnormal visceral yolk sac blood island morphology	4	5.078975e-3	1.000000e+0	1.000000e+0	1.968901e+2	5.078975e-3	1	5.078975e-3	1.000000e+0	3	3.323085e-3	1.000000e+0	1.000000e+0	3.006833e+2	3.325758e-3	1	30	5.000000e-1	3.333333e-2	unnamed	F5
Mouse Phenotype	MP:0005505	increased platelet cell number	5	5.124781e-3	1.000000e+0	1.000000e+0	1.951303e+2	5.124781e-3	1	5.124781e-3	1.000000e+0	13	6.309133e-3	1.000000e+0	1.000000e+0	1.582544e+2	6.318940e-3	1	57	5.000000e-1	1.754386e-2	unnamed	SLC19A2
Mouse Phenotype	MP:0004740	sensorineural hearing loss	6	5.184031e-3	1.000000e+0	1.000000e+0	1.929001e+2	5.184031e-3	1	5.184031e-3	1.000000e+0	4	3.544427e-3	1.000000e+0	1.000000e+0	2.818906e+2	3.547475e-3	1	32	5.000000e-1	3.125000e-2	unnamed	SLC19A2
Mouse Phenotype	MP:0005244	hemopericardium	7	5.513541e-3	1.000000e+0	1.000000e+0	1.813717e+2	5.513541e-3	1	5.513541e-3	1.000000e+0	12	5.645954e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	F5
Mouse Phenotype	MP:0004398	cochlear inner hair cell degeneration	8	6.147546e-3	1.000000e+0	1.000000e+0	1.626665e+2	6.147546e-3	1	6.147546e-3	1.000000e+0	8	5.093135e-3	1.000000e+0	1.000000e+0	1.960978e+2	5.099496e-3	1	46	5.000000e-1	2.173913e-2	unnamed	SLC19A2
Mouse Phenotype	MP:0009698	heart hemorrhage	9	6.729403e-3	1.000000e+0	1.000000e+0	1.486016e+2	6.729403e-3	1	6.729403e-3	1.000000e+0	14	6.751129e-3	1.000000e+0	1.000000e+0	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	F5
Mouse Phenotype	MP:0004736	abnormal distortion product otoacoustic emission	10	7.792838e-3	1.000000e+0	1.000000e+0	1.283229e+2	7.792838e-3	1	7.792838e-3	1.000000e+0	10	5.424845e-3	1.000000e+0	1.000000e+0	1.840918e+2	5.432071e-3	1	49	5.000000e-1	2.040816e-2	unnamed	SLC19A2
Mouse Phenotype	MP:0006336	abnormal otoacoustic response	11	7.823985e-3	1.000000e+0	1.000000e+0	1.278121e+2	7.823985e-3	1	7.823985e-3	1.000000e+0	11	5.535402e-3	1.000000e+0	1.000000e+0	1.804100e+2	5.542930e-3	1	50	5.000000e-1	2.000000e-2	unnamed	SLC19A2
Mouse Phenotype	MP:0004404	cochlear outer hair cell degeneration	12	7.833827e-3	1.000000e+0	1.000000e+0	1.276515e+2	7.833827e-3	1	7.833827e-3	1.000000e+0	15	6.972090e-3	1.000000e+0	1.000000e+0	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	SLC19A2
Mouse Phenotype	MP:0008261	arrest of male meiosis	13	9.348667e-3	1.000000e+0	1.000000e+0	1.069671e+2	9.348667e-3	1	9.348667e-3	1.000000e+0	19	1.160660e-2	1.000000e+0	1.000000e+0	8.590952e+1	1.164015e-2	1	105	5.000000e-1	9.523810e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0005048	thrombosis	14	1.008544e-2	1.000000e+0	1.000000e+0	9.915283e+1	1.008544e-2	1	1.008544e-2	1.000000e+0	21	1.193722e-2	1.000000e+0	1.000000e+0	8.352315e+1	1.197273e-2	1	108	5.000000e-1	9.259259e-3	unnamed	F5
Mouse Phenotype	MP:0004362	cochlear hair cell degeneration	15	1.060731e-2	1.000000e+0	1.000000e+0	9.427462e+1	1.060731e-2	1	1.060731e-2	1.000000e+0	16	8.628517e-3	1.000000e+0	1.000000e+0	1.156474e+2	8.646971e-3	1	78	5.000000e-1	1.282051e-2	unnamed	SLC19A2
Mouse Phenotype	MP:0001915	intracranial hemorrhage	16	1.171036e-2	1.000000e+0	1.000000e+0	8.539450e+1	1.171036e-2	1	1.171036e-2	1.000000e+0	19	1.160660e-2	1.000000e+0	1.000000e+0	8.590952e+1	1.164015e-2	1	105	5.000000e-1	9.523810e-3	unnamed	F5
Mouse Phenotype	MP:0005202	lethargy	17	1.193684e-2	1.000000e+0	1.000000e+0	8.377427e+1	1.193684e-2	1	1.193684e-2	1.000000e+0	23	1.292876e-2	1.000000e+0	1.000000e+0	7.709829e+1	1.297046e-2	1	117	5.000000e-1	8.547009e-3	unnamed	F5
Mouse Phenotype	MP:0005169	abnormal male meiosis	18	1.271718e-2	1.000000e+0	1.000000e+0	7.863377e+1	1.271718e-2	1	1.271718e-2	1.000000e+0	29	1.579039e-2	1.000000e+0	1.000000e+0	6.308042e+1	1.585278e-2	1	143	5.000000e-1	6.993007e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001601	abnormal myelopoiesis	19	1.302171e-2	1.000000e+0	1.000000e+0	7.679483e+1	1.302171e-2	1	1.302171e-2	1.000000e+0	26	1.347939e-2	1.000000e+0	1.000000e+0	7.393852e+1	1.352475e-2	1	122	5.000000e-1	8.196721e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0006380	abnormal spermatid morphology	20	1.335759e-2	1.000000e+0	1.000000e+0	7.486378e+1	1.335759e-2	1	1.335759e-2	1.000000e+0	24	1.325916e-2	1.000000e+0	1.000000e+0	7.517083e+1	1.330303e-2	1	120	5.000000e-1	8.333333e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0005159	azoospermia	21	1.395800e-2	1.000000e+0	1.000000e+0	7.164348e+1	1.395800e-2	1	1.395800e-2	1.000000e+0	34	1.853804e-2	1.000000e+0	1.000000e+0	5.369345e+1	1.862424e-2	1	168	5.000000e-1	5.952381e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001930	abnormal meiosis	22	1.460860e-2	1.000000e+0	1.000000e+0	6.845283e+1	1.460860e-2	1	1.460860e-2	1.000000e+0	34	1.853804e-2	1.000000e+0	1.000000e+0	5.369345e+1	1.862424e-2	1	168	5.000000e-1	5.952381e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001155	arrest of spermatogenesis	23	1.568035e-2	1.000000e+0	1.000000e+0	6.377410e+1	1.568035e-2	1	1.568035e-2	1.000000e+0	40	1.941648e-2	1.000000e+0	1.000000e+0	5.125284e+1	1.951111e-2	1	176	5.000000e-1	5.681818e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001117	absent gametes	24	1.602344e-2	1.000000e+0	1.000000e+0	6.240858e+1	1.602344e-2	1	1.602344e-2	1.000000e+0	41	1.963603e-2	1.000000e+0	1.000000e+0	5.067697e+1	1.973283e-2	1	178	5.000000e-1	5.617978e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0004393	abnormal cochlear inner hair cell morphology	25	1.602619e-2	1.000000e+0	1.000000e+0	6.239787e+1	1.602619e-2	1	1.602619e-2	1.000000e+0	22	1.204742e-2	1.000000e+0	1.000000e+0	8.275688e+1	1.208359e-2	1	109	5.000000e-1	9.174312e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0005312	pericardial effusion	26	1.746024e-2	1.000000e+0	1.000000e+0	5.727297e+1	1.746024e-2	1	1.746024e-2	1.000000e+0	28	1.469025e-2	1.000000e+0	1.000000e+0	6.782331e+1	1.474419e-2	1	133	5.000000e-1	7.518797e-3	unnamed	F5
Mouse Phenotype	MP:0002891	increased insulin sensitivity	27	1.830530e-2	1.000000e+0	1.000000e+0	5.462899e+1	1.830530e-2	1	1.830530e-2	1.000000e+0	30	1.623027e-2	1.000000e+0	1.000000e+0	6.136395e+1	1.629621e-2	1	147	5.000000e-1	6.802721e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0004806	absent germ cells	28	1.845597e-2	1.000000e+0	1.000000e+0	5.418301e+1	1.845597e-2	1	1.845597e-2	1.000000e+0	44	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0011898	abnormal platelet cell number	29	1.861338e-2	1.000000e+0	1.000000e+0	5.372479e+1	1.861338e-2	1	1.861338e-2	1.000000e+0	46	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0004399	abnormal cochlear outer hair cell morphology	30	1.966933e-2	1.000000e+0	1.000000e+0	5.084058e+1	1.966933e-2	1	1.966933e-2	1.000000e+0	27	1.458020e-2	1.000000e+0	1.000000e+0	6.833712e+1	1.463334e-2	1	132	5.000000e-1	7.575758e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002875	decreased erythrocyte cell number	31	2.021847e-2	1.000000e+0	1.000000e+0	4.945973e+1	2.021847e-2	1	2.021847e-2	1.000000e+0	45	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0003717	pallor	32	2.196281e-2	1.000000e+0	1.000000e+0	4.553151e+1	2.196281e-2	1	2.196281e-2	1.000000e+0	42	1.974579e-2	1.000000e+0	1.000000e+0	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	F5
Mouse Phenotype	MP:0004720	abnormal platelet morphology	33	2.260848e-2	1.000000e+0	1.000000e+0	4.423119e+1	2.260848e-2	1	2.260848e-2	1.000000e+0	56	2.566396e-2	1.000000e+0	1.000000e+0	3.871459e+1	2.583005e-2	1	233	5.000000e-1	4.291845e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0000228	abnormal thrombopoiesis	34	2.281943e-2	1.000000e+0	1.000000e+0	4.382231e+1	2.281943e-2	1	2.281943e-2	1.000000e+0	59	2.610163e-2	1.000000e+0	1.000000e+0	3.806118e+1	2.627349e-2	1	237	5.000000e-1	4.219409e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0011967	increased or absent threshold for auditory brainstem response	35	2.315799e-2	1.000000e+0	1.000000e+0	4.318163e+1	2.315799e-2	1	2.315799e-2	1.000000e+0	32	1.765921e-2	1.000000e+0	1.000000e+0	5.637812e+1	1.773738e-2	1	160	5.000000e-1	6.250000e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0006325	impaired hearing	36	2.398207e-2	1.000000e+0	1.000000e+0	4.169782e+1	2.398207e-2	1	2.398207e-2	1.000000e+0	31	1.754933e-2	1.000000e+0	1.000000e+0	5.673270e+1	1.762652e-2	1	159	5.000000e-1	6.289308e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002622	abnormal cochlear hair cell morphology	37	2.482427e-2	1.000000e+0	1.000000e+0	4.028315e+1	2.482427e-2	1	2.482427e-2	1.000000e+0	33	1.776908e-2	1.000000e+0	1.000000e+0	5.602795e+1	1.784823e-2	1	161	5.000000e-1	6.211180e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002551	abnormal blood coagulation	38	2.494121e-2	1.000000e+0	1.000000e+0	4.009429e+1	2.494121e-2	1	2.494121e-2	1.000000e+0	65	2.785133e-2	1.000000e+0	1.000000e+0	3.565415e+1	2.804723e-2	1	253	5.000000e-1	3.952569e-3	unnamed	F5
Mouse Phenotype	MP:0004852	decreased testis weight	39	2.496633e-2	1.000000e+0	1.000000e+0	4.005394e+1	2.496633e-2	1	2.496633e-2	1.000000e+0	61	2.752338e-2	1.000000e+0	1.000000e+0	3.608200e+1	2.771465e-2	1	250	5.000000e-1	4.000000e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0009676	abnormal hemostasis	40	2.502326e-2	1.000000e+0	1.000000e+0	3.996282e+1	2.502326e-2	1	2.502326e-2	1.000000e+0	66	2.806993e-2	1.000000e+0	1.000000e+0	3.537451e+1	2.826894e-2	1	255	5.000000e-1	3.921569e-3	unnamed	F5
Mouse Phenotype	MP:0002417	abnormal megakaryocyte morphology	41	2.512167e-2	1.000000e+0	1.000000e+0	3.980628e+1	2.512167e-2	1	2.512167e-2	1.000000e+0	68	2.949024e-2	1.000000e+0	1.000000e+0	3.365858e+1	2.971010e-2	1	268	5.000000e-1	3.731343e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002413	abnormal megakaryocyte progenitor cell morphology	42	2.594276e-2	1.000000e+0	1.000000e+0	3.854641e+1	2.594276e-2	1	2.594276e-2	1.000000e+0	70	3.036376e-2	1.000000e+0	1.000000e+0	3.268297e+1	3.059697e-2	1	276	5.000000e-1	3.623188e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0000045	abnormal hair cell morphology	43	2.603596e-2	1.000000e+0	1.000000e+0	3.840842e+1	2.603596e-2	1	2.603596e-2	1.000000e+0	34	1.853804e-2	1.000000e+0	1.000000e+0	5.369345e+1	1.862424e-2	1	168	5.000000e-1	5.952381e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0000042	abnormal organ of Corti morphology	44	2.603731e-2	1.000000e+0	1.000000e+0	3.840643e+1	2.603731e-2	1	2.603731e-2	1.000000e+0	39	1.864787e-2	1.000000e+0	1.000000e+0	5.337574e+1	1.873510e-2	1	169	5.000000e-1	5.917160e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0003308	abnormal cochlear sensory epithelium morphology	45	2.627385e-2	1.000000e+0	1.000000e+0	3.806065e+1	2.627385e-2	1	2.627385e-2	1.000000e+0	34	1.853804e-2	1.000000e+0	1.000000e+0	5.369345e+1	1.862424e-2	1	168	5.000000e-1	5.952381e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001586	abnormal erythrocyte cell number	46	2.631922e-2	1.000000e+0	1.000000e+0	3.799505e+1	2.631922e-2	1	2.631922e-2	1.000000e+0	60	2.686732e-2	1.000000e+0	1.000000e+0	3.696926e+1	2.704950e-2	1	244	5.000000e-1	4.098361e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002727	decreased circulating insulin level	47	2.672040e-2	1.000000e+0	1.000000e+0	3.742458e+1	2.672040e-2	1	2.672040e-2	1.000000e+0	51	2.358369e-2	1.000000e+0	1.000000e+0	4.215187e+1	2.372374e-2	1	214	5.000000e-1	4.672897e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0004850	abnormal testis weight	48	2.756270e-2	1.000000e+0	1.000000e+0	3.628092e+1	2.756270e-2	1	2.756270e-2	1.000000e+0	69	2.959946e-2	1.000000e+0	1.000000e+0	3.353346e+1	2.982096e-2	1	269	5.000000e-1	3.717472e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0003169	abnormal scala media morphology	49	2.994348e-2	1.000000e+0	1.000000e+0	3.339625e+1	2.994348e-2	1	2.994348e-2	1.000000e+0	46	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0004738	abnormal auditory brainstem response	50	3.000432e-2	1.000000e+0	1.000000e+0	3.332853e+1	3.000432e-2	1	3.000432e-2	1.000000e+0	46	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0000972	abnormal mechanoreceptor morphology	51	3.044264e-2	1.000000e+0	1.000000e+0	3.284866e+1	3.044264e-2	1	3.044264e-2	1.000000e+0	43	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0005293	impaired glucose tolerance	52	3.073714e-2	1.000000e+0	1.000000e+0	3.253393e+1	3.073714e-2	1	3.073714e-2	1.000000e+0	56	2.566396e-2	1.000000e+0	1.000000e+0	3.871459e+1	2.583005e-2	1	233	5.000000e-1	4.291845e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0008770	decreased survivor rate	53	3.107263e-2	1.000000e+0	1.000000e+0	3.218266e+1	3.107263e-2	1	3.107263e-2	1.000000e+0	51	2.358369e-2	1.000000e+0	1.000000e+0	4.215187e+1	2.372374e-2	1	214	5.000000e-1	4.672897e-3	unnamed	F5
Mouse Phenotype	MP:0001718	abnormal visceral yolk sac morphology	54	3.142786e-2	1.000000e+0	1.000000e+0	3.181891e+1	3.142786e-2	1	3.142786e-2	1.000000e+0	54	2.478833e-2	1.000000e+0	1.000000e+0	4.009111e+1	2.494318e-2	1	225	5.000000e-1	4.444444e-3	unnamed	F5
Mouse Phenotype	MP:0001688	abnormal somite development	55	3.306948e-2	1.000000e+0	1.000000e+0	3.023936e+1	3.306948e-2	1	3.306948e-2	1.000000e+0	58	2.577339e-2	1.000000e+0	1.000000e+0	3.854915e+1	2.594091e-2	1	234	5.000000e-1	4.273504e-3	unnamed	F5
Mouse Phenotype	MP:0000031	abnormal cochlea morphology	56	3.341625e-2	1.000000e+0	1.000000e+0	2.992556e+1	3.341625e-2	1	3.341625e-2	1.000000e+0	50	2.336458e-2	1.000000e+0	1.000000e+0	4.254953e+1	2.350202e-2	1	212	5.000000e-1	4.716981e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0006335	abnormal hearing electrophysiology	57	3.344369e-2	1.000000e+0	1.000000e+0	2.990100e+1	3.344369e-2	1	3.344369e-2	1.000000e+0	49	2.325502e-2	1.000000e+0	1.000000e+0	4.275118e+1	2.339116e-2	1	211	5.000000e-1	4.739336e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002673	abnormal sperm number	58	3.444445e-2	1.000000e+0	1.000000e+0	2.903225e+1	3.444445e-2	1	3.444445e-2	1.000000e+0	80	3.929468e-2	1.000000e+0	1.000000e+0	2.519693e+1	3.968738e-2	1	358	5.000000e-1	2.793296e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0010831	partial lethality	59	3.509983e-2	1.000000e+0	1.000000e+0	2.849017e+1	3.509983e-2	1	3.509983e-2	1.000000e+0	63	2.763270e-2	1.000000e+0	1.000000e+0	3.593825e+1	2.782551e-2	1	251	5.000000e-1	3.984064e-3	unnamed	F5
Mouse Phenotype	MP:0000035	abnormal membranous labyrinth morphology	60	3.561089e-2	1.000000e+0	1.000000e+0	2.808130e+1	3.561089e-2	1	3.561089e-2	1.000000e+0	55	2.522619e-2	1.000000e+0	1.000000e+0	3.939083e+1	2.538662e-2	1	229	5.000000e-1	4.366812e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001634	internal hemorrhage	61	3.621827e-2	1.000000e+0	1.000000e+0	2.761037e+1	3.621827e-2	1	3.621827e-2	1.000000e+0	74	3.363597e-2	1.000000e+0	1.000000e+0	2.947876e+1	3.392273e-2	1	306	5.000000e-1	3.267974e-3	unnamed	F5
Mouse Phenotype	MP:0001393	ataxia	62	3.690969e-2	1.000000e+0	1.000000e+0	2.709315e+1	3.690969e-2	1	3.690969e-2	1.000000e+0	71	3.156421e-2	1.000000e+0	1.000000e+0	3.143031e+1	3.181642e-2	1	287	5.000000e-1	3.484321e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0004901	decreased male germ cell number	63	3.727557e-2	1.000000e+0	1.000000e+0	2.682722e+1	3.727557e-2	1	3.727557e-2	1.000000e+0	83	4.092392e-2	1.000000e+0	1.000000e+0	2.418365e+1	4.135026e-2	1	373	5.000000e-1	2.680965e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0009763	increased sensitivity to induced morbidity/mortality	64	3.731243e-2	1.000000e+0	1.000000e+0	2.680072e+1	3.731243e-2	1	3.731243e-2	1.000000e+0	84	4.114105e-2	1.000000e+0	1.000000e+0	2.405467e+1	4.157197e-2	1	375	5.000000e-1	2.666667e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0000026	abnormal inner ear morphology	65	3.941211e-2	1.000000e+0	1.000000e+0	2.537291e+1	3.941211e-2	1	3.941211e-2	1.000000e+0	64	2.774202e-2	1.000000e+0	1.000000e+0	3.579563e+1	2.793637e-2	1	252	5.000000e-1	3.968254e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0003224	neuron degeneration	66	4.054575e-2	1.000000e+0	1.000000e+0	2.466350e+1	4.054575e-2	1	4.054575e-2	1.000000e+0	76	3.472547e-2	1.000000e+0	1.000000e+0	2.854589e+1	3.503132e-2	1	316	5.000000e-1	3.164557e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0000288	abnormal pericardium morphology	67	4.076490e-2	1.000000e+0	1.000000e+0	2.453091e+1	4.076490e-2	1	4.076490e-2	1.000000e+0	72	3.200056e-2	1.000000e+0	1.000000e+0	3.099828e+1	3.225985e-2	1	291	5.000000e-1	3.436426e-3	unnamed	F5
Mouse Phenotype	MP:0011108	partial embryonic lethality during organogenesis	68	4.094382e-2	1.000000e+0	1.000000e+0	2.442371e+1	4.094382e-2	1	4.094382e-2	1.000000e+0	73	3.298197e-2	1.000000e+0	1.000000e+0	3.006833e+1	3.325758e-2	1	300	5.000000e-1	3.333333e-3	unnamed	F5
Mouse Phenotype	MP:0001963	abnormal hearing physiology	69	4.097916e-2	1.000000e+0	1.000000e+0	2.440264e+1	4.097916e-2	1	4.097916e-2	1.000000e+0	67	2.905334e-2	1.000000e+0	1.000000e+0	3.416856e+1	2.926667e-2	1	264	5.000000e-1	3.787879e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001124	abnormal gametes	70	4.207952e-2	1.000000e+0	1.000000e+0	2.376453e+1	4.207952e-2	1	4.207952e-2	1.000000e+0	89	4.666947e-2	1.000000e+0	1.000000e+0	2.117488e+1	4.722576e-2	1	426	5.000000e-1	2.347418e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0011092	complete embryonic lethality	71	4.260939e-2	1.000000e+0	1.000000e+0	2.346900e+1	4.260939e-2	1	4.260939e-2	1.000000e+0	79	3.842519e-2	1.000000e+0	1.000000e+0	2.577286e+1	3.880051e-2	1	350	5.000000e-1	2.857143e-3	unnamed	F5
Mouse Phenotype	MP:0001560	abnormal circulating insulin level	72	4.326502e-2	1.000000e+0	1.000000e+0	2.311336e+1	4.326502e-2	1	4.326502e-2	1.000000e+0	81	3.940334e-2	1.000000e+0	1.000000e+0	2.512674e+1	3.979824e-2	1	359	5.000000e-1	2.785515e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001147	small testis	73	4.463578e-2	1.000000e+0	1.000000e+0	2.240355e+1	4.463578e-2	1	4.463578e-2	1.000000e+0	91	4.807612e-2	1.000000e+0	1.000000e+0	2.054784e+1	4.866693e-2	1	439	5.000000e-1	2.277904e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002209	decreased germ cell number	74	4.466922e-2	1.000000e+0	1.000000e+0	2.238678e+1	4.466922e-2	1	4.466922e-2	1.000000e+0	88	4.623645e-2	1.000000e+0	1.000000e+0	2.137559e+1	4.678233e-2	1	422	5.000000e-1	2.369668e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0005291	abnormal glucose tolerance	75	4.475825e-2	1.000000e+0	1.000000e+0	2.234225e+1	4.475825e-2	1	4.475825e-2	1.000000e+0	82	3.951200e-2	1.000000e+0	1.000000e+0	2.505694e+1	3.990910e-2	1	360	5.000000e-1	2.777778e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0003878	abnormal ear physiology	76	4.589014e-2	1.000000e+0	1.000000e+0	2.179117e+1	4.589014e-2	1	4.589014e-2	1.000000e+0	75	3.374495e-2	1.000000e+0	1.000000e+0	2.938274e+1	3.403359e-2	1	307	5.000000e-1	3.257329e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0006362	abnormal male germ cell morphology	77	4.700263e-2	1.000000e+0	1.000000e+0	2.127540e+1	4.700263e-2	1	4.700263e-2	1.000000e+0	94	5.272149e-2	1.000000e+0	1.000000e+0	1.871473e+1	5.343385e-2	1	482	5.000000e-1	2.074689e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0009931	abnormal skin appearance	78	4.725782e-2	1.000000e+0	1.000000e+0	2.116052e+1	4.725782e-2	1	4.725782e-2	1.000000e+0	90	4.721062e-2	1.000000e+0	1.000000e+0	2.092923e+1	4.778006e-2	1	431	5.000000e-1	2.320186e-3	unnamed	F5
Mouse Phenotype	MP:0004849	abnormal testis size	79	4.871329e-2	1.000000e+0	1.000000e+0	2.052828e+1	4.871329e-2	1	4.871329e-2	1.000000e+0	93	5.185810e-2	1.000000e+0	1.000000e+0	1.903059e+1	5.254698e-2	1	474	5.000000e-1	2.109705e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0011088	partial neonatal lethality	80	4.935548e-2	1.000000e+0	1.000000e+0	2.026118e+1	4.935548e-2	1	4.935548e-2	1.000000e+0	78	3.766407e-2	1.000000e+0	1.000000e+0	2.629883e+1	3.802450e-2	1	343	5.000000e-1	2.915452e-3	unnamed	F5
Mouse Phenotype	MP:0001116	small gonad	81	4.956812e-2	1.000000e+0	1.000000e+0	2.017426e+1	4.956812e-2	1	4.956812e-2	1.000000e+0	94	5.272149e-2	1.000000e+0	1.000000e+0	1.871473e+1	5.343385e-2	1	482	5.000000e-1	2.074689e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002229	neurodegeneration	82	4.985683e-2	1.000000e+0	1.000000e+0	2.005743e+1	4.985683e-2	1	4.985683e-2	1.000000e+0	85	4.309408e-2	1.000000e+0	1.000000e+0	2.295293e+1	4.356743e-2	1	393	5.000000e-1	2.544529e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001657	abnormal induced morbidity/mortality	83	5.088453e-2	1.000000e+0	1.000000e+0	1.965234e+1	5.088453e-2	1	5.088453e-2	1.000000e+0	104	6.036688e-2	1.000000e+0	1.000000e+0	1.631193e+1	6.130481e-2	1	553	5.000000e-1	1.808318e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001925	male infertility	84	5.253588e-2	1.000000e+0	1.000000e+0	1.903461e+1	5.253588e-2	1	5.253588e-2	1.000000e+0	97	5.520156e-2	1.000000e+0	1.000000e+0	1.786238e+1	5.598359e-2	1	505	5.000000e-1	1.980198e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002211	abnormal primary sex determination	85	5.292252e-2	1.000000e+0	1.000000e+0	1.889555e+1	5.292252e-2	1	5.292252e-2	1.000000e+0	96	5.433930e-2	1.000000e+0	1.000000e+0	1.814990e+1	5.509672e-2	1	497	5.000000e-1	2.012072e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001156	abnormal spermatogenesis	86	5.407573e-2	1.000000e+0	1.000000e+0	1.849258e+1	5.407573e-2	1	5.407573e-2	1.000000e+0	102	5.972199e-2	1.000000e+0	1.000000e+0	1.649086e+1	6.063965e-2	1	547	5.000000e-1	1.828154e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002208	abnormal germ cell morphology	87	5.558182e-2	1.000000e+0	1.000000e+0	1.799149e+1	5.558182e-2	1	5.558182e-2	1.000000e+0	103	6.004447e-2	1.000000e+0	1.000000e+0	1.640091e+1	6.097223e-2	1	550	5.000000e-1	1.818182e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002210	abnormal sex determination	88	5.670465e-2	1.000000e+0	1.000000e+0	1.763524e+1	5.670465e-2	1	5.670465e-2	1.000000e+0	101	5.832397e-2	1.000000e+0	1.000000e+0	1.689232e+1	5.919849e-2	1	534	5.000000e-1	1.872659e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002447	abnormal erythrocyte morphology	89	5.809647e-2	1.000000e+0	1.000000e+0	1.721275e+1	5.809647e-2	1	5.809647e-2	1.000000e+0	109	6.380257e-2	1.000000e+0	1.000000e+0	1.541966e+1	6.485228e-2	1	585	5.000000e-1	1.709402e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001146	abnormal testis morphology	90	6.130724e-2	1.000000e+0	1.000000e+0	1.631129e+1	6.130724e-2	1	6.130724e-2	1.000000e+0	108	6.272959e-2	1.000000e+0	1.000000e+0	1.568783e+1	6.374369e-2	1	575	5.000000e-1	1.739130e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002102	abnormal ear morphology	91	6.230597e-2	1.000000e+0	1.000000e+0	1.604983e+1	6.230597e-2	1	6.230597e-2	1.000000e+0	87	4.406985e-2	1.000000e+0	1.000000e+0	2.243905e+1	4.456516e-2	1	402	5.000000e-1	2.487562e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0000245	abnormal erythropoiesis	92	6.477947e-2	1.000000e+0	1.000000e+0	1.543699e+1	6.477947e-2	1	6.477947e-2	1.000000e+0	112	6.926518e-2	1.000000e+0	1.000000e+0	1.418318e+1	7.050607e-2	1	636	5.000000e-1	1.572327e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001914	hemorrhage	93	6.601256e-2	1.000000e+0	1.000000e+0	1.514863e+1	6.601256e-2	1	6.601256e-2	1.000000e+0	100	5.789360e-2	1.000000e+0	1.000000e+0	1.701981e+1	5.875506e-2	1	530	5.000000e-1	1.886792e-3	unnamed	F5
Mouse Phenotype	MP:0001929	abnormal gametogenesis	94	6.671849e-2	1.000000e+0	1.000000e+0	1.498835e+1	6.671849e-2	1	6.671849e-2	1.000000e+0	117	7.236424e-2	1.000000e+0	1.000000e+0	1.356466e+1	7.372097e-2	1	665	5.000000e-1	1.503759e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001698	decreased embryo size	95	6.752872e-2	1.000000e+0	1.000000e+0	1.480851e+1	6.752872e-2	1	6.752872e-2	1.000000e+0	105	6.133380e-2	1.000000e+0	1.000000e+0	1.605071e+1	6.230253e-2	1	562	5.000000e-1	1.779359e-3	unnamed	F5
Mouse Phenotype	MP:0001697	abnormal embryo size	96	6.914308e-2	1.000000e+0	1.000000e+0	1.446276e+1	6.914308e-2	1	6.914308e-2	1.000000e+0	107	6.230023e-2	1.000000e+0	1.000000e+0	1.579772e+1	6.330026e-2	1	571	5.000000e-1	1.751313e-3	unnamed	F5
Mouse Phenotype	MP:0009205	abnormal internal male genitalia morphology	97	7.063478e-2	1.000000e+0	1.000000e+0	1.415733e+1	7.063478e-2	1	7.063478e-2	1.000000e+0	114	7.076192e-2	1.000000e+0	1.000000e+0	1.387769e+1	7.205809e-2	1	650	5.000000e-1	1.538462e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0009198	abnormal male genitalia morphology	98	7.377140e-2	1.000000e+0	1.000000e+0	1.355539e+1	7.377140e-2	1	7.377140e-2	1.000000e+0	118	7.247101e-2	1.000000e+0	1.000000e+0	1.354429e+1	7.383183e-2	1	666	5.000000e-1	1.501502e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0003312	abnormal locomotor coordination	99	7.384015e-2	1.000000e+0	1.000000e+0	1.354277e+1	7.384015e-2	1	7.384015e-2	1.000000e+0	106	6.154861e-2	1.000000e+0	1.000000e+0	1.599379e+1	6.252425e-2	1	564	5.000000e-1	1.773050e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0000965	abnormal sensory neuron morphology	100	7.398278e-2	1.000000e+0	1.000000e+0	1.351666e+1	7.398278e-2	1	7.398278e-2	1.000000e+0	98	5.574028e-2	1.000000e+0	1.000000e+0	1.768725e+1	5.653789e-2	1	510	5.000000e-1	1.960784e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0005377	hearing/vestibular/ear phenotype	101	7.629812e-2	1.000000e+0	1.000000e+0	1.310648e+1	7.629812e-2	1	7.629812e-2	1.000000e+0	99	5.627884e-2	1.000000e+0	1.000000e+0	1.751553e+1	5.709218e-2	1	515	5.000000e-1	1.941748e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002086	abnormal extraembryonic tissue morphology	102	7.842157e-2	1.000000e+0	1.000000e+0	1.275159e+1	7.842157e-2	1	7.842157e-2	1.000000e+0	115	7.086879e-2	1.000000e+0	1.000000e+0	1.385637e+1	7.216895e-2	1	651	5.000000e-1	1.536098e-3	unnamed	F5
Mouse Phenotype	MP:0001924	infertility	103	7.848077e-2	1.000000e+0	1.000000e+0	1.274198e+1	7.848077e-2	1	7.848077e-2	1.000000e+0	120	7.886609e-2	1.000000e+0	1.000000e+0	1.242493e+1	8.048334e-2	1	726	5.000000e-1	1.377410e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0003698	abnormal male reproductive system physiology	104	8.181879e-2	1.000000e+0	1.000000e+0	1.222213e+1	8.181879e-2	1	8.181879e-2	1.000000e+0	125	8.396623e-2	1.000000e+0	1.000000e+0	1.165439e+1	8.580456e-2	1	774	5.000000e-1	1.291990e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0000653	abnormal sex gland morphology	105	8.328551e-2	1.000000e+0	1.000000e+0	1.200689e+1	8.328551e-2	1	8.328551e-2	1.000000e+0	123	8.088659e-2	1.000000e+0	1.000000e+0	1.210805e+1	8.258966e-2	1	745	5.000000e-1	1.342282e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0010866	abnormal prenatal body size	106	8.435389e-2	1.000000e+0	1.000000e+0	1.185482e+1	8.435389e-2	1	8.435389e-2	1.000000e+0	119	7.663033e-2	1.000000e+0	1.000000e+0	1.279504e+1	7.815531e-2	1	705	5.000000e-1	1.418440e-3	unnamed	F5
Mouse Phenotype	MP:0002060	abnormal skin morphology	107	8.538698e-2	1.000000e+0	1.000000e+0	1.171139e+1	8.538698e-2	1	8.538698e-2	1.000000e+0	126	8.428452e-2	1.000000e+0	1.000000e+0	1.160940e+1	8.613713e-2	1	777	5.000000e-1	1.287001e-3	unnamed	F5
Mouse Phenotype	MP:0000959	abnormal somatic sensory system morphology	108	8.615818e-2	1.000000e+0	1.000000e+0	1.160656e+1	8.615818e-2	1	8.615818e-2	1.000000e+0	110	6.669653e-2	1.000000e+0	1.000000e+0	1.473938e+1	6.784546e-2	1	612	5.000000e-1	1.633987e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0005418	abnormal circulating hormone level	109	8.615845e-2	1.000000e+0	1.000000e+0	1.160652e+1	8.615845e-2	1	8.615845e-2	1.000000e+0	122	8.003612e-2	1.000000e+0	1.000000e+0	1.223948e+1	8.170279e-2	1	737	5.000000e-1	1.356852e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002128	abnormal blood circulation	110	8.674022e-2	1.000000e+0	1.000000e+0	1.152868e+1	8.674022e-2	1	8.674022e-2	1.000000e+0	113	7.065505e-2	1.000000e+0	1.000000e+0	1.389908e+1	7.194723e-2	1	649	5.000000e-1	1.540832e-3	unnamed	F5
Mouse Phenotype	MP:0001784	abnormal fluid regulation	111	8.688736e-2	1.000000e+0	1.000000e+0	1.150915e+1	8.688736e-2	1	8.688736e-2	1.000000e+0	116	7.225746e-2	1.000000e+0	1.000000e+0	1.358509e+1	7.361011e-2	1	664	5.000000e-1	1.506024e-3	unnamed	F5
Mouse Phenotype	MP:0005460	abnormal leukopoiesis	112	8.694600e-2	1.000000e+0	1.000000e+0	1.150139e+1	8.694600e-2	1	8.694600e-2	1.000000e+0	130	9.306856e-2	1.000000e+0	1.000000e+0	1.048895e+1	9.533840e-2	1	860	5.000000e-1	1.162791e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002078	abnormal glucose homeostasis	113	8.818097e-2	1.000000e+0	1.000000e+0	1.134032e+1	8.818097e-2	1	8.818097e-2	1.000000e+0	124	8.141793e-2	1.000000e+0	1.000000e+0	1.202733e+1	8.314395e-2	1	750	5.000000e-1	1.333333e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0000598	abnormal liver morphology	114	9.333181e-2	1.000000e+0	1.000000e+0	1.071446e+1	9.333181e-2	1	9.333181e-2	1.000000e+0	132	9.412402e-2	1.000000e+0	1.000000e+0	1.036839e+1	9.644698e-2	1	870	5.000000e-1	1.149425e-3	unnamed	F5
Mouse Phenotype	MP:0011181	increased hematopoietic cell number	115	9.359664e-2	1.000000e+0	1.000000e+0	1.068414e+1	9.359664e-2	1	9.359664e-2	1.000000e+0	137	1.045399e-1	1.000000e+0	1.000000e+0	9.309082e+0	1.074220e-1	1	969	5.000000e-1	1.031992e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002138	abnormal hepatobiliary system morphology	116	9.450540e-2	1.000000e+0	1.000000e+0	1.058141e+1	9.450540e-2	1	9.450540e-2	1.000000e+0	134	9.549520e-2	1.000000e+0	1.000000e+0	1.021574e+1	9.788814e-2	1	883	5.000000e-1	1.132503e-3	unnamed	F5
Mouse Phenotype	MP:0011087	complete neonatal lethality	117	9.826674e-2	1.000000e+0	1.000000e+0	1.017638e+1	9.826674e-2	1	9.826674e-2	1.000000e+0	111	6.808832e-2	1.000000e+0	1.000000e+0	1.443280e+1	6.928662e-2	1	625	5.000000e-1	1.600000e-3	unnamed	F5
Mouse Phenotype	MP:0001516	abnormal motor coordination/ balance	118	9.929128e-2	1.000000e+0	1.000000e+0	1.007138e+1	9.929128e-2	1	9.929128e-2	1.000000e+0	121	7.897249e-2	1.000000e+0	1.000000e+0	1.240784e+1	8.059420e-2	1	727	5.000000e-1	1.375516e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002088	abnormal embryonic growth/weight/body size	119	9.953028e-2	1.000000e+0	1.000000e+0	1.004719e+1	9.953028e-2	1	9.953028e-2	1.000000e+0	128	8.947540e-2	1.000000e+0	1.000000e+0	1.092070e+1	9.156920e-2	1	826	5.000000e-1	1.210654e-3	unnamed	F5
Mouse Phenotype	MP:0003953	abnormal hormone level	120	1.023291e-1	1.000000e+0	1.000000e+0	9.772394e+0	1.023291e-1	1	1.023291e-1	1.000000e+0	129	9.095579e-2	1.000000e+0	1.000000e+0	1.073869e+1	9.312122e-2	1	840	5.000000e-1	1.190476e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0005370	liver/biliary system phenotype	121	1.044353e-1	1.000000e+0	1.000000e+0	9.575307e+0	1.044353e-1	1	1.044353e-1	1.000000e+0	139	1.082079e-1	1.000000e+0	1.000000e+0	8.984562e+0	1.113020e-1	1	1004	5.000000e-1	9.960159e-4	unnamed	F5
Mouse Phenotype	MP:0006207	embryonic lethality during organogenesis	122	1.055226e-1	1.000000e+0	1.000000e+0	9.476646e+0	1.055226e-1	1	1.055226e-1	1.000000e+0	133	9.486248e-2	1.000000e+0	1.000000e+0	1.028563e+1	9.722299e-2	1	877	5.000000e-1	1.140251e-3	unnamed	F5
Mouse Phenotype	MP:0002398	abnormal bone marrow cell morphology/development	123	1.085064e-1	1.000000e+0	1.000000e+0	9.216047e+0	1.085064e-1	1	1.085064e-1	1.000000e+0	142	1.211425e-1	1.000000e+0	1.000000e+0	7.996897e+0	1.250485e-1	1	1128	5.000000e-1	8.865248e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0011182	decreased hematopoietic cell number	124	1.093948e-1	1.000000e+0	1.000000e+0	9.141200e+0	1.093948e-1	1	1.093948e-1	1.000000e+0	143	1.236350e-1	1.000000e+0	1.000000e+0	7.830295e+0	1.277091e-1	1	1152	5.000000e-1	8.680556e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0002752	abnormal somatic nervous system morphology	125	1.122886e-1	1.000000e+0	1.000000e+0	8.905622e+0	1.122886e-1	1	1.122886e-1	1.000000e+0	127	8.714662e-2	1.000000e+0	1.000000e+0	1.121953e+1	8.913031e-2	1	804	5.000000e-1	1.243781e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002085	abnormal embryonic tissue morphology	126	1.131386e-1	1.000000e+0	1.000000e+0	8.838720e+0	1.131386e-1	1	1.131386e-1	1.000000e+0	131	9.391298e-2	1.000000e+0	1.000000e+0	1.039228e+1	9.622526e-2	1	868	5.000000e-1	1.152074e-3	unnamed	F5
Mouse Phenotype	MP:0002160	abnormal reproductive system morphology	127	1.137433e-1	1.000000e+0	1.000000e+0	8.791730e+0	1.137433e-1	1	1.137433e-1	1.000000e+0	140	1.128084e-1	1.000000e+0	1.000000e+0	8.607347e+0	1.161798e-1	1	1048	5.000000e-1	9.541985e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0003313	abnormal locomotor activation	128	1.143198e-1	1.000000e+0	1.000000e+0	8.747388e+0	1.143198e-1	1	1.143198e-1	1.000000e+0	136	9.675999e-2	1.000000e+0	1.000000e+0	1.007877e+1	9.921845e-2	1	895	5.000000e-1	1.117318e-3	unnamed	F5
Mouse Phenotype	MP:0004196	abnormal prenatal growth/weight/body size	129	1.174251e-1	1.000000e+0	1.000000e+0	8.516069e+0	1.174251e-1	1	1.174251e-1	1.000000e+0	138	1.056935e-1	1.000000e+0	1.000000e+0	9.204592e+0	1.086414e-1	1	980	5.000000e-1	1.020408e-3	unnamed	F5
Mouse Phenotype	MP:0002058	neonatal lethality	130	1.337691e-1	1.000000e+0	1.000000e+0	7.475567e+0	1.337691e-1	1	1.337691e-1	1.000000e+0	135	9.633849e-2	1.000000e+0	1.000000e+0	1.012402e+1	9.877501e-2	1	891	5.000000e-1	1.122334e-3	unnamed	F5
Mouse Phenotype	MP:0002161	abnormal fertility/fecundity	131	1.345122e-1	1.000000e+0	1.000000e+0	7.434268e+0	1.345122e-1	1	1.345122e-1	1.000000e+0	145	1.310914e-1	1.000000e+0	1.000000e+0	7.369690e+0	1.356909e-1	1	1224	5.000000e-1	8.169935e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0000266	abnormal heart morphology	132	1.360125e-1	1.000000e+0	1.000000e+0	7.352265e+0	1.360125e-1	1	1.360125e-1	1.000000e+0	141	1.151042e-1	1.000000e+0	1.000000e+0	8.430374e+0	1.186187e-1	1	1070	5.000000e-1	9.345794e-4	unnamed	F5
Mouse Phenotype	MP:0011180	abnormal hematopoietic cell number	133	1.429801e-1	1.000000e+0	1.000000e+0	6.993980e+0	1.429801e-1	1	1.429801e-1	1.000000e+0	151	1.595825e-1	1.000000e+0	1.000000e+0	6.005659e+0	1.665096e-1	1	1502	5.000000e-1	6.657790e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0002083	premature death	134	1.449089e-1	1.000000e+0	1.000000e+0	6.900889e+0	1.449089e-1	1	1.449089e-1	1.000000e+0	7	5.038044e-3	1.000000e+0	1.000000e+0	1.408353e+1	1.420099e-1	2	1281	1.000000e+0	1.561280e-3	unnamed	F5,SLC19A2
Mouse Phenotype	MP:0000716	abnormal immune system cell morphology	135	1.505458e-1	1.000000e+0	1.000000e+0	6.642496e+0	1.505458e-1	1	1.505458e-1	1.000000e+0	156	1.710276e-1	1.000000e+0	1.000000e+0	5.585449e+0	1.790366e-1	1	1615	5.000000e-1	6.191950e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0001392	abnormal locomotor behavior	136	1.510711e-1	1.000000e+0	1.000000e+0	6.619401e+0	1.510711e-1	1	1.510711e-1	1.000000e+0	5	4.591986e-3	1.000000e+0	1.000000e+0	1.475143e+1	1.355801e-1	2	1223	1.000000e+0	1.635323e-3	unnamed	F5,SLC19A2
Mouse Phenotype	MP:0001919	abnormal reproductive system physiology	137	1.530473e-1	1.000000e+0	1.000000e+0	6.533929e+0	1.530473e-1	1	1.530473e-1	1.000000e+0	149	1.495931e-1	1.000000e+0	1.000000e+0	6.424858e+0	1.556455e-1	1	1404	5.000000e-1	7.122507e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0002163	abnormal gland morphology	138	1.548620e-1	1.000000e+0	1.000000e+0	6.457362e+0	1.548620e-1	1	1.548620e-1	1.000000e+0	148	1.460111e-1	1.000000e+0	1.000000e+0	6.589116e+0	1.517654e-1	1	1369	5.000000e-1	7.304602e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0008762	embryonic lethality	139	1.587123e-1	1.000000e+0	1.000000e+0	6.300711e+0	1.587123e-1	1	1.587123e-1	1.000000e+0	154	1.667828e-1	1.000000e+0	1.000000e+0	5.734584e+0	1.743806e-1	1	1573	5.000000e-1	6.357279e-4	unnamed	F5
Mouse Phenotype	MP:0001544	abnormal cardiovascular system physiology	140	1.606719e-1	1.000000e+0	1.000000e+0	6.223862e+0	1.606719e-1	1	1.606719e-1	1.000000e+0	146	1.384131e-1	1.000000e+0	1.000000e+0	6.965637e+0	1.435619e-1	1	1295	5.000000e-1	7.722008e-4	unnamed	F5
Mouse Phenotype	MP:0003491	abnormal voluntary movement	141	1.639822e-1	1.000000e+0	1.000000e+0	6.098224e+0	1.639822e-1	1	1.639822e-1	1.000000e+0	9	5.268825e-3	1.000000e+0	1.000000e+0	1.377176e+1	1.452248e-1	2	1310	1.000000e+0	1.526718e-3	unnamed	F5,SLC19A2
Mouse Phenotype	MP:0005379	endocrine/exocrine gland phenotype	142	1.670185e-1	1.000000e+0	1.000000e+0	5.987362e+0	1.670185e-1	1	1.670185e-1	1.000000e+0	152	1.601922e-1	1.000000e+0	1.000000e+0	5.981764e+0	1.671748e-1	1	1508	5.000000e-1	6.631300e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0010771	integument phenotype	143	1.731215e-1	1.000000e+0	1.000000e+0	5.776291e+0	1.731215e-1	1	1.731215e-1	1.000000e+0	150	1.570398e-1	1.000000e+0	1.000000e+0	6.107312e+0	1.637382e-1	1	1477	5.000000e-1	6.770481e-4	unnamed	F5
Mouse Phenotype	MP:0001672	abnormal embryogenesis/ development	144	1.759787e-1	1.000000e+0	1.000000e+0	5.682507e+0	1.759787e-1	1	1.759787e-1	1.000000e+0	153	1.649603e-1	1.000000e+0	1.000000e+0	5.800965e+0	1.723851e-1	1	1555	5.000000e-1	6.430868e-4	unnamed	F5
Mouse Phenotype	MP:0002081	perinatal lethality	145	1.768700e-1	1.000000e+0	1.000000e+0	5.653869e+0	1.768700e-1	1	1.768700e-1	1.000000e+0	144	1.305746e-1	1.000000e+0	1.000000e+0	7.399918e+0	1.351366e-1	1	1219	5.000000e-1	8.203445e-4	unnamed	F5
Mouse Phenotype	MP:0005389	reproductive system phenotype	146	1.774158e-1	1.000000e+0	1.000000e+0	5.636476e+0	1.774158e-1	1	1.774158e-1	1.000000e+0	157	1.715322e-1	1.000000e+0	1.000000e+0	5.568210e+0	1.795909e-1	1	1620	5.000000e-1	6.172840e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0002123	abnormal hematopoiesis	147	1.777183e-1	1.000000e+0	1.000000e+0	5.626882e+0	1.777183e-1	1	1.777183e-1	1.000000e+0	160	2.055841e-1	1.000000e+0	1.000000e+0	4.599949e+0	2.173937e-1	1	1961	5.000000e-1	5.099439e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0002429	abnormal blood cell morphology/development	148	1.793335e-1	1.000000e+0	1.000000e+0	5.576203e+0	1.793335e-1	1	1.793335e-1	1.000000e+0	161	2.074604e-1	1.000000e+0	1.000000e+0	4.555808e+0	2.195000e-1	1	1980	5.000000e-1	5.050505e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0000685	abnormal immune system morphology	149	1.819041e-1	1.000000e+0	1.000000e+0	5.497404e+0	1.819041e-1	1	1.819041e-1	1.000000e+0	159	2.020229e-1	1.000000e+0	1.000000e+0	4.685974e+0	2.134028e-1	1	1925	5.000000e-1	5.194805e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0002882	abnormal neuron morphology	150	1.824896e-1	1.000000e+0	1.000000e+0	5.479764e+0	1.824896e-1	1	1.824896e-1	1.000000e+0	147	1.439609e-1	1.000000e+0	1.000000e+0	6.686805e+0	1.495483e-1	1	1349	5.000000e-1	7.412898e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0002127	abnormal cardiovascular system morphology	151	1.879460e-1	1.000000e+0	1.000000e+0	5.320677e+0	1.879460e-1	1	1.879460e-1	1.000000e+0	155	1.683001e-1	1.000000e+0	1.000000e+0	5.680416e+0	1.760435e-1	1	1588	5.000000e-1	6.297229e-4	unnamed	F5
Mouse Phenotype	MP:0002396	abnormal hematopoietic system morphology/development	152	2.022701e-1	1.000000e+0	1.000000e+0	4.943885e+0	2.022701e-1	1	2.022701e-1	1.000000e+0	165	2.274661e-1	1.000000e+0	1.000000e+0	4.130266e+0	2.421152e-1	1	2184	5.000000e-1	4.578755e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0005397	hematopoietic system phenotype	153	2.068614e-1	1.000000e+0	1.000000e+0	4.834154e+0	2.068614e-1	1	2.068614e-1	1.000000e+0	166	2.333986e-1	1.000000e+0	1.000000e+0	4.018040e+0	2.488776e-1	1	2245	5.000000e-1	4.454343e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0009642	abnormal blood homeostasis	154	2.077260e-1	1.000000e+0	1.000000e+0	4.814034e+0	2.077260e-1	1	2.077260e-1	1.000000e+0	25	1.344060e-2	1.000000e+0	1.000000e+0	8.623805e+0	2.319162e-1	2	2092	1.000000e+0	9.560229e-4	unnamed	F5,SLC19A2
Mouse Phenotype	MP:0002080	prenatal lethality	155	2.134127e-1	1.000000e+0	1.000000e+0	4.685758e+0	2.134127e-1	1	2.134127e-1	1.000000e+0	163	2.134693e-1	1.000000e+0	1.000000e+0	4.419647e+0	2.262624e-1	1	2041	5.000000e-1	4.899559e-4	unnamed	F5
Mouse Phenotype	MP:0002066	abnormal motor capabilities/coordination/movement	156	2.177788e-1	1.000000e+0	1.000000e+0	4.591816e+0	2.177788e-1	1	2.177788e-1	1.000000e+0	18	9.544673e-3	1.000000e+0	1.000000e+0	1.023313e+1	1.954437e-1	2	1763	1.000000e+0	1.134430e-3	unnamed	F5,SLC19A2
Mouse Phenotype	MP:0003633	abnormal nervous system physiology	157	2.225344e-1	1.000000e+0	1.000000e+0	4.493687e+0	2.225344e-1	1	2.225344e-1	1.000000e+0	17	9.095198e-3	1.000000e+0	1.000000e+0	1.048286e+1	1.907877e-1	2	1721	1.000000e+0	1.162115e-3	unnamed	F5,SLC19A2
Mouse Phenotype	MP:0005385	cardiovascular system phenotype	158	2.326762e-1	1.000000e+0	1.000000e+0	4.297818e+0	2.326762e-1	1	2.326762e-1	1.000000e+0	162	2.103199e-1	1.000000e+0	1.000000e+0	4.490045e+0	2.227149e-1	1	2009	5.000000e-1	4.977601e-4	unnamed	F5
Mouse Phenotype	MP:0005387	immune system phenotype	159	2.446842e-1	1.000000e+0	1.000000e+0	4.086901e+0	2.446842e-1	1	2.446842e-1	1.000000e+0	168	2.754183e-1	1.000000e+0	1.000000e+0	3.360842e+0	2.975445e-1	1	2684	5.000000e-1	3.725782e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0010832	lethality during fetal growth through weaning	160	2.758093e-1	1.000000e+0	1.000000e+0	3.625694e+0	2.758093e-1	1	2.758093e-1	1.000000e+0	164	2.188676e-1	1.000000e+0	1.000000e+0	4.303674e+0	2.323596e-1	1	2096	5.000000e-1	4.770992e-4	unnamed	F5
Mouse Phenotype	MP:0003632	abnormal nervous system morphology	161	2.827167e-1	1.000000e+0	1.000000e+0	3.537110e+0	2.827167e-1	1	2.827167e-1	1.000000e+0	167	2.350478e-1	1.000000e+0	1.000000e+0	3.987843e+0	2.507622e-1	1	2262	5.000000e-1	4.420866e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0004924	abnormal behavior	162	2.945352e-1	1.000000e+0	1.000000e+0	3.395180e+0	2.945352e-1	1	2.945352e-1	1.000000e+0	38	1.861669e-2	1.000000e+0	1.000000e+0	7.327782e+0	2.729339e-1	2	2462	1.000000e+0	8.123477e-4	unnamed	F5,SLC19A2
Mouse Phenotype	MP:0001764	abnormal homeostasis	163	2.990593e-1	1.000000e+0	1.000000e+0	3.343818e+0	2.990593e-1	1	2.990593e-1	1.000000e+0	62	2.755190e-2	1.000000e+0	1.000000e+0	6.023706e+0	3.320215e-1	2	2995	1.000000e+0	6.677796e-4	unnamed	F5,SLC19A2
Mouse Phenotype	MP:0005376	homeostasis/metabolism phenotype	164	3.389663e-1	1.000000e+0	1.000000e+0	2.950146e+0	3.389663e-1	1	3.389663e-1	1.000000e+0	77	3.677304e-2	1.000000e+0	1.000000e+0	5.214162e+0	3.835708e-1	2	3460	1.000000e+0	5.780347e-4	unnamed	F5,SLC19A2
Mouse Phenotype	MP:0003631	nervous system phenotype	165	3.410385e-1	1.000000e+0	1.000000e+0	2.932220e+0	3.410385e-1	1	3.410385e-1	1.000000e+0	53	2.373757e-2	1.000000e+0	1.000000e+0	6.489568e+0	3.081869e-1	2	2780	1.000000e+0	7.194245e-4	unnamed	F5,SLC19A2
Mouse Phenotype	MP:0005378	growth/size phenotype	166	3.447235e-1	1.000000e+0	1.000000e+0	2.900875e+0	3.447235e-1	1	3.447235e-1	1.000000e+0	169	3.172618e-1	1.000000e+0	1.000000e+0	2.878271e+0	3.474309e-1	1	3134	5.000000e-1	3.190810e-4	unnamed	F5
Mouse Phenotype	MP:0010770	preweaning lethality	167	3.585301e-1	1.000000e+0	1.000000e+0	2.789166e+0	3.585301e-1	1	3.585301e-1	1.000000e+0	170	3.286641e-1	1.000000e+0	1.000000e+0	2.767874e+0	3.612882e-1	1	3259	5.000000e-1	3.068426e-4	unnamed	F5
Mouse Phenotype	MP:0010769	abnormal survival	168	3.982821e-1	1.000000e+0	1.000000e+0	2.510783e+0	3.982821e-1	1	3.982821e-1	1.000000e+0	86	4.382095e-2	1.000000e+0	1.000000e+0	4.776542e+0	4.187129e-1	2	3777	1.000000e+0	5.295208e-4	unnamed	F5,SLC19A2
Mouse Phenotype	MP:0010768	mortality/aging	169	4.155501e-1	1.000000e+0	1.000000e+0	2.406449e+0	4.155501e-1	1	4.155501e-1	1.000000e+0	92	5.028602e-2	1.000000e+0	1.000000e+0	4.458972e+0	4.485339e-1	2	4046	1.000000e+0	4.943154e-4	unnamed	F5,SLC19A2
Mouse Phenotype	MP:0000001	mammalian phenotype	170	6.422596e-1	1.000000e+0	1.000000e+0	1.557003e+0	6.422596e-1	1	6.422596e-1	1.000000e+0	158	1.739173e-1	1.000000e+0	1.000000e+0	2.397794e+0	8.341001e-1	2	7524	1.000000e+0	2.658161e-4	unnamed	F5,SLC19A2
Human Phenotype	HP:0004760	Congenital septal defect	1	4.190995e-5	2.575786e-1	2.575786e-1	2.386068e+4	4.190995e-5	1	4.190995e-5	1.000000e+0	2	1.108586e-4	6.813370e-1	3.406685e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	SLC19A2
Human Phenotype	HP:0004860	Thiamine-responsive megaloblastic anemia	1	4.190995e-5	2.575786e-1	2.575786e-1	2.386068e+4	4.190995e-5	1	4.190995e-5	1.000000e+0	2	1.108586e-4	6.813370e-1	3.406685e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	SLC19A2
Human Phenotype	HP:0012175	Resistance to activated protein C	3	4.826709e-5	2.966495e-1	9.888318e-2	2.071805e+4	4.826709e-5	1	4.826709e-5	1.000000e+0	2	1.108586e-4	6.813370e-1	3.406685e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	F5
Human Phenotype	HP:0003225	Reduced factor V activity	4	2.610873e-4	1.000000e+0	4.011606e-1	3.830136e+3	2.610873e-4	1	2.610873e-4	1.000000e+0	5	3.325574e-4	1.000000e+0	4.087796e-1	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	F5
Human Phenotype	HP:0001924	Sideroblastic anemia	5	2.724910e-4	1.000000e+0	3.349459e-1	3.669845e+3	2.724910e-4	1	2.724910e-4	1.000000e+0	8	6.650594e-4	1.000000e+0	5.109319e-1	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	SLC19A2
Human Phenotype	HP:0005542	Prolonged whole-blood clotting time	6	3.131089e-4	1.000000e+0	3.207279e-1	3.193777e+3	3.131089e-4	1	3.131089e-4	1.000000e+0	6	4.433975e-4	1.000000e+0	4.541868e-1	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	F5
Human Phenotype	HP:0003645	Prolonged partial thromboplastin time	7	5.157008e-4	1.000000e+0	4.527853e-1	1.939109e+3	5.157008e-4	1	5.157008e-4	1.000000e+0	14	1.219107e-3	1.000000e+0	5.351880e-1	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	F5
Human Phenotype	HP:0000548	Cone-rod dystrophy	8	5.472534e-4	1.000000e+0	4.204274e-1	1.827307e+3	5.472534e-4	1	5.472534e-4	1.000000e+0	14	1.219107e-3	1.000000e+0	5.351880e-1	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	SLC19A2
Human Phenotype	HP:0100602	Preeclampsia	9	5.540236e-4	1.000000e+0	3.783366e-1	1.804977e+3	5.540236e-4	1	5.540236e-4	1.000000e+0	6	4.433975e-4	1.000000e+0	4.541868e-1	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	F5
Human Phenotype	HP:0002625	Deep venous thrombosis	10	6.149232e-4	1.000000e+0	3.779318e-1	1.626219e+3	6.149232e-4	1	6.149232e-4	1.000000e+0	10	9.975062e-4	1.000000e+0	6.130673e-1	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	F5
Human Phenotype	HP:0000132	Menorrhagia	11	7.250279e-4	1.000000e+0	4.050929e-1	1.379257e+3	7.250279e-4	1	7.250279e-4	1.000000e+0	19	1.883760e-3	1.000000e+0	6.093468e-1	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	F5
Human Phenotype	HP:0010990	Abnormality of the common coagulation pathway	12	1.105575e-3	1.000000e+0	5.662387e-1	9.045065e+2	1.105575e-3	1	1.105575e-3	1.000000e+0	18	1.662234e-3	1.000000e+0	5.675606e-1	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	F5
Human Phenotype	HP:0100651	Type I diabetes mellitus	13	1.506192e-3	1.000000e+0	7.120812e-1	6.639259e+2	1.506192e-3	1	1.506192e-3	1.000000e+0	21	1.994515e-3	1.000000e+0	5.837281e-1	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	SLC19A2
Human Phenotype	HP:0100603	Toxemia of pregnancy	14	1.714526e-3	1.000000e+0	7.526769e-1	5.832515e+2	1.714526e-3	1	1.714526e-3	1.000000e+0	10	9.975062e-4	1.000000e+0	6.130673e-1	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	F5
Human Phenotype	HP:0003010	Prolonged bleeding time	15	2.062413e-3	1.000000e+0	8.450394e-1	4.848689e+2	2.062413e-3	1	2.062413e-3	1.000000e+0	22	2.326740e-3	1.000000e+0	6.500065e-1	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	F5
Human Phenotype	HP:0001889	Megaloblastic anemia	16	2.215031e-3	1.000000e+0	8.508488e-1	4.514609e+2	2.215031e-3	1	2.215031e-3	1.000000e+0	19	1.883760e-3	1.000000e+0	6.093468e-1	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	SLC19A2
Human Phenotype	HP:0002637	Cerebral ischemia	17	2.236316e-3	1.000000e+0	8.084940e-1	4.471641e+2	2.236316e-3	1	2.236316e-3	1.000000e+0	26	3.655089e-3	1.000000e+0	8.640068e-1	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	SLC19A2
Human Phenotype	HP:0004936	Venous thrombosis	18	2.348555e-3	1.000000e+0	8.019011e-1	4.257937e+2	2.348555e-3	1	2.348555e-3	1.000000e+0	27	3.765745e-3	1.000000e+0	8.571951e-1	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	F5
Human Phenotype	HP:0001297	Stroke	19	2.591234e-3	1.000000e+0	8.381960e-1	3.859165e+2	2.591234e-3	1	2.591234e-3	1.000000e+0	25	3.323085e-3	1.000000e+0	8.169472e-1	3.006833e+2	3.325758e-3	1	30	5.000000e-1	3.333333e-2	unnamed	SLC19A2
Human Phenotype	HP:0000421	Epistaxis	20	2.652259e-3	1.000000e+0	8.150392e-1	3.770371e+2	2.652259e-3	1	2.652259e-3	1.000000e+0	32	4.318932e-3	1.000000e+0	8.295049e-1	2.312949e+2	4.323485e-3	1	39	5.000000e-1	2.564103e-2	unnamed	F5
Human Phenotype	HP:0003256	Abnormality of the coagulation cascade	21	2.916983e-3	1.000000e+0	8.537037e-1	3.428199e+2	2.916983e-3	1	2.916983e-3	1.000000e+0	36	4.761371e-3	1.000000e+0	8.128718e-1	2.097791e+2	4.766920e-3	1	43	5.000000e-1	2.325581e-2	unnamed	F5
Human Phenotype	HP:0009145	Abnormality of cerebral artery	22	3.077277e-3	1.000000e+0	8.596793e-1	3.249627e+2	3.077277e-3	1	3.077277e-3	1.000000e+0	33	4.540164e-3	1.000000e+0	8.455711e-1	2.200122e+2	4.545203e-3	1	41	5.000000e-1	2.439024e-2	unnamed	SLC19A2
Human Phenotype	HP:0001977	Abnormal thrombosis	23	3.135726e-3	1.000000e+0	8.379205e-1	3.189054e+2	3.135726e-3	1	3.135726e-3	1.000000e+0	37	4.871965e-3	1.000000e+0	8.092729e-1	2.050114e+2	4.877778e-3	1	44	5.000000e-1	2.272727e-2	unnamed	F5
Human Phenotype	HP:0002686	Prenatal maternal abnormality	24	3.255058e-3	1.000000e+0	8.335661e-1	3.072142e+2	3.255058e-3	1	3.255058e-3	1.000000e+0	23	2.437470e-3	1.000000e+0	6.513344e-1	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	F5
Human Phenotype	HP:0001972	Macrocytic anemia	25	3.459319e-3	1.000000e+0	8.504390e-1	2.890742e+2	3.459319e-3	1	3.459319e-3	1.000000e+0	28	3.876395e-3	1.000000e+0	8.508687e-1	2.577286e+2	3.880051e-3	1	35	5.000000e-1	2.857143e-2	unnamed	SLC19A2
Human Phenotype	HP:0001696	Situs inversus totalis	26	3.849380e-3	1.000000e+0	9.099342e-1	2.597821e+2	3.849380e-3	1	3.849380e-3	1.000000e+0	39	5.977571e-3	1.000000e+0	9.420039e-1	1.670463e+2	5.986364e-3	1	54	5.000000e-1	1.851852e-2	unnamed	SLC19A2
Human Phenotype	HP:0001609	Hoarse voice	27	3.873796e-3	1.000000e+0	8.817907e-1	2.581447e+2	3.873796e-3	1	3.873796e-3	1.000000e+0	30	3.987038e-3	1.000000e+0	8.168112e-1	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	SLC19A2
Human Phenotype	HP:0011534	Abnormal spatial orientation of the cardiac segments	28	3.969625e-3	1.000000e+0	8.713327e-1	2.519130e+2	3.969625e-3	1	3.969625e-3	1.000000e+0	40	6.198618e-3	1.000000e+0	9.524177e-1	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	SLC19A2
Human Phenotype	HP:0000556	Retinal dystrophy	29	4.437371e-3	1.000000e+0	9.404166e-1	2.253587e+2	4.437371e-3	1	4.437371e-3	1.000000e+0	38	5.424845e-3	1.000000e+0	8.773973e-1	1.840918e+2	5.432071e-3	1	49	5.000000e-1	2.040816e-2	unnamed	SLC19A2
Human Phenotype	HP:0001651	Dextrocardia	30	4.497777e-3	1.000000e+0	9.214446e-1	2.223320e+2	4.497777e-3	1	4.497777e-3	1.000000e+0	43	6.530143e-3	1.000000e+0	9.333549e-1	1.528898e+2	6.540657e-3	1	59	5.000000e-1	1.694915e-2	unnamed	SLC19A2
Human Phenotype	HP:0000546	Retinal degeneration	31	4.578161e-3	1.000000e+0	9.076573e-1	2.184283e+2	4.578161e-3	1	4.578161e-3	1.000000e+0	31	4.208307e-3	1.000000e+0	8.343308e-1	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	SLC19A2
Human Phenotype	HP:0004307	Abnormal anatomic location of the heart	32	4.647322e-3	1.000000e+0	8.925763e-1	2.151777e+2	4.647322e-3	1	4.647322e-3	1.000000e+0	44	6.861613e-3	1.000000e+0	9.584426e-1	1.454919e+2	6.873233e-3	1	62	5.000000e-1	1.612903e-2	unnamed	SLC19A2
Human Phenotype	HP:0003363	Abdominal situs inversus	33	5.017624e-3	1.000000e+0	9.344945e-1	1.992975e+2	5.017624e-3	1	5.017624e-3	1.000000e+0	45	6.972090e-3	1.000000e+0	9.522326e-1	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	SLC19A2
Human Phenotype	HP:0010972	Anemia of inadequate production	34	5.774497e-3	1.000000e+0	1.000000e+0	1.731752e+2	5.774497e-3	1	5.774497e-3	1.000000e+0	48	8.297342e-3	1.000000e+0	1.000000e+0	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	SLC19A2
Human Phenotype	HP:0100545	Arterial stenosis	35	5.845884e-3	1.000000e+0	1.000000e+0	1.710605e+2	5.845884e-3	1	5.845884e-3	1.000000e+0	50	8.738896e-3	1.000000e+0	1.000000e+0	1.141835e+2	8.757829e-3	1	79	5.000000e-1	1.265823e-2	unnamed	SLC19A2
Human Phenotype	HP:0001645	Sudden cardiac death	36	6.099072e-3	1.000000e+0	1.000000e+0	1.639594e+2	6.099072e-3	1	6.099072e-3	1.000000e+0	41	6.309133e-3	1.000000e+0	9.457544e-1	1.582544e+2	6.318940e-3	1	57	5.000000e-1	1.754386e-2	unnamed	SLC19A2
Human Phenotype	HP:0001695	Cardiac arrest	37	6.130267e-3	1.000000e+0	1.000000e+0	1.631250e+2	6.130267e-3	1	6.130267e-3	1.000000e+0	42	6.419641e-3	1.000000e+0	9.394075e-1	1.555259e+2	6.429799e-3	1	58	5.000000e-1	1.724138e-2	unnamed	SLC19A2
Human Phenotype	HP:0000572	Visual loss	38	6.223177e-3	1.000000e+0	1.000000e+0	1.606896e+2	6.223177e-3	1	6.223177e-3	1.000000e+0	46	7.745261e-3	1.000000e+0	1.000000e+0	1.288643e+2	7.760102e-3	1	70	5.000000e-1	1.428571e-2	unnamed	SLC19A2
Human Phenotype	HP:0002020	Gastroesophageal reflux	39	6.299038e-3	1.000000e+0	9.926638e-1	1.587544e+2	6.299038e-3	1	6.299038e-3	1.000000e+0	33	4.540164e-3	1.000000e+0	8.455711e-1	2.200122e+2	4.545203e-3	1	41	5.000000e-1	2.439024e-2	unnamed	SLC19A2
Human Phenotype	HP:0000978	Bruising susceptibility	40	7.665722e-3	1.000000e+0	1.000000e+0	1.304509e+2	7.665722e-3	1	7.665722e-3	1.000000e+0	48	8.297342e-3	1.000000e+0	1.000000e+0	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	F5
Human Phenotype	HP:0100659	Abnormality of the cerebral vasculature	41	8.176608e-3	1.000000e+0	1.000000e+0	1.223001e+2	8.176608e-3	1	8.176608e-3	1.000000e+0	53	1.083493e-2	1.000000e+0	1.000000e+0	9.204592e+1	1.086414e-2	1	98	5.000000e-1	1.020408e-2	unnamed	SLC19A2
Human Phenotype	HP:0001928	Abnormality of coagulation	42	8.415919e-3	1.000000e+0	1.000000e+0	1.188224e+2	8.415919e-3	1	8.415919e-3	1.000000e+0	57	1.259830e-2	1.000000e+0	1.000000e+0	7.912719e+1	1.263788e-2	1	114	5.000000e-1	8.771930e-3	unnamed	F5
Human Phenotype	HP:0003355	Aminoaciduria	43	8.458357e-3	1.000000e+0	1.000000e+0	1.182263e+2	8.458357e-3	1	8.458357e-3	1.000000e+0	51	9.621709e-3	1.000000e+0	1.000000e+0	1.036839e+2	9.644698e-3	1	87	5.000000e-1	1.149425e-2	unnamed	SLC19A2
Human Phenotype	HP:0001635	Congestive heart failure	44	9.050497e-3	1.000000e+0	1.000000e+0	1.104912e+2	9.050497e-3	1	9.050497e-3	1.000000e+0	52	1.072467e-2	1.000000e+0	1.000000e+0	9.299485e+1	1.075328e-2	1	97	5.000000e-1	1.030928e-2	unnamed	SLC19A2
Human Phenotype	HP:0003581	Adult onset	45	9.734951e-3	1.000000e+0	1.000000e+0	1.027227e+2	9.734951e-3	1	9.734951e-3	1.000000e+0	54	1.094519e-2	1.000000e+0	1.000000e+0	9.111616e+1	1.097500e-2	1	99	5.000000e-1	1.010101e-2	unnamed	F5
Human Phenotype	HP:0001933	Subcutaneous hemorrhage	46	9.738658e-3	1.000000e+0	1.000000e+0	1.026836e+2	9.738658e-3	1	9.738658e-3	1.000000e+0	59	1.358950e-2	1.000000e+0	1.000000e+0	7.333740e+1	1.363561e-2	1	123	5.000000e-1	8.130081e-3	unnamed	F5
Human Phenotype	HP:0012072	Aciduria	47	1.017783e-2	1.000000e+0	1.000000e+0	9.825273e+1	1.017783e-2	1	1.017783e-2	1.000000e+0	56	1.226779e-2	1.000000e+0	1.000000e+0	8.126577e+1	1.230530e-2	1	111	5.000000e-1	9.009009e-3	unnamed	SLC19A2
Human Phenotype	HP:0004337	Abnormality of amino acid metabolism	48	1.235776e-2	1.000000e+0	1.000000e+0	8.092080e+1	1.235776e-2	1	1.235776e-2	1.000000e+0	58	1.292876e-2	1.000000e+0	1.000000e+0	7.709829e+1	1.297046e-2	1	117	5.000000e-1	8.547009e-3	unnamed	SLC19A2
Human Phenotype	HP:0001873	Thrombocytopenia	49	1.287046e-2	1.000000e+0	1.000000e+0	7.769728e+1	1.287046e-2	1	1.287046e-2	1.000000e+0	62	1.710974e-2	1.000000e+0	1.000000e+0	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	SLC19A2
Human Phenotype	HP:0011873	Abnormal platelet count	50	1.307528e-2	1.000000e+0	1.000000e+0	7.648017e+1	1.307528e-2	1	1.307528e-2	1.000000e+0	66	1.754933e-2	1.000000e+0	1.000000e+0	5.673270e+1	1.762652e-2	1	159	5.000000e-1	6.289308e-3	unnamed	SLC19A2
Human Phenotype	HP:0000140	Abnormality of the menstrual cycle	51	1.313793e-2	1.000000e+0	1.000000e+0	7.611552e+1	1.313793e-2	1	1.313793e-2	1.000000e+0	55	1.171681e-2	1.000000e+0	1.000000e+0	8.509906e+1	1.175101e-2	1	106	5.000000e-1	9.433962e-3	unnamed	F5
Human Phenotype	HP:0004354	Abnormality of carboxylic acid metabolism	52	1.349326e-2	1.000000e+0	1.000000e+0	7.411106e+1	1.349326e-2	1	1.349326e-2	1.000000e+0	60	1.535041e-2	1.000000e+0	1.000000e+0	6.489568e+1	1.540935e-2	1	139	5.000000e-1	7.194245e-3	unnamed	SLC19A2
Human Phenotype	HP:0001872	Abnormality of thrombocytes	53	1.595131e-2	1.000000e+0	1.000000e+0	6.269078e+1	1.595131e-2	1	1.595131e-2	1.000000e+0	1	1.091748e-4	6.709883e-1	6.709883e-1	9.545503e+1	2.095228e-2	2	189	1.000000e+0	1.058201e-2	unnamed	F5,SLC19A2
Human Phenotype	HP:0000819	Diabetes mellitus	54	1.619858e-2	1.000000e+0	1.000000e+0	6.173382e+1	1.619858e-2	1	1.619858e-2	1.000000e+0	69	1.974579e-2	1.000000e+0	1.000000e+0	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	SLC19A2
Human Phenotype	HP:0001892	Abnormal bleeding	55	1.685969e-2	1.000000e+0	1.000000e+0	5.931306e+1	1.685969e-2	1	1.685969e-2	1.000000e+0	75	2.270712e-2	1.000000e+0	1.000000e+0	4.378883e+1	2.283687e-2	1	206	5.000000e-1	4.854369e-3	unnamed	F5
Human Phenotype	HP:0002577	Abnormality of the stomach	56	1.809177e-2	1.000000e+0	1.000000e+0	5.527375e+1	1.809177e-2	1	1.809177e-2	1.000000e+0	67	1.776908e-2	1.000000e+0	1.000000e+0	5.602795e+1	1.784823e-2	1	161	5.000000e-1	6.211180e-3	unnamed	SLC19A2
Human Phenotype	HP:0011004	Abnormality of the systemic arterial tree	57	1.891919e-2	1.000000e+0	1.000000e+0	5.285638e+1	1.891919e-2	1	1.891919e-2	1.000000e+0	70	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	SLC19A2
Human Phenotype	HP:0011276	Vascular skin abnormality	58	1.939619e-2	1.000000e+0	1.000000e+0	5.155651e+1	1.939619e-2	1	1.939619e-2	1.000000e+0	84	2.719538e-2	1.000000e+0	1.000000e+0	3.652024e+1	2.738207e-2	1	247	5.000000e-1	4.048583e-3	unnamed	F5
Human Phenotype	HP:0007703	Abnormal retinal pigmentation	59	1.943895e-2	1.000000e+0	1.000000e+0	5.144311e+1	1.943895e-2	1	1.943895e-2	1.000000e+0	73	2.226868e-2	1.000000e+0	1.000000e+0	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	SLC19A2
Human Phenotype	HP:0001903	Anemia	60	1.958596e-2	1.000000e+0	1.000000e+0	5.105699e+1	1.958596e-2	1	1.958596e-2	1.000000e+0	86	2.839779e-2	1.000000e+0	1.000000e+0	3.496318e+1	2.860152e-2	1	258	5.000000e-1	3.875969e-3	unnamed	SLC19A2
Human Phenotype	HP:0001638	Cardiomyopathy	61	2.024024e-2	1.000000e+0	1.000000e+0	4.940652e+1	2.024024e-2	1	2.024024e-2	1.000000e+0	83	2.686732e-2	1.000000e+0	1.000000e+0	3.696926e+1	2.704950e-2	1	244	5.000000e-1	4.098361e-3	unnamed	SLC19A2
Human Phenotype	HP:0001631	Defect in the atrial septum	62	2.042369e-2	1.000000e+0	1.000000e+0	4.896274e+1	2.042369e-2	1	2.042369e-2	1.000000e+0	62	1.710974e-2	1.000000e+0	1.000000e+0	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	SLC19A2
Human Phenotype	HP:0001637	Abnormality of the myocardium	63	2.048425e-2	1.000000e+0	1.000000e+0	4.881799e+1	2.048425e-2	1	2.048425e-2	1.000000e+0	85	2.741405e-2	1.000000e+0	1.000000e+0	3.622691e+1	2.760379e-2	1	249	5.000000e-1	4.016064e-3	unnamed	SLC19A2
Human Phenotype	HP:0005120	Abnormality of cardiac atrium	64	2.064140e-2	1.000000e+0	1.000000e+0	4.844632e+1	2.064140e-2	1	2.064140e-2	1.000000e+0	65	1.732955e-2	1.000000e+0	1.000000e+0	5.745541e+1	1.740480e-2	1	157	5.000000e-1	6.369427e-3	unnamed	SLC19A2
Human Phenotype	HP:0001629	Ventricular septal defect	65	2.091358e-2	1.000000e+0	1.000000e+0	4.781582e+1	2.091358e-2	1	2.091358e-2	1.000000e+0	61	1.677999e-2	1.000000e+0	1.000000e+0	5.934539e+1	1.685051e-2	1	152	5.000000e-1	6.578947e-3	unnamed	SLC19A2
Human Phenotype	HP:0010438	Abnormality of the ventricular septum	66	2.136910e-2	1.000000e+0	1.000000e+0	4.679655e+1	2.136910e-2	1	2.136910e-2	1.000000e+0	62	1.710974e-2	1.000000e+0	1.000000e+0	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	SLC19A2
Human Phenotype	HP:0008051	Abnormality of the retinal pigment epithelium	67	2.142508e-2	1.000000e+0	1.000000e+0	4.667427e+1	2.142508e-2	1	2.142508e-2	1.000000e+0	77	2.391230e-2	1.000000e+0	1.000000e+0	4.156912e+1	2.405632e-2	1	217	5.000000e-1	4.608295e-3	unnamed	SLC19A2
Human Phenotype	HP:0001608	Abnormality of the voice	68	2.156663e-2	1.000000e+0	1.000000e+0	4.636794e+1	2.156663e-2	1	2.156663e-2	1.000000e+0	68	1.886750e-2	1.000000e+0	1.000000e+0	5.275146e+1	1.895682e-2	1	171	5.000000e-1	5.847953e-3	unnamed	SLC19A2
Human Phenotype	HP:0011675	Arrhythmia	69	2.164317e-2	1.000000e+0	1.000000e+0	4.620396e+1	2.164317e-2	1	2.164317e-2	1.000000e+0	76	2.325502e-2	1.000000e+0	1.000000e+0	4.275118e+1	2.339116e-2	1	211	5.000000e-1	4.739336e-3	unnamed	SLC19A2
Human Phenotype	HP:0008373	Puberty and gonadal disorders	70	2.230960e-2	1.000000e+0	1.000000e+0	4.482376e+1	2.230960e-2	1	2.230960e-2	1.000000e+0	72	2.204943e-2	1.000000e+0	1.000000e+0	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	F5
Human Phenotype	HP:0001877	Abnormality of erythrocytes	71	2.240890e-2	1.000000e+0	1.000000e+0	4.462513e+1	2.240890e-2	1	2.240890e-2	1.000000e+0	89	3.101865e-2	1.000000e+0	1.000000e+0	3.198759e+1	3.126213e-2	1	282	5.000000e-1	3.546099e-3	unnamed	SLC19A2
Human Phenotype	HP:0003110	Abnormality of urine homeostasis	72	2.316703e-2	1.000000e+0	1.000000e+0	4.316480e+1	2.316703e-2	1	2.316703e-2	1.000000e+0	88	3.090952e-2	1.000000e+0	1.000000e+0	3.210142e+1	3.115127e-2	1	281	5.000000e-1	3.558719e-3	unnamed	SLC19A2
Human Phenotype	HP:0011014	Abnormal glucose homeostasis	73	2.584232e-2	1.000000e+0	1.000000e+0	3.869621e+1	2.584232e-2	1	2.584232e-2	1.000000e+0	92	3.265489e-2	1.000000e+0	1.000000e+0	3.037205e+1	3.292500e-2	1	297	5.000000e-1	3.367003e-3	unnamed	SLC19A2
Human Phenotype	HP:0001251	Ataxia	74	2.648195e-2	1.000000e+0	1.000000e+0	3.776157e+1	2.648195e-2	1	2.648195e-2	1.000000e+0	91	3.210963e-2	1.000000e+0	1.000000e+0	3.089212e+1	3.237071e-2	1	292	5.000000e-1	3.424658e-3	unnamed	SLC19A2
Human Phenotype	HP:0001713	Abnormality of cardiac ventricle	75	2.770630e-2	1.000000e+0	1.000000e+0	3.609287e+1	2.770630e-2	1	2.770630e-2	1.000000e+0	74	2.248791e-2	1.000000e+0	1.000000e+0	4.421814e+1	2.261515e-2	1	204	5.000000e-1	4.901961e-3	unnamed	SLC19A2
Human Phenotype	HP:0002031	Abnormality of the esophagus	76	2.788607e-2	1.000000e+0	1.000000e+0	3.586019e+1	2.788607e-2	1	2.788607e-2	1.000000e+0	81	2.478833e-2	1.000000e+0	1.000000e+0	4.009111e+1	2.494318e-2	1	225	5.000000e-1	4.444444e-3	unnamed	SLC19A2
Human Phenotype	HP:0001600	Abnormality of the larynx	77	2.804911e-2	1.000000e+0	1.000000e+0	3.565176e+1	2.804911e-2	1	2.804911e-2	1.000000e+0	79	2.402182e-2	1.000000e+0	1.000000e+0	4.137844e+1	2.416717e-2	1	218	5.000000e-1	4.587156e-3	unnamed	SLC19A2
Human Phenotype	HP:0011013	Abnormality of carbohydrate metabolism/homeostasis	78	2.907742e-2	1.000000e+0	1.000000e+0	3.439095e+1	2.907742e-2	1	2.907742e-2	1.000000e+0	97	3.799030e-2	1.000000e+0	1.000000e+0	2.607081e+1	3.835708e-2	1	346	5.000000e-1	2.890173e-3	unnamed	SLC19A2
Human Phenotype	HP:0000648	Optic atrophy	79	2.952567e-2	1.000000e+0	1.000000e+0	3.386883e+1	2.952567e-2	1	2.952567e-2	1.000000e+0	93	3.374495e-2	1.000000e+0	1.000000e+0	2.938274e+1	3.403359e-2	1	307	5.000000e-1	3.257329e-3	unnamed	SLC19A2
Human Phenotype	HP:0001671	Abnormality of the cardiac septa	80	3.031987e-2	1.000000e+0	1.000000e+0	3.298167e+1	3.031987e-2	1	3.031987e-2	1.000000e+0	82	2.566396e-2	1.000000e+0	1.000000e+0	3.871459e+1	2.583005e-2	1	233	5.000000e-1	4.291845e-3	unnamed	SLC19A2
Human Phenotype	HP:0001197	Abnormality of prenatal development or birth	81	3.130800e-2	1.000000e+0	1.000000e+0	3.194072e+1	3.130800e-2	1	3.130800e-2	1.000000e+0	89	3.101865e-2	1.000000e+0	1.000000e+0	3.198759e+1	3.126213e-2	1	282	5.000000e-1	3.546099e-3	unnamed	F5
Human Phenotype	HP:0000587	Abnormality of the optic nerve	82	3.320424e-2	1.000000e+0	1.000000e+0	3.011663e+1	3.320424e-2	1	3.320424e-2	1.000000e+0	98	3.896867e-2	1.000000e+0	1.000000e+0	2.540986e+1	3.935480e-2	1	355	5.000000e-1	2.816901e-3	unnamed	SLC19A2
Human Phenotype	HP:0000008	Abnormality of female internal genitalia	83	3.365925e-2	1.000000e+0	1.000000e+0	2.970951e+1	3.365925e-2	1	3.365925e-2	1.000000e+0	87	2.981786e-2	1.000000e+0	1.000000e+0	3.328598e+1	3.004268e-2	1	271	5.000000e-1	3.690037e-3	unnamed	F5
Human Phenotype	HP:0002087	Abnormality of the upper respiratory tract	84	3.607184e-2	1.000000e+0	1.000000e+0	2.772246e+1	3.607184e-2	1	3.607184e-2	1.000000e+0	95	3.450762e-2	1.000000e+0	1.000000e+0	2.872771e+1	3.480960e-2	1	314	5.000000e-1	3.184713e-3	unnamed	SLC19A2
Human Phenotype	HP:0010460	Abnormality of the female genitalia	85	3.799718e-2	1.000000e+0	1.000000e+0	2.631774e+1	3.799718e-2	1	3.799718e-2	1.000000e+0	94	3.418080e-2	1.000000e+0	1.000000e+0	2.900482e+1	3.447702e-2	1	311	5.000000e-1	3.215434e-3	unnamed	F5
Human Phenotype	HP:0011277	Abnormality of the urinary system physiology	86	3.851912e-2	1.000000e+0	1.000000e+0	2.596113e+1	3.851912e-2	1	3.851912e-2	1.000000e+0	100	4.623645e-2	1.000000e+0	1.000000e+0	2.137559e+1	4.678233e-2	1	422	5.000000e-1	2.369668e-3	unnamed	SLC19A2
Human Phenotype	HP:0011443	Abnormality of coordination	87	4.159660e-2	1.000000e+0	1.000000e+0	2.404043e+1	4.159660e-2	1	4.159660e-2	1.000000e+0	99	4.482844e-2	1.000000e+0	1.000000e+0	2.205501e+1	4.534117e-2	1	409	5.000000e-1	2.444988e-3	unnamed	SLC19A2
Human Phenotype	HP:0000479	Abnormality of the retina	88	4.191016e-2	1.000000e+0	1.000000e+0	2.386056e+1	4.191016e-2	1	4.191016e-2	1.000000e+0	104	4.829244e-2	1.000000e+0	1.000000e+0	2.045465e+1	4.888864e-2	1	441	5.000000e-1	2.267574e-3	unnamed	SLC19A2
Human Phenotype	HP:0000028	Cryptorchidism	89	4.205640e-2	1.000000e+0	1.000000e+0	2.377759e+1	4.205640e-2	1	4.205640e-2	1.000000e+0	96	3.461655e-2	1.000000e+0	1.000000e+0	2.863651e+1	3.492046e-2	1	315	5.000000e-1	3.174603e-3	unnamed	SLC19A2
Human Phenotype	HP:0002597	Abnormality of the vasculature	90	4.289777e-2	1.000000e+0	1.000000e+0	2.331124e+1	4.289777e-2	1	4.289777e-2	1.000000e+0	109	5.023817e-2	1.000000e+0	1.000000e+0	1.965251e+1	5.088410e-2	1	459	5.000000e-1	2.178649e-3	unnamed	SLC19A2
Human Phenotype	HP:0000505	Visual impairment	91	4.619257e-2	1.000000e+0	1.000000e+0	2.164850e+1	4.619257e-2	1	4.619257e-2	1.000000e+0	105	4.872500e-2	1.000000e+0	1.000000e+0	2.027079e+1	4.933208e-2	1	445	5.000000e-1	2.247191e-3	unnamed	SLC19A2
Human Phenotype	HP:0011025	Abnormality of cardiovascular system physiology	92	4.649297e-2	1.000000e+0	1.000000e+0	2.150863e+1	4.649297e-2	1	4.649297e-2	1.000000e+0	107	4.958982e-2	1.000000e+0	1.000000e+0	1.991280e+1	5.021895e-2	1	453	5.000000e-1	2.207506e-3	unnamed	SLC19A2
Human Phenotype	HP:0000407	Sensorineural hearing impairment	93	4.795301e-2	1.000000e+0	1.000000e+0	2.085375e+1	4.795301e-2	1	4.795301e-2	1.000000e+0	102	4.753523e-2	1.000000e+0	1.000000e+0	2.078456e+1	4.811263e-2	1	434	5.000000e-1	2.304147e-3	unnamed	SLC19A2
Human Phenotype	HP:0001317	Abnormality of the cerebellum	94	4.894940e-2	1.000000e+0	1.000000e+0	2.042926e+1	4.894940e-2	1	4.894940e-2	1.000000e+0	114	5.423149e-2	1.000000e+0	1.000000e+0	1.818649e+1	5.498587e-2	1	496	5.000000e-1	2.016129e-3	unnamed	SLC19A2
Human Phenotype	HP:0000504	Abnormality of vision	95	4.984025e-2	1.000000e+0	1.000000e+0	2.006411e+1	4.984025e-2	1	4.984025e-2	1.000000e+0	113	5.412367e-2	1.000000e+0	1.000000e+0	1.822323e+1	5.487501e-2	1	495	5.000000e-1	2.020202e-3	unnamed	SLC19A2
Human Phenotype	HP:0011389	Functional abnormality of the inner ear	96	5.010074e-2	1.000000e+0	1.000000e+0	1.995978e+1	5.010074e-2	1	5.010074e-2	1.000000e+0	106	4.937365e-2	1.000000e+0	1.000000e+0	2.000111e+1	4.999723e-2	1	451	5.000000e-1	2.217295e-3	unnamed	SLC19A2
Human Phenotype	HP:0000359	Abnormality of the inner ear	97	5.043815e-2	1.000000e+0	1.000000e+0	1.982626e+1	5.043815e-2	1	5.043815e-2	1.000000e+0	108	4.980596e-2	1.000000e+0	1.000000e+0	1.982527e+1	5.044066e-2	1	455	5.000000e-1	2.197802e-3	unnamed	SLC19A2
Human Phenotype	HP:0000035	Abnormality of the testis	98	5.101368e-2	1.000000e+0	1.000000e+0	1.960258e+1	5.101368e-2	1	5.101368e-2	1.000000e+0	101	4.645297e-2	1.000000e+0	1.000000e+0	2.127476e+1	4.700405e-2	1	424	5.000000e-1	2.358491e-3	unnamed	SLC19A2
Human Phenotype	HP:0000639	Nystagmus	99	5.150322e-2	1.000000e+0	1.000000e+0	1.941626e+1	5.150322e-2	1	5.150322e-2	1.000000e+0	111	5.293728e-2	1.000000e+0	1.000000e+0	1.863740e+1	5.365556e-2	1	484	5.000000e-1	2.066116e-3	unnamed	SLC19A2
Human Phenotype	HP:0000022	Abnormality of male internal genitalia	100	5.264829e-2	1.000000e+0	1.000000e+0	1.899397e+1	5.264829e-2	1	5.264829e-2	1.000000e+0	103	4.775160e-2	1.000000e+0	1.000000e+0	2.068922e+1	4.833435e-2	1	436	5.000000e-1	2.293578e-3	unnamed	SLC19A2
Human Phenotype	HP:0011007	Age of onset	101	5.358267e-2	1.000000e+0	1.000000e+0	1.866275e+1	5.358267e-2	1	5.358267e-2	1.000000e+0	118	6.380257e-2	1.000000e+0	1.000000e+0	1.541966e+1	6.485228e-2	1	585	5.000000e-1	1.709402e-3	unnamed	F5
Human Phenotype	HP:0003674	Onset	102	5.502040e-2	1.000000e+0	1.000000e+0	1.817508e+1	5.502040e-2	1	5.502040e-2	1.000000e+0	121	6.530370e-2	1.000000e+0	1.000000e+0	1.505927e+1	6.640430e-2	1	599	5.000000e-1	1.669449e-3	unnamed	F5
Human Phenotype	HP:0001263	Global developmental delay	103	5.775253e-2	1.000000e+0	1.000000e+0	1.731526e+1	5.775253e-2	1	5.775253e-2	1.000000e+0	119	6.390983e-2	1.000000e+0	1.000000e+0	1.539334e+1	6.496314e-2	1	586	5.000000e-1	1.706485e-3	unnamed	SLC19A2
Human Phenotype	HP:0000496	Abnormality of eye movement	104	5.789715e-2	1.000000e+0	1.000000e+0	1.727201e+1	5.789715e-2	1	5.789715e-2	1.000000e+0	116	6.187077e-2	1.000000e+0	1.000000e+0	1.590917e+1	6.285683e-2	1	567	5.000000e-1	1.763668e-3	unnamed	SLC19A2
Human Phenotype	HP:0000818	Abnormality of the endocrine system	105	5.830630e-2	1.000000e+0	1.000000e+0	1.715081e+1	5.830630e-2	1	5.830630e-2	1.000000e+0	12	1.021177e-3	1.000000e+0	5.230128e-1	3.126690e+1	6.396541e-2	2	577	1.000000e+0	3.466205e-3	unnamed	F5,SLC19A2
Human Phenotype	HP:0001871	Abnormality of  blood and blood-forming tissues	106	5.831227e-2	1.000000e+0	1.000000e+0	1.714905e+1	5.831227e-2	1	5.831227e-2	1.000000e+0	17	1.490544e-3	1.000000e+0	5.388755e-1	2.588379e+1	7.726844e-2	2	697	1.000000e+0	2.869440e-3	unnamed	F5,SLC19A2
Human Phenotype	HP:0000032	Abnormality of male external genitalia	107	5.856997e-2	1.000000e+0	1.000000e+0	1.707359e+1	5.856997e-2	1	5.856997e-2	1.000000e+0	110	5.207398e-2	1.000000e+0	1.000000e+0	1.895063e+1	5.276869e-2	1	476	5.000000e-1	2.100840e-3	unnamed	SLC19A2
Human Phenotype	HP:0001098	Abnormality of the fundus	108	5.873513e-2	1.000000e+0	1.000000e+0	1.702559e+1	5.873513e-2	1	5.873513e-2	1.000000e+0	120	6.498213e-2	1.000000e+0	1.000000e+0	1.513507e+1	6.607173e-2	1	596	5.000000e-1	1.677852e-3	unnamed	SLC19A2
Human Phenotype	HP:0004329	Abnormality of the posterior segment of the eye	109	5.909903e-2	1.000000e+0	1.000000e+0	1.692075e+1	5.909903e-2	1	5.909903e-2	1.000000e+0	122	6.541088e-2	1.000000e+0	1.000000e+0	1.503417e+1	6.651516e-2	1	600	5.000000e-1	1.666667e-3	unnamed	SLC19A2
Human Phenotype	HP:0000811	Abnormal external genitalia	110	5.948677e-2	1.000000e+0	1.000000e+0	1.681046e+1	5.948677e-2	1	5.948677e-2	1.000000e+0	112	5.336878e-2	1.000000e+0	1.000000e+0	1.848463e+1	5.409900e-2	1	488	5.000000e-1	2.049180e-3	unnamed	SLC19A2
Human Phenotype	HP:0010461	Abnormality of the male genitalia	111	6.153041e-2	1.000000e+0	1.000000e+0	1.625213e+1	6.153041e-2	1	6.153041e-2	1.000000e+0	115	5.477048e-2	1.000000e+0	1.000000e+0	1.800499e+1	5.554016e-2	1	501	5.000000e-1	1.996008e-3	unnamed	SLC19A2
Human Phenotype	HP:0004322	Short stature	112	6.307451e-2	1.000000e+0	1.000000e+0	1.585427e+1	6.307451e-2	1	6.307451e-2	1.000000e+0	117	6.197814e-2	1.000000e+0	1.000000e+0	1.588116e+1	6.296768e-2	1	568	5.000000e-1	1.760563e-3	unnamed	SLC19A2
Human Phenotype	HP:0000812	Abnormal internal genitalia	113	6.482038e-2	1.000000e+0	1.000000e+0	1.542725e+1	6.482038e-2	1	6.482038e-2	1.000000e+0	9	9.481360e-4	1.000000e+0	6.474715e-1	3.244784e+1	6.163738e-2	2	556	1.000000e+0	3.597122e-3	unnamed	F5,SLC19A2
Human Phenotype	HP:0011024	Abnormality of the gastrointestinal tract	114	6.745114e-2	1.000000e+0	1.000000e+0	1.482555e+1	6.745114e-2	1	6.745114e-2	1.000000e+0	123	6.626808e-2	1.000000e+0	1.000000e+0	1.483635e+1	6.740203e-2	1	608	5.000000e-1	1.644737e-3	unnamed	SLC19A2
Human Phenotype	HP:0000002	Abnormality of body height	115	6.858327e-2	1.000000e+0	1.000000e+0	1.458081e+1	6.858327e-2	1	6.858327e-2	1.000000e+0	124	6.637520e-2	1.000000e+0	1.000000e+0	1.481199e+1	6.751289e-2	1	609	5.000000e-1	1.642036e-3	unnamed	SLC19A2
Human Phenotype	HP:0002564	Malformation of the heart and great vessels	116	7.308175e-2	1.000000e+0	1.000000e+0	1.368331e+1	7.308175e-2	1	7.308175e-2	1.000000e+0	125	6.979987e-2	1.000000e+0	1.000000e+0	1.407254e+1	7.106036e-2	1	641	5.000000e-1	1.560062e-3	unnamed	SLC19A2
Human Phenotype	HP:0012243	Abnormal genital system morphology	117	7.339808e-2	1.000000e+0	1.000000e+0	1.362434e+1	7.339808e-2	1	7.339808e-2	1.000000e+0	13	1.164015e-3	1.000000e+0	5.503105e-1	2.928734e+1	6.828890e-2	2	616	1.000000e+0	3.246753e-3	unnamed	F5,SLC19A2
Human Phenotype	HP:0000365	Hearing impairment	118	7.358601e-2	1.000000e+0	1.000000e+0	1.358954e+1	7.358601e-2	1	7.358601e-2	1.000000e+0	127	7.300478e-2	1.000000e+0	1.000000e+0	1.344337e+1	7.438612e-2	1	671	5.000000e-1	1.490313e-3	unnamed	SLC19A2
Human Phenotype	HP:0001627	Abnormality of the heart	119	7.369587e-2	1.000000e+0	1.000000e+0	1.356928e+1	7.369587e-2	1	7.369587e-2	1.000000e+0	126	7.129618e-2	1.000000e+0	1.000000e+0	1.377176e+1	7.261238e-2	1	655	5.000000e-1	1.526718e-3	unnamed	SLC19A2
Human Phenotype	HP:0000364	Hearing abnormality	120	7.499185e-2	1.000000e+0	1.000000e+0	1.333478e+1	7.499185e-2	1	7.499185e-2	1.000000e+0	128	7.449852e-2	1.000000e+0	1.000000e+0	1.316861e+1	7.593814e-2	1	685	5.000000e-1	1.459854e-3	unnamed	SLC19A2
Human Phenotype	HP:0001510	Growth delay	121	7.829812e-2	1.000000e+0	1.000000e+0	1.277170e+1	7.829812e-2	1	7.829812e-2	1.000000e+0	130	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	SLC19A2
Human Phenotype	HP:0000078	Abnormality of the genital system	122	7.832480e-2	1.000000e+0	1.000000e+0	1.276735e+1	7.832480e-2	1	7.832480e-2	1.000000e+0	16	1.464974e-3	1.000000e+0	5.627331e-1	2.610854e+1	7.660329e-2	2	691	1.000000e+0	2.894356e-3	unnamed	F5,SLC19A2
Human Phenotype	HP:0011354	Generalized abnormality of skin	123	7.852036e-2	1.000000e+0	1.000000e+0	1.273555e+1	7.852036e-2	1	7.852036e-2	1.000000e+0	135	9.349082e-2	1.000000e+0	1.000000e+0	1.044039e+1	9.578183e-2	1	864	5.000000e-1	1.157407e-3	unnamed	F5
Human Phenotype	HP:0001250	Seizures	124	7.857598e-2	1.000000e+0	1.000000e+0	1.272654e+1	7.857598e-2	1	7.857598e-2	1.000000e+0	131	8.216155e-2	1.000000e+0	1.000000e+0	1.191612e+1	8.391996e-2	1	757	5.000000e-1	1.321004e-3	unnamed	SLC19A2
Human Phenotype	HP:0011442	Abnormality of central motor function	125	7.946206e-2	1.000000e+0	1.000000e+0	1.258462e+1	7.946206e-2	1	7.946206e-2	1.000000e+0	133	8.767615e-2	1.000000e+0	1.000000e+0	1.115019e+1	8.968461e-2	1	809	5.000000e-1	1.236094e-3	unnamed	SLC19A2
Human Phenotype	HP:0012252	Abnormal respiratory system morphology	126	8.040224e-2	1.000000e+0	1.000000e+0	1.243746e+1	8.040224e-2	1	8.040224e-2	1.000000e+0	132	8.661694e-2	1.000000e+0	1.000000e+0	1.128974e+1	8.857602e-2	1	799	5.000000e-1	1.251564e-3	unnamed	SLC19A2
Human Phenotype	HP:0000366	Abnormality of the nose	127	8.197813e-2	1.000000e+0	1.000000e+0	1.219838e+1	8.197813e-2	1	8.197813e-2	1.000000e+0	129	7.833401e-2	1.000000e+0	1.000000e+0	1.251110e+1	7.992905e-2	1	721	5.000000e-1	1.386963e-3	unnamed	F5
Human Phenotype	HP:0000004	Onset and clinical course	128	8.609761e-2	1.000000e+0	1.000000e+0	1.161472e+1	8.609761e-2	1	8.609761e-2	1.000000e+0	138	9.886599e-2	1.000000e+0	1.000000e+0	9.858470e+0	1.014356e-1	1	915	5.000000e-1	1.092896e-3	unnamed	F5
Human Phenotype	HP:0002086	Abnormality of the respiratory system	129	8.717457e-2	1.000000e+0	1.000000e+0	1.147124e+1	8.717457e-2	1	8.717457e-2	1.000000e+0	136	9.359637e-2	1.000000e+0	1.000000e+0	1.042832e+1	9.589269e-2	1	865	5.000000e-1	1.156069e-3	unnamed	SLC19A2
Human Phenotype	HP:0000079	Abnormality of the urinary system	130	8.807497e-2	1.000000e+0	1.000000e+0	1.135396e+1	8.807497e-2	1	8.807497e-2	1.000000e+0	134	9.053295e-2	1.000000e+0	1.000000e+0	1.079007e+1	9.267779e-2	1	836	5.000000e-1	1.196172e-3	unnamed	SLC19A2
Human Phenotype	HP:0012443	Abnormality of the brain	131	9.259756e-2	1.000000e+0	1.000000e+0	1.079942e+1	9.259756e-2	1	9.259756e-2	1.000000e+0	137	9.833972e-2	1.000000e+0	1.000000e+0	9.912637e+0	1.008813e-1	1	910	5.000000e-1	1.098901e-3	unnamed	SLC19A2
Human Phenotype	HP:0002012	Abnormality of the abdominal organs	132	9.395144e-2	1.000000e+0	1.000000e+0	1.064380e+1	9.395144e-2	1	9.395144e-2	1.000000e+0	139	1.060080e-1	1.000000e+0	1.000000e+0	9.176501e+0	1.089740e-1	1	983	5.000000e-1	1.017294e-3	unnamed	SLC19A2
Human Phenotype	HP:0000951	Abnormality of the skin	133	9.900756e-2	1.000000e+0	1.000000e+0	1.010024e+1	9.900756e-2	1	9.900756e-2	1.000000e+0	24	3.206118e-3	1.000000e+0	8.210334e-1	1.765264e+1	1.132975e-1	2	1022	1.000000e+0	1.956947e-3	unnamed	F5,SLC19A2
Human Phenotype	HP:0000598	Abnormality of the ear	134	1.055161e-1	1.000000e+0	1.000000e+0	9.477228e+0	1.055161e-1	1	1.055161e-1	1.000000e+0	140	1.062177e-1	1.000000e+0	1.000000e+0	9.157868e+0	1.091957e-1	1	985	5.000000e-1	1.015228e-3	unnamed	SLC19A2
Human Phenotype	HP:0012373	Abnormal eye physiology	135	1.069560e-1	1.000000e+0	1.000000e+0	9.349641e+0	1.069560e-1	1	1.069560e-1	1.000000e+0	142	1.137480e-1	1.000000e+0	1.000000e+0	8.534059e+0	1.171775e-1	1	1057	5.000000e-1	9.460738e-4	unnamed	SLC19A2
Human Phenotype	HP:0001626	Abnormality of the cardiovascular system	136	1.079230e-1	1.000000e+0	1.000000e+0	9.265867e+0	1.079230e-1	1	1.079230e-1	1.000000e+0	141	1.132260e-1	1.000000e+0	1.000000e+0	8.574620e+0	1.166232e-1	1	1052	5.000000e-1	9.505703e-4	unnamed	SLC19A2
Human Phenotype	HP:0012374	Abnormality of the globe	137	1.087826e-1	1.000000e+0	1.000000e+0	9.192650e+0	1.087826e-1	1	1.087826e-1	1.000000e+0	143	1.140610e-1	1.000000e+0	1.000000e+0	8.509906e+0	1.175101e-1	1	1060	5.000000e-1	9.433962e-4	unnamed	SLC19A2
Human Phenotype	HP:0012372	Abnormal eye morphology	138	1.118366e-1	1.000000e+0	1.000000e+0	8.941615e+0	1.118366e-1	1	1.118366e-1	1.000000e+0	145	1.175012e-1	1.000000e+0	1.000000e+0	8.252973e+0	1.211684e-1	1	1093	5.000000e-1	9.149131e-4	unnamed	SLC19A2
Human Phenotype	HP:0001507	Growth abnormality	139	1.155115e-1	1.000000e+0	1.000000e+0	8.657146e+0	1.155115e-1	1	1.155115e-1	1.000000e+0	144	1.160425e-1	1.000000e+0	1.000000e+0	8.360056e+0	1.196164e-1	1	1079	5.000000e-1	9.267841e-4	unnamed	SLC19A2
Human Phenotype	HP:0000119	Abnormality of the genitourinary system	140	1.156102e-1	1.000000e+0	1.000000e+0	8.649757e+0	1.156102e-1	1	1.156102e-1	1.000000e+0	29	3.892188e-3	1.000000e+0	8.248754e-1	1.602220e+1	1.248268e-1	2	1126	1.000000e+0	1.776199e-3	unnamed	F5,SLC19A2
Human Phenotype	HP:0001939	Abnormality of metabolism/homeostasis	141	1.159749e-1	1.000000e+0	1.000000e+0	8.622554e+0	1.159749e-1	1	1.159749e-1	1.000000e+0	151	1.414974e-1	1.000000e+0	1.000000e+0	6.807925e+0	1.468876e-1	1	1325	5.000000e-1	7.547170e-4	unnamed	SLC19A2
Human Phenotype	HP:0001438	Abnormality of the abdomen	142	1.198484e-1	1.000000e+0	1.000000e+0	8.343876e+0	1.198484e-1	1	1.198484e-1	1.000000e+0	147	1.315047e-1	1.000000e+0	1.000000e+0	7.345684e+0	1.361344e-1	1	1228	5.000000e-1	8.143322e-4	unnamed	SLC19A2
Human Phenotype	HP:0000006	Autosomal dominant inheritance	143	1.208130e-1	1.000000e+0	1.000000e+0	8.277255e+0	1.208130e-1	1	1.208130e-1	1.000000e+0	146	1.191667e-1	1.000000e+0	1.000000e+0	8.133904e+0	1.229422e-1	1	1109	5.000000e-1	9.017133e-4	unnamed	F5
Human Phenotype	HP:0001574	Abnormality of the integument	144	1.221743e-1	1.000000e+0	1.000000e+0	8.185030e+0	1.221743e-1	1	1.221743e-1	1.000000e+0	35	4.599501e-3	1.000000e+0	8.076724e-1	1.473938e+1	1.356909e-1	2	1224	1.000000e+0	1.633987e-3	unnamed	F5,SLC19A2
Human Phenotype	HP:0007319	Morphological abnormality of the central nervous system	145	1.231213e-1	1.000000e+0	1.000000e+0	8.122074e+0	1.231213e-1	1	1.231213e-1	1.000000e+0	148	1.321245e-1	1.000000e+0	1.000000e+0	7.309968e+0	1.367995e-1	1	1234	5.000000e-1	8.103728e-4	unnamed	SLC19A2
Human Phenotype	HP:0100543	Cognitive impairment	146	1.275944e-1	1.000000e+0	1.000000e+0	7.837337e+0	1.275944e-1	1	1.275944e-1	1.000000e+0	149	1.328473e-1	1.000000e+0	1.000000e+0	7.268735e+0	1.375755e-1	1	1241	5.000000e-1	8.058018e-4	unnamed	SLC19A2
Human Phenotype	HP:0000271	Abnormality of the face	147	1.330333e-1	1.000000e+0	1.000000e+0	7.516916e+0	1.330333e-1	1	1.330333e-1	1.000000e+0	150	1.358386e-1	1.000000e+0	1.000000e+0	7.102756e+0	1.407904e-1	1	1270	5.000000e-1	7.874016e-4	unnamed	F5
Human Phenotype	HP:0000007	Autosomal recessive inheritance	148	1.382544e-1	1.000000e+0	1.000000e+0	7.233043e+0	1.382544e-1	1	1.382544e-1	1.000000e+0	47	7.959482e-3	1.000000e+0	1.000000e+0	1.120559e+1	1.784823e-1	2	1610	1.000000e+0	1.242236e-3	unnamed	F5,SLC19A2
Human Phenotype	HP:0000478	Abnormality of the eye	149	1.387497e-1	1.000000e+0	1.000000e+0	7.207222e+0	1.387497e-1	1	1.387497e-1	1.000000e+0	152	1.483658e-1	1.000000e+0	1.000000e+0	6.480244e+0	1.543152e-1	1	1392	5.000000e-1	7.183908e-4	unnamed	SLC19A2
Human Phenotype	HP:0011446	Abnormality of higher mental function	150	1.446140e-1	1.000000e+0	1.000000e+0	6.914961e+0	1.446140e-1	1	1.446140e-1	1.000000e+0	153	1.507173e-1	1.000000e+0	1.000000e+0	6.374912e+0	1.568649e-1	1	1415	5.000000e-1	7.067138e-4	unnamed	SLC19A2
Human Phenotype	HP:0000234	Abnormality of the head	151	1.454011e-1	1.000000e+0	1.000000e+0	6.877527e+0	1.454011e-1	1	1.454011e-1	1.000000e+0	154	1.516365e-1	1.000000e+0	1.000000e+0	6.334621e+0	1.578626e-1	1	1424	5.000000e-1	7.022472e-4	unnamed	F5
Human Phenotype	HP:0000152	Abnormality of head and neck	152	1.484435e-1	1.000000e+0	1.000000e+0	6.736568e+0	1.484435e-1	1	1.484435e-1	1.000000e+0	155	1.541874e-1	1.000000e+0	1.000000e+0	6.225328e+0	1.606341e-1	1	1449	5.000000e-1	6.901311e-4	unnamed	F5
Human Phenotype	HP:0002011	Abnormality of the central nervous system	153	1.748665e-1	1.000000e+0	1.000000e+0	5.718647e+0	1.748665e-1	1	1.748665e-1	1.000000e+0	156	1.821938e-1	1.000000e+0	1.000000e+0	5.226246e+0	1.913419e-1	1	1726	5.000000e-1	5.793743e-4	unnamed	SLC19A2
Human Phenotype	HP:0000707	Abnormality of the nervous system	154	1.846645e-1	1.000000e+0	1.000000e+0	5.415226e+0	1.846645e-1	1	1.846645e-1	1.000000e+0	157	1.902943e-1	1.000000e+0	1.000000e+0	4.991976e+0	2.003215e-1	1	1807	5.000000e-1	5.534034e-4	unnamed	SLC19A2
Human Phenotype	HP:0000005	Mode of inheritance	155	2.495240e-1	1.000000e+0	1.000000e+0	4.007630e+0	2.495240e-1	1	2.495240e-1	1.000000e+0	71	2.108335e-2	1.000000e+0	1.000000e+0	6.885878e+0	2.904495e-1	2	2620	1.000000e+0	7.633588e-4	unnamed	F5,SLC19A2
Human Phenotype	HP:0000118	Phenotypic abnormality	156	2.682332e-1	1.000000e+0	1.000000e+0	3.728099e+0	2.682332e-1	1	2.682332e-1	1.000000e+0	78	2.396013e-2	1.000000e+0	1.000000e+0	6.459363e+0	3.096281e-1	2	2793	1.000000e+0	7.160759e-4	unnamed	F5,SLC19A2
Human Phenotype	HP:0000001	All	157	2.696410e-1	1.000000e+0	1.000000e+0	3.708635e+0	2.696410e-1	1	2.696410e-1	1.000000e+0	80	2.446037e-2	1.000000e+0	1.000000e+0	6.392984e+0	3.128430e-1	2	2822	1.000000e+0	7.087172e-4	unnamed	F5,SLC19A2
Disease Ontology	DOID:10915	Wernicke-Korsakoff syndrome	1	4.190995e-5	9.366874e-2	9.366874e-2	2.386068e+4	4.190995e-5	1	4.190995e-5	1.000000e+0	1	1.108586e-4	2.477690e-1	2.477690e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	SLC19A2
Disease Ontology	DOID:2216	factor V deficiency	2	6.493510e-5	1.451299e-1	7.256497e-2	1.539999e+4	6.493510e-5	1	6.493510e-5	1.000000e+0	3	2.217111e-4	4.955243e-1	1.651748e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	F5
Disease Ontology	DOID:13620	patent foramen ovale	3	1.610436e-4	3.599324e-1	1.199775e-1	6.209498e+3	1.610436e-4	1	1.610436e-4	1.000000e+0	4	3.325574e-4	7.432658e-1	1.858164e-1	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	F5
Disease Ontology	DOID:3756	protein C deficiency	4	2.352925e-4	5.258787e-1	1.314697e-1	4.250029e+3	2.352925e-4	1	2.352925e-4	1.000000e+0	8	5.542315e-4	1.000000e+0	1.548384e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	F5
Disease Ontology	DOID:13382	megaloblastic anemia	5	2.562795e-4	5.727847e-1	1.145569e-1	3.901991e+3	2.562795e-4	1	2.562795e-4	1.000000e+0	6	4.433975e-4	9.909934e-1	1.651656e-1	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	SLC19A2
Disease Ontology	DOID:11512	hepatic vein thrombosis	6	2.659710e-4	5.944452e-1	9.907420e-2	3.759808e+3	2.659710e-4	1	2.659710e-4	1.000000e+0	6	4.433975e-4	9.909934e-1	1.651656e-1	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	F5
Disease Ontology	DOID:12134	hemophilia A	7	3.462618e-4	7.738951e-1	1.105564e-1	2.887988e+3	3.462618e-4	1	3.462618e-4	1.000000e+0	11	8.866967e-4	1.000000e+0	1.801606e-1	1.127562e+3	8.868688e-4	1	8	5.000000e-1	1.250000e-1	unnamed	F5
Disease Ontology	DOID:2451	protein S deficiency	8	4.073379e-4	9.104002e-1	1.138000e-1	2.454964e+3	4.073379e-4	1	4.073379e-4	1.000000e+0	4	3.325574e-4	7.432658e-1	1.858164e-1	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	F5
Disease Ontology	DOID:11695	portal vein thrombosis	9	4.083381e-4	9.126357e-1	1.014040e-1	2.448951e+3	4.083381e-4	1	4.083381e-4	1.000000e+0	11	8.866967e-4	1.000000e+0	1.801606e-1	1.127562e+3	8.868688e-4	1	8	5.000000e-1	1.250000e-1	unnamed	F5
Disease Ontology	DOID:2212	coagulation protein disease	10	4.721535e-4	1.000000e+0	1.055263e-1	2.117955e+3	4.721535e-4	1	4.721535e-4	1.000000e+0	9	7.758812e-4	1.000000e+0	1.926772e-1	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	F5
Disease Ontology	DOID:1727	Retinal Vein Occlusion	11	6.039979e-4	1.000000e+0	1.227214e-1	1.655635e+3	6.039979e-4	1	6.039979e-4	1.000000e+0	9	7.758812e-4	1.000000e+0	1.926772e-1	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	F5
Disease Ontology	DOID:1729	retinal vascular occlusion	12	6.516926e-4	1.000000e+0	1.213777e-1	1.534466e+3	6.516926e-4	1	6.516926e-4	1.000000e+0	13	9.975062e-4	1.000000e+0	1.714943e-1	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	F5
Disease Ontology	DOID:9477	pulmonary embolism	13	7.955439e-4	1.000000e+0	1.367724e-1	1.257002e+3	7.955439e-4	1	7.955439e-4	1.000000e+0	17	1.883760e-3	1.000000e+0	2.476590e-1	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	F5
Disease Ontology	DOID:9667	placental abruption	14	1.013492e-3	1.000000e+0	1.617968e-1	9.866874e+2	1.013492e-3	1	1.013492e-3	1.000000e+0	16	1.551461e-3	1.000000e+0	2.167197e-1	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	F5
Disease Ontology	DOID:224	transient cerebral ischemia	15	1.104986e-3	1.000000e+0	1.646429e-1	9.049891e+2	1.104986e-3	1	1.104986e-3	1.000000e+0	14	1.329898e-3	1.000000e+0	2.123087e-1	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	F5
Disease Ontology	DOID:1882	atrial heart septal defect	16	1.501851e-3	1.000000e+0	2.097898e-1	6.658452e+2	1.501851e-3	1	1.501851e-3	1.000000e+0	15	1.440682e-3	1.000000e+0	2.146616e-1	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	F5
Disease Ontology	DOID:5113	nutritional deficiency disease	17	1.563754e-3	1.000000e+0	2.055877e-1	6.394868e+2	1.563754e-3	1	1.563754e-3	1.000000e+0	19	1.994515e-3	1.000000e+0	2.346179e-1	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	SLC19A2
Disease Ontology	DOID:1969	cerebral palsy	18	1.839316e-3	1.000000e+0	2.283817e-1	5.436805e+2	1.839316e-3	1	1.839316e-3	1.000000e+0	17	1.883760e-3	1.000000e+0	2.476590e-1	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	F5
Disease Ontology	DOID:2214	inherited blood coagulation disease	19	1.857800e-3	1.000000e+0	2.185359e-1	5.382710e+2	1.857800e-3	1	1.857800e-3	1.000000e+0	26	2.880326e-3	1.000000e+0	2.475973e-1	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	F5
Disease Ontology	DOID:9279	hyperhomocysteinemia	20	1.994380e-3	1.000000e+0	2.228720e-1	5.014090e+2	1.994380e-3	1	1.994380e-3	1.000000e+0	24	2.658910e-3	1.000000e+0	2.476110e-1	3.758542e+2	2.660606e-3	1	24	5.000000e-1	4.166667e-2	unnamed	F5
Disease Ontology	DOID:866	vein disease	21	2.449530e-3	1.000000e+0	2.607000e-1	4.082416e+2	2.449530e-3	1	2.449530e-3	1.000000e+0	27	2.991025e-3	1.000000e+0	2.475904e-1	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	F5
Disease Ontology	DOID:2988	antiphospholipid syndrome	22	2.625484e-3	1.000000e+0	2.667253e-1	3.808822e+2	2.625484e-3	1	2.625484e-3	1.000000e+0	22	2.326740e-3	1.000000e+0	2.363756e-1	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	F5
Disease Ontology	DOID:10923	sickle cell anemia	23	2.656963e-3	1.000000e+0	2.581875e-1	3.763696e+2	2.656963e-3	1	2.656963e-3	1.000000e+0	27	2.991025e-3	1.000000e+0	2.475904e-1	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	F5
Disease Ontology	DOID:272	hepatic vascular disease	24	2.697569e-3	1.000000e+0	2.512111e-1	3.707042e+2	2.697569e-3	1	2.697569e-3	1.000000e+0	24	2.658910e-3	1.000000e+0	2.476110e-1	3.758542e+2	2.660606e-3	1	24	5.000000e-1	4.166667e-2	unnamed	F5
Disease Ontology	DOID:1921	Klinefelter's syndrome	25	2.793409e-3	1.000000e+0	2.497308e-1	3.579855e+2	2.793409e-3	1	2.793409e-3	1.000000e+0	20	2.105263e-3	1.000000e+0	2.352631e-1	4.747632e+2	2.106313e-3	1	19	5.000000e-1	5.263158e-2	unnamed	F5
Disease Ontology	DOID:2316	brain ischemia	26	2.911956e-3	1.000000e+0	2.503162e-1	3.434118e+2	2.911956e-3	1	2.911956e-3	1.000000e+0	22	2.326740e-3	1.000000e+0	2.363756e-1	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	F5
Disease Ontology	DOID:1681	heart septal defect	27	2.919171e-3	1.000000e+0	2.416425e-1	3.425630e+2	2.919171e-3	1	2.919171e-3	1.000000e+0	20	2.105263e-3	1.000000e+0	2.352631e-1	4.747632e+2	2.106313e-3	1	19	5.000000e-1	5.263158e-2	unnamed	F5
Disease Ontology	DOID:2452	thrombophilia	28	3.407725e-3	1.000000e+0	2.720095e-1	2.934509e+2	3.407725e-3	1	3.407725e-3	1.000000e+0	34	3.987038e-3	1.000000e+0	2.620891e-1	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	F5
Disease Ontology	DOID:10159	osteonecrosis	29	3.672227e-3	1.000000e+0	2.830147e-1	2.723143e+2	3.672227e-3	1	3.672227e-3	1.000000e+0	27	2.991025e-3	1.000000e+0	2.475904e-1	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	F5
Disease Ontology	DOID:2228	thrombocytosis	30	3.703179e-3	1.000000e+0	2.758868e-1	2.700383e+2	3.703179e-3	1	3.703179e-3	1.000000e+0	30	3.212404e-3	1.000000e+0	2.393241e-1	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	F5
Disease Ontology	DOID:11946	habitual abortion	31	3.711028e-3	1.000000e+0	2.675531e-1	2.694671e+2	3.711028e-3	1	3.711028e-3	1.000000e+0	35	4.429551e-3	1.000000e+0	2.828585e-1	2.255125e+2	4.434344e-3	1	40	5.000000e-1	2.500000e-2	unnamed	F5
Disease Ontology	DOID:10003	sensorineural hearing loss	32	3.741026e-3	1.000000e+0	2.612873e-1	2.673064e+2	3.741026e-3	1	3.741026e-3	1.000000e+0	39	5.203711e-3	1.000000e+0	2.982127e-1	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	F5
Disease Ontology	DOID:8997	polycythemia vera	33	3.815071e-3	1.000000e+0	2.583844e-1	2.621183e+2	3.815071e-3	1	3.815071e-3	1.000000e+0	31	3.323085e-3	1.000000e+0	2.395837e-1	3.006833e+2	3.325758e-3	1	30	5.000000e-1	3.333333e-2	unnamed	F5
Disease Ontology	DOID:9252	inborn errors of amino acid metabolism	34	3.885425e-3	1.000000e+0	2.554096e-1	2.573721e+2	3.885425e-3	1	3.885425e-3	1.000000e+0	38	5.093135e-3	1.000000e+0	2.995568e-1	1.960978e+2	5.099496e-3	1	46	5.000000e-1	2.173913e-2	unnamed	F5
Disease Ontology	DOID:1924	hypogonadism	35	4.019640e-3	1.000000e+0	2.566827e-1	2.487785e+2	4.019640e-3	1	4.019640e-3	1.000000e+0	32	3.544427e-3	1.000000e+0	2.475561e-1	2.818906e+2	3.547475e-3	1	32	5.000000e-1	3.125000e-2	unnamed	F5
Disease Ontology	DOID:2226	chronic myeloproliferative disease	36	4.432622e-3	1.000000e+0	2.751919e-1	2.256001e+2	4.432622e-3	1	4.432622e-3	1.000000e+0	33	3.655089e-3	1.000000e+0	2.475492e-1	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	F5
Disease Ontology	DOID:8432	polycythemia	37	5.030485e-3	1.000000e+0	3.038685e-1	1.987880e+2	5.030485e-3	1	5.030485e-3	1.000000e+0	35	4.429551e-3	1.000000e+0	2.828585e-1	2.255125e+2	4.434344e-3	1	40	5.000000e-1	2.500000e-2	unnamed	F5
Disease Ontology	DOID:620	blood protein disease	38	5.275237e-3	1.000000e+0	3.102672e-1	1.895649e+2	5.275237e-3	1	5.275237e-3	1.000000e+0	42	6.198618e-3	1.000000e+0	3.298550e-1	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	F5
Disease Ontology	DOID:722	spontaneous abortion	39	5.907872e-3	1.000000e+0	3.385665e-1	1.692657e+2	5.907872e-3	1	5.907872e-3	1.000000e+0	45	6.972090e-3	1.000000e+0	3.462805e-1	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	F5
Disease Ontology	DOID:3526	cerebral infarction	40	5.920627e-3	1.000000e+0	3.308150e-1	1.689010e+2	5.920627e-3	1	5.920627e-3	1.000000e+0	41	6.088097e-3	1.000000e+0	3.318755e-1	1.640091e+2	6.097223e-3	1	55	5.000000e-1	1.818182e-2	unnamed	F5
Disease Ontology	DOID:1588	thrombocytopenia	41	6.097374e-3	1.000000e+0	3.323812e-1	1.640050e+2	6.097374e-3	1	6.097374e-3	1.000000e+0	52	8.849269e-3	1.000000e+0	3.803484e-1	1.127562e+2	8.868688e-3	1	80	5.000000e-1	1.250000e-2	unnamed	F5
Disease Ontology	DOID:13241	Behcet's disease	42	6.146019e-3	1.000000e+0	3.270560e-1	1.627069e+2	6.146019e-3	1	6.146019e-3	1.000000e+0	49	8.076528e-3	1.000000e+0	3.683886e-1	1.235685e+2	8.092678e-3	1	73	5.000000e-1	1.369863e-2	unnamed	F5
Disease Ontology	DOID:1184	nephrotic syndrome	43	6.246850e-3	1.000000e+0	3.246909e-1	1.600807e+2	6.246850e-3	1	6.246850e-3	1.000000e+0	46	7.082562e-3	1.000000e+0	3.441201e-1	1.409453e+2	7.094950e-3	1	64	5.000000e-1	1.562500e-2	unnamed	F5
Disease Ontology	DOID:2952	inner ear disease	44	6.247436e-3	1.000000e+0	3.173414e-1	1.600657e+2	6.247436e-3	1	6.247436e-3	1.000000e+0	47	7.193027e-3	1.000000e+0	3.420514e-1	1.387769e+2	7.205809e-3	1	65	5.000000e-1	1.538462e-2	unnamed	F5
Disease Ontology	DOID:0080008	avascular bone disease	45	6.253802e-3	1.000000e+0	3.106055e-1	1.599027e+2	6.253802e-3	1	6.253802e-3	1.000000e+0	37	4.982553e-3	1.000000e+0	3.009731e-1	2.004556e+2	4.988637e-3	1	45	5.000000e-1	2.222222e-2	unnamed	F5
Disease Ontology	DOID:3454	brain infarction	46	6.448977e-3	1.000000e+0	3.133362e-1	1.550633e+2	6.448977e-3	1	6.448977e-3	1.000000e+0	44	6.751129e-3	1.000000e+0	3.429267e-1	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	F5
Disease Ontology	DOID:2527	nephrosis	47	6.529991e-3	1.000000e+0	3.105219e-1	1.531396e+2	6.529991e-3	1	6.529991e-3	1.000000e+0	48	7.524386e-3	1.000000e+0	3.503542e-1	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	F5
Disease Ontology	DOID:9219	pregnancy complication	48	6.843688e-3	1.000000e+0	3.186592e-1	1.461200e+2	6.843688e-3	1	6.843688e-3	1.000000e+0	49	8.076528e-3	1.000000e+0	3.683886e-1	1.235685e+2	8.092678e-3	1	73	5.000000e-1	1.369863e-2	unnamed	F5
Disease Ontology	DOID:5366	pregnancy disease	49	7.627223e-3	1.000000e+0	3.478948e-1	1.311093e+2	7.627223e-3	1	7.627223e-3	1.000000e+0	53	8.959636e-3	1.000000e+0	3.778262e-1	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	F5
Disease Ontology	DOID:9408	acute myocardial infarction	50	8.449918e-3	1.000000e+0	3.777113e-1	1.183443e+2	8.449918e-3	1	8.449918e-3	1.000000e+0	55	9.732033e-3	1.000000e+0	3.954744e-1	1.025057e+2	9.755557e-3	1	88	5.000000e-1	1.136364e-2	unnamed	F5
Disease Ontology	DOID:2462	retinal vascular disease	51	8.884987e-3	1.000000e+0	3.893715e-1	1.125494e+2	8.884987e-3	1	8.884987e-3	1.000000e+0	54	9.180352e-3	1.000000e+0	3.799646e-1	1.086807e+2	9.201264e-3	1	83	5.000000e-1	1.204819e-2	unnamed	F5
Disease Ontology	DOID:1682	congenital heart defect	52	9.173625e-3	1.000000e+0	3.942895e-1	1.090082e+2	9.173625e-3	1	9.173625e-3	1.000000e+0	43	6.419641e-3	1.000000e+0	3.336720e-1	1.555259e+2	6.429799e-3	1	58	5.000000e-1	1.724138e-2	unnamed	F5
Disease Ontology	DOID:2218	blood platelet disease	53	1.030053e-2	1.000000e+0	4.343714e-1	9.708242e+1	1.030053e-2	1	1.030053e-2	1.000000e+0	59	1.270846e-2	1.000000e+0	4.814137e-1	7.843913e+1	1.274874e-2	1	115	5.000000e-1	8.695652e-3	unnamed	F5
Disease Ontology	DOID:8510	encephalopathy	54	1.139598e-2	1.000000e+0	4.716669e-1	8.775027e+1	1.139598e-2	1	1.139598e-2	1.000000e+0	59	1.270846e-2	1.000000e+0	4.814137e-1	7.843913e+1	1.274874e-2	1	115	5.000000e-1	8.695652e-3	unnamed	F5
Disease Ontology	DOID:865	vasculitis	55	1.141538e-2	1.000000e+0	4.638795e-1	8.760113e+1	1.141538e-2	1	1.141538e-2	1.000000e+0	61	1.513038e-2	1.000000e+0	5.543672e-1	6.584307e+1	1.518763e-2	1	137	5.000000e-1	7.299270e-3	unnamed	F5
Disease Ontology	DOID:0080014	chromosomal disease	56	1.185475e-2	1.000000e+0	4.731315e-1	8.435439e+1	1.185475e-2	1	1.185475e-2	1.000000e+0	56	1.083493e-2	1.000000e+0	4.324298e-1	9.204592e+1	1.086414e-2	1	98	5.000000e-1	1.020408e-2	unnamed	F5
Disease Ontology	DOID:2742	auditory system disease	57	1.208485e-2	1.000000e+0	4.738533e-1	8.274826e+1	1.208485e-2	1	1.208485e-2	1.000000e+0	58	1.226779e-2	1.000000e+0	4.727329e-1	8.126577e+1	1.230530e-2	1	111	5.000000e-1	9.009009e-3	unnamed	F5
Disease Ontology	DOID:8778	Crohn's disease	58	1.382583e-2	1.000000e+0	5.327712e-1	7.232841e+1	1.382583e-2	1	1.382583e-2	1.000000e+0	68	1.930669e-2	1.000000e+0	6.345655e-1	5.154571e+1	1.940025e-2	1	175	5.000000e-1	5.714286e-3	unnamed	F5
Disease Ontology	DOID:0060031	autoimmune disease of gastrointestinal tract	59	1.484353e-2	1.000000e+0	5.622930e-1	6.736941e+1	1.484353e-2	1	1.484353e-2	1.000000e+0	70	2.128185e-2	1.000000e+0	6.794991e-1	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	F5
Disease Ontology	DOID:11612	polycystic ovary syndrome	60	1.801809e-2	1.000000e+0	6.711739e-1	5.549979e+1	1.801809e-2	1	1.801809e-2	1.000000e+0	63	1.798882e-2	1.000000e+0	6.381748e-1	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	F5
Disease Ontology	DOID:11613	hyperandrogenism	61	1.812359e-2	1.000000e+0	6.640365e-1	5.517671e+1	1.812359e-2	1	1.812359e-2	1.000000e+0	64	1.809867e-2	1.000000e+0	6.320395e-1	5.500305e+1	1.818081e-2	1	164	5.000000e-1	6.097561e-3	unnamed	F5
Disease Ontology	DOID:5119	ovarian cyst	62	1.840495e-2	1.000000e+0	6.634688e-1	5.433322e+1	1.840495e-2	1	1.840495e-2	1.000000e+0	65	1.842821e-2	1.000000e+0	6.336469e-1	5.401497e+1	1.851339e-2	1	167	5.000000e-1	5.988024e-3	unnamed	F5
Disease Ontology	DOID:1414	ovarian dysfunction	63	1.898341e-2	1.000000e+0	6.734591e-1	5.267756e+1	1.898341e-2	1	1.898341e-2	1.000000e+0	65	1.842821e-2	1.000000e+0	6.336469e-1	5.401497e+1	1.851339e-2	1	167	5.000000e-1	5.988024e-3	unnamed	F5
Disease Ontology	DOID:2355	anemia	64	1.971202e-2	1.000000e+0	6.883807e-1	5.073048e+1	1.971202e-2	1	1.971202e-2	1.000000e+0	2	1.646656e-4	3.680276e-1	1.840138e-1	7.776293e+1	2.571920e-2	2	232	1.000000e+0	8.620690e-3	unnamed	F5,SLC19A2
Disease Ontology	DOID:2370	diabetic nephropathy	65	2.028896e-2	1.000000e+0	6.976281e-1	4.928788e+1	2.028896e-2	1	2.028896e-2	1.000000e+0	62	1.787895e-2	1.000000e+0	6.445073e-1	5.568210e+1	1.795909e-2	1	162	5.000000e-1	6.172840e-3	unnamed	F5
Disease Ontology	DOID:655	inborn errors of metabolism	66	2.149170e-2	1.000000e+0	7.277871e-1	4.652958e+1	2.149170e-2	1	2.149170e-2	1.000000e+0	77	2.686732e-2	1.000000e+0	7.798501e-1	3.696926e+1	2.704950e-2	1	244	5.000000e-1	4.098361e-3	unnamed	F5
Disease Ontology	DOID:1923	sex differentiation disease	67	2.155736e-2	1.000000e+0	7.191149e-1	4.638786e+1	2.155736e-2	1	2.155736e-2	1.000000e+0	69	1.996530e-2	1.000000e+0	6.467021e-1	4.983702e+1	2.006541e-2	1	181	5.000000e-1	5.524862e-3	unnamed	F5
Disease Ontology	DOID:5223	infertility	68	2.336707e-2	1.000000e+0	7.680206e-1	4.279527e+1	2.336707e-2	1	2.336707e-2	1.000000e+0	72	2.303588e-2	1.000000e+0	7.150721e-1	4.316029e+1	2.316945e-2	1	209	5.000000e-1	4.784689e-3	unnamed	F5
Disease Ontology	DOID:2277	gonadal disease	69	2.375525e-2	1.000000e+0	7.694635e-1	4.209596e+1	2.375525e-2	1	2.375525e-2	1.000000e+0	71	2.193980e-2	1.000000e+0	6.906402e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	F5
Disease Ontology	DOID:1100	ovarian disease	70	2.439417e-2	1.000000e+0	7.788710e-1	4.099340e+1	2.439417e-2	1	2.439417e-2	1.000000e+0	72	2.303588e-2	1.000000e+0	7.150721e-1	4.316029e+1	2.316945e-2	1	209	5.000000e-1	4.784689e-3	unnamed	F5
Disease Ontology	DOID:9352	diabetes mellitus type 2	71	2.639624e-2	1.000000e+0	8.309239e-1	3.788418e+1	2.639624e-2	1	2.639624e-2	1.000000e+0	76	2.435036e-2	1.000000e+0	7.160928e-1	4.081674e+1	2.449975e-2	1	221	5.000000e-1	4.524887e-3	unnamed	F5
Disease Ontology	DOID:10591	pre-eclampsia	72	2.656005e-2	1.000000e+0	8.244682e-1	3.765053e+1	2.656005e-2	1	2.656005e-2	1.000000e+0	82	2.938103e-2	1.000000e+0	8.008122e-1	3.378464e+1	2.959925e-2	1	267	5.000000e-1	3.745318e-3	unnamed	F5
Disease Ontology	DOID:5844	myocardial infarction	73	2.663515e-2	1.000000e+0	8.154734e-1	3.754437e+1	2.663515e-2	1	2.663515e-2	1.000000e+0	82	2.938103e-2	1.000000e+0	8.008122e-1	3.378464e+1	2.959925e-2	1	267	5.000000e-1	3.745318e-3	unnamed	F5
Disease Ontology	DOID:3455	cerebrovascular accident	74	2.682361e-2	1.000000e+0	8.101455e-1	3.728059e+1	2.682361e-2	1	2.682361e-2	1.000000e+0	84	3.036376e-2	1.000000e+0	8.078929e-1	3.268297e+1	3.059697e-2	1	276	5.000000e-1	3.623188e-3	unnamed	F5
Disease Ontology	DOID:9074	systemic lupus erythematosus	75	2.739422e-2	1.000000e+0	8.163478e-1	3.650406e+1	2.739422e-2	1	2.739422e-2	1.000000e+0	86	3.178240e-2	1.000000e+0	8.259728e-1	3.121280e+1	3.203814e-2	1	289	5.000000e-1	3.460208e-3	unnamed	F5
Disease Ontology	DOID:1936	atherosclerosis	76	3.199454e-2	1.000000e+0	9.408921e-1	3.125533e+1	3.199454e-2	1	3.199454e-2	1.000000e+0	89	3.679384e-2	1.000000e+0	9.239801e-1	2.692687e+1	3.713763e-2	1	335	5.000000e-1	2.985075e-3	unnamed	F5
Disease Ontology	DOID:2348	arteriosclerotic cardiovascular disease	77	3.203444e-2	1.000000e+0	9.298308e-1	3.121640e+1	3.203444e-2	1	3.203444e-2	1.000000e+0	90	3.690264e-2	1.000000e+0	9.164156e-1	2.684673e+1	3.724849e-2	1	336	5.000000e-1	2.976190e-3	unnamed	F5
Disease Ontology	DOID:9973	substance dependence	78	3.222615e-2	1.000000e+0	9.234031e-1	3.103070e+1	3.222615e-2	1	3.222615e-2	1.000000e+0	80	2.883484e-2	1.000000e+0	8.055733e-1	3.442939e+1	2.904495e-2	1	262	5.000000e-1	3.816794e-3	unnamed	SLC19A2
Disease Ontology	DOID:8857	lupus erythematosus	79	3.295243e-2	1.000000e+0	9.322618e-1	3.034678e+1	3.295243e-2	1	3.295243e-2	1.000000e+0	92	3.929468e-2	1.000000e+0	9.546045e-1	2.519693e+1	3.968738e-2	1	358	5.000000e-1	2.793296e-3	unnamed	F5
Disease Ontology	DOID:6713	cerebrovascular disease	80	3.298186e-2	1.000000e+0	9.214307e-1	3.031970e+1	3.298186e-2	1	3.298186e-2	1.000000e+0	88	3.614091e-2	1.000000e+0	9.178970e-1	2.741793e+1	3.647248e-2	1	329	5.000000e-1	3.039514e-3	unnamed	F5
Disease Ontology	DOID:303	substance-related disease	81	3.398230e-2	1.000000e+0	9.376598e-1	2.942708e+1	3.398230e-2	1	3.398230e-2	1.000000e+0	85	3.123689e-2	1.000000e+0	8.213465e-1	3.176232e+1	3.148384e-2	1	284	5.000000e-1	3.521127e-3	unnamed	SLC19A2
Disease Ontology	DOID:3394	myocardial ischemia	82	3.417720e-2	1.000000e+0	9.315371e-1	2.925927e+1	3.417720e-2	1	3.417720e-2	1.000000e+0	91	3.842519e-2	1.000000e+0	9.437396e-1	2.577286e+1	3.880051e-2	1	350	5.000000e-1	2.857143e-3	unnamed	F5
Disease Ontology	DOID:5295	intestinal disease	83	3.418180e-2	1.000000e+0	9.204376e-1	2.925534e+1	3.418180e-2	1	3.418180e-2	1.000000e+0	98	4.233480e-2	1.000000e+0	9.654926e-1	2.336917e+1	4.279142e-2	1	386	5.000000e-1	2.590674e-3	unnamed	F5
Disease Ontology	DOID:2349	arteriosclerosis	84	3.511376e-2	1.000000e+0	9.342768e-1	2.847886e+1	3.511376e-2	1	3.511376e-2	1.000000e+0	93	3.962064e-2	1.000000e+0	9.521734e-1	2.498753e+1	4.001995e-2	1	361	5.000000e-1	2.770083e-3	unnamed	F5
Disease Ontology	DOID:2868	arterial occlusive disease	85	3.554737e-2	1.000000e+0	9.346867e-1	2.813148e+1	3.554737e-2	1	3.554737e-2	1.000000e+0	95	4.048959e-2	1.000000e+0	9.525709e-1	2.444580e+1	4.090682e-2	1	369	5.000000e-1	2.710027e-3	unnamed	F5
Disease Ontology	DOID:2213	hemorrhagic disease	86	3.724211e-2	1.000000e+0	9.678618e-1	2.685133e+1	3.724211e-2	1	3.724211e-2	1.000000e+0	100	4.309408e-2	1.000000e+0	9.631527e-1	2.295293e+1	4.356743e-2	1	393	5.000000e-1	2.544529e-3	unnamed	F5
Disease Ontology	DOID:3978	extrinsic cardiomyopathy	87	3.730842e-2	1.000000e+0	9.584404e-1	2.680360e+1	3.730842e-2	1	3.730842e-2	1.000000e+0	96	4.059818e-2	1.000000e+0	9.451764e-1	2.437973e+1	4.101768e-2	1	370	5.000000e-1	2.702703e-3	unnamed	F5
Disease Ontology	DOID:1247	blood coagulation disease	88	3.813833e-2	1.000000e+0	9.686269e-1	2.622034e+1	3.813833e-2	1	3.813833e-2	1.000000e+0	101	4.417824e-2	1.000000e+0	9.776076e-1	2.238337e+1	4.467602e-2	1	403	5.000000e-1	2.481390e-3	unnamed	F5
Disease Ontology	DOID:2869	arteriopathy	89	3.890202e-2	1.000000e+0	9.769215e-1	2.570561e+1	3.890202e-2	1	3.890202e-2	1.000000e+0	102	4.472009e-2	1.000000e+0	9.798961e-1	2.210907e+1	4.523031e-2	1	408	5.000000e-1	2.450980e-3	unnamed	F5
Disease Ontology	DOID:374	nutrition disease	90	3.940307e-2	1.000000e+0	9.785096e-1	2.537873e+1	3.940307e-2	1	3.940307e-2	1.000000e+0	94	4.027239e-2	1.000000e+0	9.575403e-1	2.457902e+1	4.068511e-2	1	367	5.000000e-1	2.724796e-3	unnamed	SLC19A2
Disease Ontology	DOID:0080015	physical disorder	91	3.945404e-2	1.000000e+0	9.690086e-1	2.534595e+1	3.945404e-2	1	3.945404e-2	1.000000e+0	78	2.774202e-2	1.000000e+0	7.949156e-1	3.579563e+1	2.793637e-2	1	252	5.000000e-1	3.968254e-3	unnamed	F5
Disease Ontology	DOID:0070004	myeloma	92	4.117706e-2	1.000000e+0	1.000000e+0	2.428537e+1	4.117706e-2	1	4.117706e-2	1.000000e+0	96	4.059818e-2	1.000000e+0	9.451764e-1	2.437973e+1	4.101768e-2	1	370	5.000000e-1	2.702703e-3	unnamed	F5
Disease Ontology	DOID:4960	bone marrow cancer	93	4.244589e-2	1.000000e+0	1.000000e+0	2.355941e+1	4.244589e-2	1	4.244589e-2	1.000000e+0	98	4.233480e-2	1.000000e+0	9.654926e-1	2.336917e+1	4.279142e-2	1	386	5.000000e-1	2.590674e-3	unnamed	F5
Disease Ontology	DOID:326	ischemia	94	4.429986e-2	1.000000e+0	1.000000e+0	2.257343e+1	4.429986e-2	1	4.429986e-2	1.000000e+0	105	4.969789e-2	1.000000e+0	1.000000e+0	1.986894e+1	5.032980e-2	1	454	5.000000e-1	2.202643e-3	unnamed	F5
Disease Ontology	DOID:5679	retinal disease	95	4.769824e-2	1.000000e+0	1.000000e+0	2.096514e+1	4.769824e-2	1	4.769824e-2	1.000000e+0	104	4.850873e-2	1.000000e+0	1.000000e+0	2.036230e+1	4.911036e-2	1	443	5.000000e-1	2.257336e-3	unnamed	F5
Disease Ontology	DOID:4961	bone marrow disease	96	4.784351e-2	1.000000e+0	1.000000e+0	2.090148e+1	4.784351e-2	1	4.784351e-2	1.000000e+0	103	4.818428e-2	1.000000e+0	1.000000e+0	2.050114e+1	4.877778e-2	1	440	5.000000e-1	2.272727e-3	unnamed	F5
Disease Ontology	DOID:229	female reproductive system disease	97	5.249388e-2	1.000000e+0	1.000000e+0	1.904984e+1	5.249388e-2	1	5.249388e-2	1.000000e+0	106	5.185810e-2	1.000000e+0	1.000000e+0	1.903059e+1	5.254698e-2	1	474	5.000000e-1	2.109705e-3	unnamed	F5
Disease Ontology	DOID:409	liver disease	98	5.695922e-2	1.000000e+0	1.000000e+0	1.755642e+1	5.695922e-2	1	5.695922e-2	1.000000e+0	109	6.862335e-2	1.000000e+0	1.000000e+0	1.431825e+1	6.984092e-2	1	630	5.000000e-1	1.587302e-3	unnamed	F5
Disease Ontology	DOID:0050177	simple genetic disease	99	5.697693e-2	1.000000e+0	1.000000e+0	1.755096e+1	5.697693e-2	1	5.697693e-2	1.000000e+0	108	6.337345e-2	1.000000e+0	1.000000e+0	1.552582e+1	6.440885e-2	1	581	5.000000e-1	1.721170e-3	unnamed	F5
Disease Ontology	DOID:10763	hypertension	100	6.448833e-2	1.000000e+0	1.000000e+0	1.550668e+1	6.448833e-2	1	6.448833e-2	1.000000e+0	107	6.197814e-2	1.000000e+0	1.000000e+0	1.588116e+1	6.296768e-2	1	568	5.000000e-1	1.760563e-3	unnamed	F5
Disease Ontology	DOID:630	genetic disease	101	6.499915e-2	1.000000e+0	1.000000e+0	1.538482e+1	6.499915e-2	1	6.499915e-2	1.000000e+0	111	6.926518e-2	1.000000e+0	1.000000e+0	1.418318e+1	7.050607e-2	1	636	5.000000e-1	1.572327e-3	unnamed	F5
Disease Ontology	DOID:3118	hepatobiliary disease	102	6.824507e-2	1.000000e+0	1.000000e+0	1.465307e+1	6.824507e-2	1	6.824507e-2	1.000000e+0	114	8.109914e-2	1.000000e+0	1.000000e+0	1.207564e+1	8.281137e-2	1	747	5.000000e-1	1.338688e-3	unnamed	F5
Disease Ontology	DOID:5614	eye disease	103	6.845790e-2	1.000000e+0	1.000000e+0	1.460752e+1	6.845790e-2	1	6.845790e-2	1.000000e+0	110	6.883732e-2	1.000000e+0	1.000000e+0	1.427294e+1	7.006264e-2	1	632	5.000000e-1	1.582278e-3	unnamed	F5
Disease Ontology	DOID:114	heart disease	104	7.093406e-2	1.000000e+0	1.000000e+0	1.409760e+1	7.093406e-2	1	7.093406e-2	1.000000e+0	112	7.012061e-2	1.000000e+0	1.000000e+0	1.400699e+1	7.139294e-2	1	644	5.000000e-1	1.552795e-3	unnamed	F5
Disease Ontology	DOID:417	autoimmune disease	105	7.426329e-2	1.000000e+0	1.000000e+0	1.346560e+1	7.426329e-2	1	7.426329e-2	1.000000e+0	116	8.820552e-2	1.000000e+0	1.000000e+0	1.108170e+1	9.023890e-2	1	814	5.000000e-1	1.228501e-3	unnamed	F5
Disease Ontology	DOID:0050155	sensory system disease	106	7.608032e-2	1.000000e+0	1.000000e+0	1.314400e+1	7.608032e-2	1	7.608032e-2	1.000000e+0	113	7.673686e-2	1.000000e+0	1.000000e+0	1.277691e+1	7.826617e-2	1	706	5.000000e-1	1.416431e-3	unnamed	F5
Disease Ontology	DOID:0080001	bone disease	107	8.760496e-2	1.000000e+0	1.000000e+0	1.141488e+1	8.760496e-2	1	8.760496e-2	1.000000e+0	117	8.831138e-2	1.000000e+0	1.000000e+0	1.106810e+1	9.034976e-2	1	815	5.000000e-1	1.226994e-3	unnamed	F5
Disease Ontology	DOID:15	reproductive system disease	108	8.872162e-2	1.000000e+0	1.000000e+0	1.127121e+1	8.872162e-2	1	8.872162e-2	1.000000e+0	115	8.290487e-2	1.000000e+0	1.000000e+0	1.180694e+1	8.469597e-2	1	764	5.000000e-1	1.308901e-3	unnamed	F5
Disease Ontology	DOID:684	hepatocellular carcinoma	109	9.124792e-2	1.000000e+0	1.000000e+0	1.095915e+1	9.124792e-2	1	9.124792e-2	1.000000e+0	119	9.211812e-2	1.000000e+0	1.000000e+0	1.059988e+1	9.434067e-2	1	851	5.000000e-1	1.175088e-3	unnamed	F5
Disease Ontology	DOID:686	liver and intrahepatic biliary tract carcinoma	110	9.251093e-2	1.000000e+0	1.000000e+0	1.080953e+1	9.251093e-2	1	9.251093e-2	1.000000e+0	120	9.338526e-2	1.000000e+0	1.000000e+0	1.045249e+1	9.567097e-2	1	863	5.000000e-1	1.158749e-3	unnamed	F5
Disease Ontology	DOID:1289	neurodegenerative disease	111	9.274080e-2	1.000000e+0	1.000000e+0	1.078274e+1	9.274080e-2	1	9.274080e-2	1.000000e+0	124	9.981289e-2	1.000000e+0	1.000000e+0	9.762446e+0	1.024333e-1	1	924	5.000000e-1	1.082251e-3	unnamed	F5
Disease Ontology	DOID:9351	diabetes mellitus	112	9.310870e-2	1.000000e+0	1.000000e+0	1.074013e+1	9.310870e-2	1	9.310870e-2	1.000000e+0	121	9.465152e-2	1.000000e+0	1.000000e+0	1.030914e+1	9.700127e-2	1	875	5.000000e-1	1.142857e-3	unnamed	F5
Disease Ontology	DOID:1428	endocrine pancreas disease	113	9.553022e-2	1.000000e+0	1.000000e+0	1.046789e+1	9.553022e-2	1	9.553022e-2	1.000000e+0	122	9.654925e-2	1.000000e+0	1.000000e+0	1.010134e+1	9.899673e-2	1	893	5.000000e-1	1.119821e-3	unnamed	F5
Disease Ontology	DOID:4194	glucose metabolism disease	114	9.709597e-2	1.000000e+0	1.000000e+0	1.029909e+1	9.709597e-2	1	9.709597e-2	1.000000e+0	123	9.844499e-2	1.000000e+0	1.000000e+0	9.901756e+0	1.009922e-1	1	911	5.000000e-1	1.097695e-3	unnamed	F5
Disease Ontology	DOID:26	pancreas disease	115	9.807021e-2	1.000000e+0	1.000000e+0	1.019678e+1	9.807021e-2	1	9.807021e-2	1.000000e+0	125	1.001284e-1	1.000000e+0	1.000000e+0	9.730852e+0	1.027659e-1	1	927	5.000000e-1	1.078749e-3	unnamed	F5
Disease Ontology	DOID:0050013	carbohydrate metabolism disease	116	1.011074e-1	1.000000e+0	1.000000e+0	9.890476e+0	1.011074e-1	1	1.011074e-1	1.000000e+0	126	1.026506e-1	1.000000e+0	1.000000e+0	9.485279e+0	1.054265e-1	1	951	5.000000e-1	1.051525e-3	unnamed	F5
Disease Ontology	DOID:0060035	medical disorder	117	1.146356e-1	1.000000e+0	1.000000e+0	8.723297e+0	1.146356e-1	1	1.146356e-1	1.000000e+0	118	9.148422e-2	1.000000e+0	1.000000e+0	1.067515e+1	9.367552e-2	1	845	5.000000e-1	1.183432e-3	unnamed	F5
Disease Ontology	DOID:178	vascular disease	118	1.205522e-1	1.000000e+0	1.000000e+0	8.295164e+0	1.205522e-1	1	1.205522e-1	1.000000e+0	129	1.288165e-1	1.000000e+0	1.000000e+0	7.504576e+0	1.332520e-1	1	1202	5.000000e-1	8.319468e-4	unnamed	F5
Disease Ontology	DOID:0050117	disease by infectious agent	119	1.209421e-1	1.000000e+0	1.000000e+0	8.268418e+0	1.209421e-1	1	1.209421e-1	1.000000e+0	131	1.508194e-1	1.000000e+0	1.000000e+0	6.370410e+0	1.569758e-1	1	1416	5.000000e-1	7.062147e-4	unnamed	F5
Disease Ontology	DOID:65	connective tissue disease	120	1.230503e-1	1.000000e+0	1.000000e+0	8.126760e+0	1.230503e-1	1	1.230503e-1	1.000000e+0	128	1.217659e-1	1.000000e+0	1.000000e+0	7.954586e+0	1.257137e-1	1	1134	5.000000e-1	8.818342e-4	unnamed	F5
Disease Ontology	DOID:28	endocrine system disease	121	1.359578e-1	1.000000e+0	1.000000e+0	7.355222e+0	1.359578e-1	1	1.359578e-1	1.000000e+0	130	1.392361e-1	1.000000e+0	1.000000e+0	6.922870e+0	1.444488e-1	1	1303	5.000000e-1	7.674597e-4	unnamed	F5
Disease Ontology	DOID:0014667	disease of metabolism	122	1.387898e-1	1.000000e+0	1.000000e+0	7.205143e+0	1.387898e-1	1	1.387898e-1	1.000000e+0	40	5.983599e-3	1.000000e+0	3.343336e-1	1.292335e+1	1.547586e-1	2	1396	1.000000e+0	1.432665e-3	unnamed	F5,SLC19A2
Disease Ontology	DOID:2531	hematologic cancer	123	1.484252e-1	1.000000e+0	1.000000e+0	6.737401e+0	1.484252e-1	1	1.484252e-1	1.000000e+0	132	1.514323e-1	1.000000e+0	1.000000e+0	6.343530e+0	1.576409e-1	1	1422	5.000000e-1	7.032349e-4	unnamed	F5
Disease Ontology	DOID:77	gastrointestinal system disease	124	1.566959e-1	1.000000e+0	1.000000e+0	6.381787e+0	1.566959e-1	1	1.566959e-1	1.000000e+0	140	1.749595e-1	1.000000e+0	1.000000e+0	5.453748e+0	1.833601e-1	1	1654	5.000000e-1	6.045949e-4	unnamed	F5
Disease Ontology	DOID:74	hematopoietic system disease	125	1.634383e-1	1.000000e+0	1.000000e+0	6.118517e+0	1.634383e-1	1	1.634383e-1	1.000000e+0	51	8.168540e-3	1.000000e+0	3.579743e-1	1.106131e+1	1.808104e-1	2	1631	1.000000e+0	1.226242e-3	unnamed	F5,SLC19A2
Disease Ontology	DOID:4241	malignant neoplasm of breast	126	1.689834e-1	1.000000e+0	1.000000e+0	5.917740e+0	1.689834e-1	1	1.689834e-1	1.000000e+0	134	1.624258e-1	1.000000e+0	1.000000e+0	5.895752e+0	1.696137e-1	1	1530	5.000000e-1	6.535948e-4	unnamed	F5
Disease Ontology	DOID:3937	malignant neoplasm of thorax	127	1.691008e-1	1.000000e+0	1.000000e+0	5.913634e+0	1.691008e-1	1	1.691008e-1	1.000000e+0	135	1.626287e-1	1.000000e+0	1.000000e+0	5.888055e+0	1.698354e-1	1	1532	5.000000e-1	6.527415e-4	unnamed	F5
Disease Ontology	DOID:5093	thoracic cancer	128	1.702657e-1	1.000000e+0	1.000000e+0	5.873173e+0	1.702657e-1	1	1.702657e-1	1.000000e+0	136	1.639470e-1	1.000000e+0	1.000000e+0	5.838511e+0	1.712765e-1	1	1545	5.000000e-1	6.472492e-4	unnamed	F5
Disease Ontology	DOID:299	adenocarcinoma	129	1.706462e-1	1.000000e+0	1.000000e+0	5.860077e+0	1.706462e-1	1	1.706462e-1	1.000000e+0	138	1.699169e-1	1.000000e+0	1.000000e+0	5.623753e+0	1.778172e-1	1	1604	5.000000e-1	6.234414e-4	unnamed	F5
Disease Ontology	DOID:150	disease of mental health	130	1.737444e-1	1.000000e+0	1.000000e+0	5.755580e+0	1.737444e-1	1	1.737444e-1	1.000000e+0	133	1.522491e-1	1.000000e+0	1.000000e+0	6.308042e+0	1.585278e-1	1	1430	5.000000e-1	6.993007e-4	unnamed	SLC19A2
Disease Ontology	DOID:1612	mammary cancer	131	1.772500e-1	1.000000e+0	1.000000e+0	5.641748e+0	1.772500e-1	1	1.772500e-1	1.000000e+0	137	1.677945e-1	1.000000e+0	1.000000e+0	5.698358e+0	1.754892e-1	1	1583	5.000000e-1	6.317119e-4	unnamed	F5
Disease Ontology	DOID:197	glandular cell epithelial neoplasm	132	1.860840e-1	1.000000e+0	1.000000e+0	5.373918e+0	1.860840e-1	1	1.860840e-1	1.000000e+0	141	1.850986e-1	1.000000e+0	1.000000e+0	5.139886e+0	1.945568e-1	1	1755	5.000000e-1	5.698006e-4	unnamed	F5
Disease Ontology	DOID:936	brain disease	133	1.872681e-1	1.000000e+0	1.000000e+0	5.339937e+0	1.872681e-1	1	1.872681e-1	1.000000e+0	139	1.748588e-1	1.000000e+0	1.000000e+0	5.457048e+0	1.832493e-1	1	1653	5.000000e-1	6.049607e-4	unnamed	F5
Disease Ontology	DOID:225	syndrome	134	2.011593e-1	1.000000e+0	1.000000e+0	4.971185e+0	2.011593e-1	1	2.011593e-1	1.000000e+0	57	1.106283e-2	1.000000e+0	4.337794e-1	9.505269e+0	2.104096e-1	2	1898	1.000000e+0	1.053741e-3	unnamed	F5,SLC19A2
Disease Ontology	DOID:193	reproductive system cancer	135	2.095200e-1	1.000000e+0	1.000000e+0	4.772814e+0	2.095200e-1	1	2.095200e-1	1.000000e+0	143	2.033098e-1	1.000000e+0	1.000000e+0	4.654541e+0	2.148440e-1	1	1938	5.000000e-1	5.159959e-4	unnamed	F5
Disease Ontology	DOID:17	musculoskeletal system disease	136	2.136568e-1	1.000000e+0	1.000000e+0	4.680403e+0	2.136568e-1	1	2.136568e-1	1.000000e+0	144	2.140591e-1	1.000000e+0	1.000000e+0	4.406693e+0	2.269276e-1	1	2047	5.000000e-1	4.885198e-4	unnamed	F5
Disease Ontology	DOID:157	epithelial carcinoma	137	2.158701e-1	1.000000e+0	1.000000e+0	4.632416e+0	2.158701e-1	1	2.158701e-1	1.000000e+0	145	2.169067e-1	1.000000e+0	1.000000e+0	4.345135e+0	2.301425e-1	1	2076	5.000000e-1	4.816956e-4	unnamed	F5
Disease Ontology	DOID:331	central nervous system disease	138	2.247960e-1	1.000000e+0	1.000000e+0	4.448477e+0	2.247960e-1	1	2.247960e-1	1.000000e+0	146	2.201408e-1	1.000000e+0	1.000000e+0	4.277146e+0	2.338008e-1	1	2109	5.000000e-1	4.741584e-4	unnamed	F5
Disease Ontology	DOID:1287	cardiovascular system disease	139	2.464292e-1	1.000000e+0	1.000000e+0	4.057961e+0	2.464292e-1	1	2.464292e-1	1.000000e+0	67	1.930360e-2	1.000000e+0	6.439335e-1	7.196250e+0	2.779225e-1	2	2507	1.000000e+0	7.977663e-4	unnamed	F5,SLC19A2
Disease Ontology	DOID:863	nervous system disease	140	2.662634e-1	1.000000e+0	1.000000e+0	3.755680e+0	2.662634e-1	1	2.662634e-1	1.000000e+0	147	2.652858e-1	1.000000e+0	1.000000e+0	3.500388e+0	2.856826e-1	1	2577	5.000000e-1	3.880481e-4	unnamed	F5
Disease Ontology	DOID:2985	chronic rejection of renal transplant	141	2.674662e-1	1.000000e+0	1.000000e+0	3.738791e+0	2.674662e-1	1	2.674662e-1	1.000000e+0	74	2.413204e-2	1.000000e+0	7.288528e-1	6.436318e+0	3.107367e-1	2	2803	1.000000e+0	7.135212e-4	unnamed	F5,SLC19A2
Disease Ontology	DOID:2108	transplant-related disease	142	2.674780e-1	1.000000e+0	1.000000e+0	3.738626e+0	2.674780e-1	1	2.674780e-1	1.000000e+0	75	2.414927e-2	1.000000e+0	7.196482e-1	6.434023e+0	3.108475e-1	2	2804	1.000000e+0	7.132668e-4	unnamed	F5,SLC19A2
Disease Ontology	DOID:557	kidney disease	143	2.854845e-1	1.000000e+0	1.000000e+0	3.502817e+0	2.854845e-1	1	2.854845e-1	1.000000e+0	79	2.790264e-2	1.000000e+0	7.893975e-1	5.985733e+0	3.341278e-1	2	3014	1.000000e+0	6.635700e-4	unnamed	F5,SLC19A2
Disease Ontology	DOID:18	urinary system disease	144	2.923209e-1	1.000000e+0	1.000000e+0	3.420898e+0	2.923209e-1	1	2.923209e-1	1.000000e+0	81	2.911932e-2	1.000000e+0	8.034775e-1	5.859370e+0	3.413336e-1	2	3079	1.000000e+0	6.495615e-4	unnamed	F5,SLC19A2
Disease Ontology	DOID:2914	immune system disease	145	3.205063e-1	1.000000e+0	1.000000e+0	3.120063e+0	3.205063e-1	1	3.205063e-1	1.000000e+0	87	3.599066e-2	1.000000e+0	9.245876e-1	5.270523e+0	3.794690e-1	2	3423	1.000000e+0	5.842828e-4	unnamed	F5,SLC19A2
Disease Ontology	DOID:305	carcinoma	146	3.218892e-1	1.000000e+0	1.000000e+0	3.106659e+0	3.218892e-1	1	3.218892e-1	1.000000e+0	148	3.253901e-1	1.000000e+0	1.000000e+0	2.798790e+0	3.572973e-1	1	3223	5.000000e-1	3.102699e-4	unnamed	F5
Disease Ontology	DOID:462	cancer by anatomical entity	147	3.485076e-1	1.000000e+0	1.000000e+0	2.869378e+0	3.485076e-1	1	3.485076e-1	1.000000e+0	149	3.467081e-1	1.000000e+0	1.000000e+0	2.607835e+0	3.834599e-1	1	3459	5.000000e-1	2.891009e-4	unnamed	F5
Disease Ontology	DOID:162	cancer	148	4.681931e-1	1.000000e+0	1.000000e+0	2.135871e+0	4.681931e-1	1	4.681931e-1	1.000000e+0	150	4.854768e-1	1.000000e+0	1.000000e+0	1.768725e+0	5.653789e-1	1	5100	5.000000e-1	1.960784e-4	unnamed	F5
Disease Ontology	DOID:7	disease of anatomical entity	149	5.144599e-1	1.000000e+0	1.000000e+0	1.943786e+0	5.144599e-1	1	5.144599e-1	1.000000e+0	127	1.068296e-1	1.000000e+0	1.000000e+0	3.059352e+0	6.537332e-1	2	5897	1.000000e+0	3.391555e-4	unnamed	F5,SLC19A2
Disease Ontology	DOID:4	disease	150	6.581397e-1	1.000000e+0	1.000000e+0	1.519434e+0	6.581397e-1	1	6.581397e-1	1.000000e+0	142	1.910563e-1	1.000000e+0	1.000000e+0	2.287725e+0	8.742309e-1	2	7886	1.000000e+0	2.536140e-4	unnamed	F5,SLC19A2
Placenta Disorders	00003	Genes with SNPs significantly associated with pre-eclampsia	1	9.168487e-3	2.750546e-2	2.750546e-2	1.090693e+2	9.168487e-3	1	9.168487e-3	1.000000e+0	1	9.952663e-3	2.985799e-2	2.985799e-2	1.002278e+2	9.977274e-3	1	90	5.000000e-1	1.111111e-2	unnamed	F5
Placenta Disorders	00002	Genes with SNPs studied in association with pre-eclampsia	2	1.556817e-2	4.670451e-2	2.335225e-2	6.423364e+1	1.556817e-2	1	1.556817e-2	1.000000e+0	2	1.645017e-2	4.935051e-2	2.467526e-2	6.054027e+1	1.651793e-2	1	149	5.000000e-1	6.711409e-3	unnamed	F5
Placenta Disorders	00001	Genes associated with preterm birth from dbPTB	3	6.332664e-2	1.899799e-1	6.332664e-2	1.579114e+1	6.332664e-2	1	6.332664e-2	1.000000e+0	3	6.455328e-2	1.936598e-1	6.455328e-2	1.523733e+1	6.562829e-2	1	592	5.000000e-1	1.689189e-3	unnamed	F5
MSigDB Pathway	REACTOME_COMMON_PATHWAY	Genes involved in Common Pathway	1	6.696229e-4	8.839022e-1	8.839022e-1	1.493378e+3	6.696229e-4	1	6.696229e-4	1.000000e+0	2	1.551461e-3	1.000000e+0	1.000000e+0	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	F5
MSigDB Pathway	BIOCARTA_EXTRINSIC_PATHWAY	Extrinsic Prothrombin Activation Pathway	2	8.868257e-4	1.000000e+0	5.853050e-1	1.127617e+3	8.868257e-4	1	8.868257e-4	1.000000e+0	1	1.440682e-3	1.000000e+0	1.000000e+0	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	F5
MSigDB Pathway	BIOCARTA_INTRINSIC_PATHWAY	Intrinsic Prothrombin Activation Pathway	3	1.491050e-3	1.000000e+0	6.560620e-1	6.706683e+2	1.491050e-3	1	1.491050e-3	1.000000e+0	3	2.548193e-3	1.000000e+0	1.000000e+0	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	F5
MSigDB Pathway	REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE	Genes involved in Formation of Fibrin Clot (Clotting Cascade)	4	2.267795e-3	1.000000e+0	7.483724e-1	4.409571e+2	2.267795e-3	1	2.267795e-3	1.000000e+0	4	3.655089e-3	1.000000e+0	1.000000e+0	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	F5
MSigDB Pathway	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	Complement and coagulation cascades	5	4.175434e-3	1.000000e+0	1.000000e+0	2.394961e+2	4.175434e-3	1	4.175434e-3	1.000000e+0	6	7.634827e-3	1.000000e+0	1.000000e+0	1.307319e+2	7.649243e-3	1	69	5.000000e-1	1.449275e-2	unnamed	F5
MSigDB Pathway	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS	Genes involved in Metabolism of vitamins and cofactors	6	4.559091e-3	1.000000e+0	1.000000e+0	2.193420e+2	4.559091e-3	1	4.559091e-3	1.000000e+0	5	5.535402e-3	1.000000e+0	1.000000e+0	1.804100e+2	5.542930e-3	1	50	5.000000e-1	2.000000e-2	unnamed	SLC19A2
MSigDB Pathway	REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_	Genes involved in Response to elevated platelet cytosolic Ca2+	7	7.455682e-3	1.000000e+0	1.000000e+0	1.341259e+2	7.455682e-3	1	7.455682e-3	1.000000e+0	7	8.849269e-3	1.000000e+0	1.000000e+0	1.127562e+2	8.868688e-3	1	80	5.000000e-1	1.250000e-2	unnamed	F5
MSigDB Pathway	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION	Genes involved in Platelet activation, signaling and aggregation	8	1.957477e-2	1.000000e+0	1.000000e+0	5.108616e+1	1.957477e-2	1	1.957477e-2	1.000000e+0	8	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	F5
MSigDB Pathway	REACTOME_HEMOSTASIS	Genes involved in Hemostasis	9	4.242109e-2	1.000000e+0	1.000000e+0	2.357318e+1	4.242109e-2	1	4.242109e-2	1.000000e+0	9	4.948174e-2	1.000000e+0	1.000000e+0	1.995686e+1	5.010809e-2	1	452	5.000000e-1	2.212389e-3	unnamed	F5
MGI Expression: Detected	385	TS12_notochord	1	8.577855e-3	1.000000e+0	1.000000e+0	1.165793e+2	8.577855e-3	1	8.577855e-3	1.000000e+0	1	6.861613e-3	1.000000e+0	1.000000e+0	1.454919e+2	6.873233e-3	1	62	5.000000e-1	1.612903e-2	unnamed	F5
MGI Expression: Detected	10645	TS23_liver right lobe	2	9.310380e-3	1.000000e+0	1.000000e+0	1.074070e+2	9.310380e-3	1	9.310380e-3	1.000000e+0	3	1.425002e-2	1.000000e+0	1.000000e+0	6.992636e+1	1.430076e-2	1	129	5.000000e-1	7.751938e-3	unnamed	F5
MGI Expression: Detected	10641	TS23_liver left lobe	3	9.501099e-3	1.000000e+0	1.000000e+0	1.052510e+2	9.501099e-3	1	9.501099e-3	1.000000e+0	4	1.436009e-2	1.000000e+0	1.000000e+0	6.938846e+1	1.441162e-2	1	130	5.000000e-1	7.692308e-3	unnamed	F5
MGI Expression: Detected	639	TS13_notochord	4	1.518888e-2	1.000000e+0	1.000000e+0	6.583762e+1	1.518888e-2	1	1.518888e-2	1.000000e+0	2	9.290700e-3	1.000000e+0	1.000000e+0	1.073869e+2	9.312122e-3	1	84	5.000000e-1	1.190476e-2	unnamed	F5
MGI Expression: Detected	9388	TS23_liver lobe	5	2.934597e-2	1.000000e+0	1.000000e+0	3.407623e+1	2.934597e-2	1	2.934597e-2	1.000000e+0	7	4.482844e-2	1.000000e+0	1.000000e+0	2.205501e+1	4.534117e-2	1	409	5.000000e-1	2.444988e-3	unnamed	F5
MGI Expression: Detected	116	TS10_embryo	6	7.866411e-2	1.000000e+0	1.000000e+0	1.271228e+1	7.866411e-2	1	7.866411e-2	1.000000e+0	11	7.556473e-2	1.000000e+0	1.000000e+0	1.297914e+1	7.704673e-2	1	695	5.000000e-1	1.438849e-3	unnamed	SLC19A2
MGI Expression: Detected	219	TS12_embryo	7	8.097750e-2	1.000000e+0	1.000000e+0	1.234911e+1	8.097750e-2	1	8.097750e-2	1.000000e+0	8	6.133380e-2	1.000000e+0	1.000000e+0	1.605071e+1	6.230253e-2	1	562	5.000000e-1	1.779359e-3	unnamed	F5
MGI Expression: Detected	115	Theiler_stage_10	8	8.203126e-2	1.000000e+0	1.000000e+0	1.219048e+1	8.203126e-2	1	8.203126e-2	1.000000e+0	12	7.929164e-2	1.000000e+0	1.000000e+0	1.235685e+1	8.092678e-2	1	730	5.000000e-1	1.369863e-3	unnamed	SLC19A2
MGI Expression: Detected	218	Theiler_stage_12	9	8.311604e-2	1.000000e+0	1.000000e+0	1.203137e+1	8.311604e-2	1	8.311604e-2	1.000000e+0	9	6.337345e-2	1.000000e+0	1.000000e+0	1.552582e+1	6.440885e-2	1	581	5.000000e-1	1.721170e-3	unnamed	F5
MGI Expression: Detected	7897	TS23_liver	10	8.884109e-2	1.000000e+0	1.000000e+0	1.125605e+1	8.884109e-2	1	8.884109e-2	1.000000e+0	13	1.088360e-1	1.000000e+0	1.000000e+0	8.931188e+0	1.119672e-1	1	1010	5.000000e-1	9.900990e-4	unnamed	F5
MGI Expression: Detected	7632	TS23_liver and biliary system	11	8.889924e-2	1.000000e+0	1.000000e+0	1.124869e+1	8.889924e-2	1	8.889924e-2	1.000000e+0	14	1.091499e-1	1.000000e+0	1.000000e+0	8.904738e+0	1.122998e-1	1	1013	5.000000e-1	9.871668e-4	unnamed	F5
MGI Expression: Detected	158	TS11_embryo	12	1.371263e-1	1.000000e+0	1.000000e+0	7.292547e+0	1.371263e-1	1	1.371263e-1	1.000000e+0	15	1.143740e-1	1.000000e+0	1.000000e+0	8.485889e+0	1.178427e-1	1	1063	5.000000e-1	9.407338e-4	unnamed	F5
MGI Expression: Detected	157	Theiler_stage_11	13	1.460195e-1	1.000000e+0	1.000000e+0	6.848400e+0	1.460195e-1	1	1.460195e-1	1.000000e+0	16	1.264349e-1	1.000000e+0	1.000000e+0	7.650975e+0	1.307023e-1	1	1179	5.000000e-1	8.481764e-4	unnamed	F5
MGI Expression: Detected	7125	TS28_skeletal muscle	14	1.519191e-1	1.000000e+0	1.000000e+0	6.582450e+0	1.519191e-1	1	1.519191e-1	1.000000e+0	18	1.554104e-1	1.000000e+0	1.000000e+0	6.174196e+0	1.619644e-1	1	1461	5.000000e-1	6.844627e-4	unnamed	SLC19A2
MGI Expression: Detected	2654	TS18_embryo	15	1.821313e-1	1.000000e+0	1.000000e+0	5.490544e+0	1.821313e-1	1	1.821313e-1	1.000000e+0	21	1.620199e-1	1.000000e+0	1.000000e+0	5.911206e+0	1.691702e-1	1	1526	5.000000e-1	6.553080e-4	unnamed	SLC19A2
MGI Expression: Detected	2653	Theiler_stage_18	16	1.826749e-1	1.000000e+0	1.000000e+0	5.474206e+0	1.826749e-1	1	1.826749e-1	1.000000e+0	22	1.627301e-1	1.000000e+0	1.000000e+0	5.884214e+0	1.699462e-1	1	1533	5.000000e-1	6.523157e-4	unnamed	SLC19A2
MGI Expression: Detected	7038	TS28_spleen	17	1.850698e-1	1.000000e+0	1.000000e+0	5.403366e+0	1.850698e-1	1	1.850698e-1	1.000000e+0	25	1.970636e-1	1.000000e+0	1.000000e+0	4.810933e+0	2.078599e-1	1	1875	5.000000e-1	5.333333e-4	unnamed	SLC19A2
MGI Expression: Detected	415	TS13_embryo	18	1.867453e-1	1.000000e+0	1.000000e+0	5.354887e+0	1.867453e-1	1	1.867453e-1	1.000000e+0	20	1.591759e-1	1.000000e+0	1.000000e+0	6.021696e+0	1.660662e-1	1	1498	5.000000e-1	6.675567e-4	unnamed	F5
MGI Expression: Detected	7123	TS28_muscle	19	1.884267e-1	1.000000e+0	1.000000e+0	5.307102e+0	1.884267e-1	1	1.884267e-1	1.000000e+0	24	1.924875e-1	1.000000e+0	1.000000e+0	4.931930e+0	2.027604e-1	1	1829	5.000000e-1	5.467469e-4	unnamed	SLC19A2
MGI Expression: Detected	414	Theiler_stage_13	20	1.906274e-1	1.000000e+0	1.000000e+0	5.245836e+0	1.906274e-1	1	1.906274e-1	1.000000e+0	23	1.649603e-1	1.000000e+0	1.000000e+0	5.800965e+0	1.723851e-1	1	1555	5.000000e-1	6.430868e-4	unnamed	F5
MGI Expression: Detected	6963	TS28_liver	21	2.213497e-1	1.000000e+0	1.000000e+0	4.517739e+0	2.213497e-1	1	2.213497e-1	1.000000e+0	5	1.730937e-2	1.000000e+0	1.000000e+0	7.599410e+0	2.631783e-1	2	2374	1.000000e+0	8.424600e-4	unnamed	F5,SLC19A2
MGI Expression: Detected	7036	TS28_haemolymphoid system	22	2.241684e-1	1.000000e+0	1.000000e+0	4.460933e+0	2.241684e-1	1	2.241684e-1	1.000000e+0	34	2.393082e-1	1.000000e+0	1.000000e+0	3.911752e+0	2.556399e-1	1	2306	5.000000e-1	4.336513e-4	unnamed	SLC19A2
MGI Expression: Detected	6962	TS28_liver and biliary system	23	2.293478e-1	1.000000e+0	1.000000e+0	4.360190e+0	2.293478e-1	1	2.293478e-1	1.000000e+0	6	1.843562e-2	1.000000e+0	1.000000e+0	7.363673e+0	2.716036e-1	2	2450	1.000000e+0	8.163265e-4	unnamed	F5,SLC19A2
MGI Expression: Detected	6948	TS28_lung	24	2.297513e-1	1.000000e+0	1.000000e+0	4.352532e+0	2.297513e-1	1	2.297513e-1	1.000000e+0	30	2.341749e-1	1.000000e+0	1.000000e+0	4.003773e+0	2.497644e-1	1	2253	5.000000e-1	4.438526e-4	unnamed	SLC19A2
MGI Expression: Detected	6946	TS28_respiratory system	25	2.309063e-1	1.000000e+0	1.000000e+0	4.330761e+0	2.309063e-1	1	2.309063e-1	1.000000e+0	33	2.354356e-1	1.000000e+0	1.000000e+0	3.980803e+0	2.512056e-1	1	2266	5.000000e-1	4.413063e-4	unnamed	SLC19A2
MGI Expression: Detected	6952	TS28_testis	26	2.313330e-1	1.000000e+0	1.000000e+0	4.322774e+0	2.313330e-1	1	2.313330e-1	1.000000e+0	35	2.397915e-1	1.000000e+0	1.000000e+0	3.903289e+0	2.561942e-1	1	2311	5.000000e-1	4.327131e-4	unnamed	SLC19A2
MGI Expression: Detected	6951	TS28_male reproductive system	27	2.379727e-1	1.000000e+0	1.000000e+0	4.202163e+0	2.379727e-1	1	2.379727e-1	1.000000e+0	37	2.476009e-1	1.000000e+0	1.000000e+0	3.771112e+0	2.651738e-1	1	2392	5.000000e-1	4.180602e-4	unnamed	SLC19A2
MGI Expression: Detected	7103	TS28_heart	28	2.471289e-1	1.000000e+0	1.000000e+0	4.046471e+0	2.471289e-1	1	2.471289e-1	1.000000e+0	36	2.465427e-1	1.000000e+0	1.000000e+0	3.788534e+0	2.639543e-1	1	2381	5.000000e-1	4.199916e-4	unnamed	SLC19A2
MGI Expression: Detected	6931	TS25_embryo	29	2.493552e-1	1.000000e+0	1.000000e+0	4.010344e+0	2.493552e-1	1	2.493552e-1	1.000000e+0	28	2.315532e-1	1.000000e+0	1.000000e+0	4.052336e+0	2.467712e-1	1	2226	5.000000e-1	4.492363e-4	unnamed	SLC19A2
MGI Expression: Detected	6930	Theiler_stage_25	30	2.502634e-1	1.000000e+0	1.000000e+0	3.995791e+0	2.502634e-1	1	2.502634e-1	1.000000e+0	29	2.329132e-1	1.000000e+0	1.000000e+0	4.027009e+0	2.483233e-1	1	2240	5.000000e-1	4.464286e-4	unnamed	SLC19A2
MGI Expression: Detected	6960	TS28_kidney	31	2.525264e-1	1.000000e+0	1.000000e+0	3.959982e+0	2.525264e-1	1	2.525264e-1	1.000000e+0	39	2.607175e-1	1.000000e+0	1.000000e+0	3.566825e+0	2.803614e-1	1	2529	5.000000e-1	3.954132e-4	unnamed	SLC19A2
MGI Expression: Detected	1016	TS15_embryo	32	2.533670e-1	1.000000e+0	1.000000e+0	3.946844e+0	2.533670e-1	1	2.533670e-1	1.000000e+0	26	2.237590e-1	1.000000e+0	1.000000e+0	4.203402e+0	2.379026e-1	1	2146	5.000000e-1	4.659832e-4	unnamed	F5
MGI Expression: Detected	7098	TS28_cardiovascular system	33	2.541249e-1	1.000000e+0	1.000000e+0	3.935073e+0	2.541249e-1	1	2.541249e-1	1.000000e+0	38	2.524013e-1	1.000000e+0	1.000000e+0	3.693898e+0	2.707167e-1	1	2442	5.000000e-1	4.095004e-4	unnamed	SLC19A2
MGI Expression: Detected	1015	Theiler_stage_15	34	2.573675e-1	1.000000e+0	1.000000e+0	3.885495e+0	2.573675e-1	1	2.573675e-1	1.000000e+0	27	2.277584e-1	1.000000e+0	1.000000e+0	4.124600e+0	2.424478e-1	1	2187	5.000000e-1	4.572474e-4	unnamed	F5
MGI Expression: Detected	6959	TS28_renal-urinary system	35	2.619747e-1	1.000000e+0	1.000000e+0	3.817163e+0	2.619747e-1	1	2.619747e-1	1.000000e+0	40	2.693662e-1	1.000000e+0	1.000000e+0	3.442939e+0	2.904495e-1	1	2620	5.000000e-1	3.816794e-4	unnamed	SLC19A2
MGI Expression: Detected	4000	TS20_embryo	36	3.348154e-1	1.000000e+0	1.000000e+0	2.986720e+0	3.348154e-1	1	3.348154e-1	1.000000e+0	41	2.872599e-1	1.000000e+0	1.000000e+0	3.210142e+0	3.115127e-1	1	2810	5.000000e-1	3.558719e-4	unnamed	F5
MGI Expression: Detected	6950	TS28_reproductive system	37	3.370939e-1	1.000000e+0	1.000000e+0	2.966533e+0	3.370939e-1	1	3.370939e-1	1.000000e+0	49	3.615866e-1	1.000000e+0	1.000000e+0	2.487728e+0	4.019733e-1	1	3626	5.000000e-1	2.757860e-4	unnamed	SLC19A2
MGI Expression: Detected	3999	Theiler_stage_20	38	3.376967e-1	1.000000e+0	1.000000e+0	2.961237e+0	3.376967e-1	1	3.376967e-1	1.000000e+0	42	2.900650e-1	1.000000e+0	1.000000e+0	3.176232e+0	3.148384e-1	1	2840	5.000000e-1	3.521127e-4	unnamed	F5
MGI Expression: Detected	2023	TS17_embryo	39	3.504112e-1	1.000000e+0	1.000000e+0	2.853790e+0	3.504112e-1	1	3.504112e-1	1.000000e+0	47	3.281190e-1	1.000000e+0	1.000000e+0	2.772979e+0	3.606230e-1	1	3253	5.000000e-1	3.074085e-4	unnamed	F5
MGI Expression: Detected	2022	Theiler_stage_17	40	3.517739e-1	1.000000e+0	1.000000e+0	2.842735e+0	3.517739e-1	1	3.517739e-1	1.000000e+0	48	3.303888e-1	1.000000e+0	1.000000e+0	2.751830e+0	3.633945e-1	1	3278	5.000000e-1	3.050641e-4	unnamed	F5
MGI Expression: Detected	4761	TS21_embryo	41	3.653552e-1	1.000000e+0	1.000000e+0	2.737062e+0	3.653552e-1	1	3.653552e-1	1.000000e+0	43	3.195499e-1	1.000000e+0	1.000000e+0	2.855492e+0	3.502023e-1	1	3159	5.000000e-1	3.165559e-4	unnamed	F5
MGI Expression: Detected	4760	Theiler_stage_21	42	3.661005e-1	1.000000e+0	1.000000e+0	2.731490e+0	3.661005e-1	1	3.661005e-1	1.000000e+0	44	3.205555e-1	1.000000e+0	1.000000e+0	2.845584e+0	3.514218e-1	1	3170	5.000000e-1	3.154574e-4	unnamed	F5
MGI Expression: Detected	3341	TS19_embryo	43	3.699199e-1	1.000000e+0	1.000000e+0	2.703288e+0	3.699199e-1	1	3.699199e-1	1.000000e+0	45	3.257542e-1	1.000000e+0	1.000000e+0	2.795321e+0	3.577407e-1	1	3227	5.000000e-1	3.098853e-4	unnamed	F5
MGI Expression: Detected	3340	Theiler_stage_19	44	3.711587e-1	1.000000e+0	1.000000e+0	2.694265e+0	3.711587e-1	1	3.711587e-1	1.000000e+0	46	3.271190e-1	1.000000e+0	1.000000e+0	2.782387e+0	3.594036e-1	1	3242	5.000000e-1	3.084516e-4	unnamed	F5
MGI Expression: Detected	6945	TS28_visceral organ	45	4.216843e-1	1.000000e+0	1.000000e+0	2.371443e+0	4.216843e-1	1	4.216843e-1	1.000000e+0	10	6.585231e-2	1.000000e+0	1.000000e+0	3.896544e+0	5.132753e-1	2	4630	1.000000e+0	4.319654e-4	unnamed	F5,SLC19A2
MGI Expression: Detected	7005	TS28_brain	46	4.776274e-1	1.000000e+0	1.000000e+0	2.093682e+0	4.776274e-1	1	4.776274e-1	1.000000e+0	50	4.562057e-1	1.000000e+0	1.000000e+0	1.904264e+0	5.251372e-1	1	4737	5.000000e-1	2.111041e-4	unnamed	SLC19A2
MGI Expression: Detected	7003	TS28_central nervous system	47	4.961740e-1	1.000000e+0	1.000000e+0	2.015422e+0	4.961740e-1	1	4.961740e-1	1.000000e+0	53	4.783750e-1	1.000000e+0	1.000000e+0	1.800140e+0	5.555124e-1	1	5011	5.000000e-1	1.995610e-4	unnamed	SLC19A2
MGI Expression: Detected	7001	TS28_nervous system	48	4.974351e-1	1.000000e+0	1.000000e+0	2.010313e+0	4.974351e-1	1	4.974351e-1	1.000000e+0	54	4.798952e-1	1.000000e+0	1.000000e+0	1.793340e+0	5.576188e-1	1	5030	5.000000e-1	1.988072e-4	unnamed	SLC19A2
MGI Expression: Detected	5741	TS22_embryo	49	5.012384e-1	1.000000e+0	1.000000e+0	1.995059e+0	5.012384e-1	1	5.012384e-1	1.000000e+0	51	4.751674e-1	1.000000e+0	1.000000e+0	1.814625e+0	5.510781e-1	1	4971	5.000000e-1	2.011668e-4	unnamed	F5
MGI Expression: Detected	5740	Theiler_stage_22	50	5.025708e-1	1.000000e+0	1.000000e+0	1.989769e+0	5.025708e-1	1	5.025708e-1	1.000000e+0	52	4.770932e-1	1.000000e+0	1.000000e+0	1.805906e+0	5.537387e-1	1	4995	5.000000e-1	2.002002e-4	unnamed	F5
MGI Expression: Detected	7489	TS23_visceral organ	51	5.150818e-1	1.000000e+0	1.000000e+0	1.941439e+0	5.150818e-1	1	5.150818e-1	1.000000e+0	55	5.216365e-1	1.000000e+0	1.000000e+0	1.621517e+0	6.167064e-1	1	5563	5.000000e-1	1.797591e-4	unnamed	F5
MGI Expression: Detected	6944	TS28_organ system	52	6.191523e-1	1.000000e+0	1.000000e+0	1.615112e+0	6.191523e-1	1	6.191523e-1	1.000000e+0	17	1.551287e-1	1.000000e+0	1.000000e+0	2.538840e+0	7.877612e-1	2	7106	1.000000e+0	2.814523e-4	unnamed	F5,SLC19A2
MGI Expression: Detected	6937	TS28_postnatal mouse	53	6.225233e-1	1.000000e+0	1.000000e+0	1.606366e+0	6.225233e-1	1	6.225233e-1	1.000000e+0	19	1.582444e-1	1.000000e+0	1.000000e+0	2.513724e+0	7.956322e-1	2	7177	1.000000e+0	2.786680e-4	unnamed	F5,SLC19A2
MGI Expression: Detected	7445	TS23_organ system	54	6.921258e-1	1.000000e+0	1.000000e+0	1.444824e+0	6.921258e-1	1	6.921258e-1	1.000000e+0	56	6.938167e-1	1.000000e+0	1.000000e+0	1.119447e+0	8.932986e-1	1	8058	5.000000e-1	1.241003e-4	unnamed	F5
MGI Expression: Detected	6925	TS23_embryo	55	7.220129e-1	1.000000e+0	1.000000e+0	1.385017e+0	7.220129e-1	1	7.220129e-1	1.000000e+0	31	2.342505e-1	1.000000e+0	1.000000e+0	2.066079e+0	9.680173e-1	2	8732	1.000000e+0	2.290426e-4	unnamed	F5,SLC19A2
MGI Expression: Detected	6924	Theiler_stage_23	56	7.220179e-1	1.000000e+0	1.000000e+0	1.385007e+0	7.220179e-1	1	7.220179e-1	1.000000e+0	32	2.344115e-1	1.000000e+0	1.000000e+0	2.065369e+0	9.683499e-1	2	8735	1.000000e+0	2.289639e-4	unnamed	F5,SLC19A2
MSigDB Perturbation	ROY_WOUND_BLOOD_VESSEL_DN	Genes down-regulated in blood vessel cells from wound site.	1	2.441141e-3	1.000000e+0	1.000000e+0	4.096445e+2	2.441141e-3	1	2.441141e-3	1.000000e+0	1	2.326740e-3	1.000000e+0	1.000000e+0	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	F5
MSigDB Perturbation	MATZUK_SPERMATOGONIA	Genes important for spermatogonia, based on mouse models with male reproductive defects.	2	2.711030e-3	1.000000e+0	1.000000e+0	3.688635e+2	2.711030e-3	1	2.711030e-3	1.000000e+0	2	2.658910e-3	1.000000e+0	1.000000e+0	3.758542e+2	2.660606e-3	1	24	5.000000e-1	4.166667e-2	unnamed	SLC19A2
MSigDB Perturbation	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN	Genes down-regulated in CT60/4 cells (breast cancer reverted to normal by transfer of chromosome 8p region) vs parental MDA-MB-231 cells (deleted chromosome 8p).	3	3.253237e-3	1.000000e+0	1.000000e+0	3.073861e+2	3.253237e-3	1	3.253237e-3	1.000000e+0	3	3.323085e-3	1.000000e+0	1.000000e+0	3.006833e+2	3.325758e-3	1	30	5.000000e-1	3.333333e-2	unnamed	SLC19A2
MSigDB Perturbation	GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP	Up-regulated genes from the set D (Fig. 5a): specific signature shared by cells expressing MLL-AF4 [GeneID=4297;4299] alone and those expressing both MLL-AF4 and AF4-MLL fusion proteins.	4	4.922407e-3	1.000000e+0	1.000000e+0	2.031527e+2	4.922407e-3	1	4.922407e-3	1.000000e+0	4	4.208307e-3	1.000000e+0	1.000000e+0	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	F5
MSigDB Perturbation	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP	Genes up-regulated in K562 cells (lymphoblast) by MYC [GeneID=4609] in the presence of PSMD9 [GeneID=5715].	5	5.619655e-3	1.000000e+0	1.000000e+0	1.779469e+2	5.619655e-3	1	5.619655e-3	1.000000e+0	8	8.738896e-3	1.000000e+0	1.000000e+0	1.141835e+2	8.757829e-3	1	79	5.000000e-1	1.265823e-2	unnamed	SLC19A2
MSigDB Perturbation	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN	Down-regulated genesin the left ventricle myocardium of patients with heart failure following implantation of LVAD (left ventricular assist device).	6	6.003653e-3	1.000000e+0	1.000000e+0	1.665652e+2	6.003653e-3	1	6.003653e-3	1.000000e+0	5	4.650770e-3	1.000000e+0	1.000000e+0	2.147738e+2	4.656061e-3	1	42	5.000000e-1	2.380952e-2	unnamed	F5
MSigDB Perturbation	MIKKELSEN_ES_LCP_WITH_H3K4ME3	Genes with low-CpG-density promoters (LCP) bearing histone H3 trimethylation mark at K4 (H3K4me3) in embryonic stem cells (ES).	7	6.049852e-3	1.000000e+0	1.000000e+0	1.652933e+2	6.049852e-3	1	6.049852e-3	1.000000e+0	17	1.413995e-2	1.000000e+0	1.000000e+0	7.047266e+1	1.418990e-2	1	128	5.000000e-1	7.812500e-3	unnamed	F5
MSigDB Perturbation	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN	Genes down-regulated in papillary thyroid carcinoma (PTC) compared to other thyroid tumors.	8	6.234314e-3	1.000000e+0	1.000000e+0	1.604026e+2	6.234314e-3	1	6.234314e-3	1.000000e+0	6	7.966112e-3	1.000000e+0	1.000000e+0	1.252847e+2	7.981819e-3	1	72	5.000000e-1	1.388889e-2	unnamed	F5
MSigDB Perturbation	HAHTOLA_SEZARY_SYNDROM_UP	Genes up-regulated in monocytes isolated from peripheral blood samples of Sezary syndrom patients compared to those from healthy normal donors.	9	8.481801e-3	1.000000e+0	1.000000e+0	1.178995e+2	8.481801e-3	1	8.481801e-3	1.000000e+0	11	1.072467e-2	1.000000e+0	1.000000e+0	9.299485e+1	1.075328e-2	1	97	5.000000e-1	1.030928e-2	unnamed	F5
MSigDB Perturbation	MIKKELSEN_IPS_LCP_WITH_H3K4ME3	Table 2S. Genes in MEF, MCV6, MCV8.1 and ES cells by  epigenetic mark of their promoter	10	8.837648e-3	1.000000e+0	1.000000e+0	1.131523e+2	8.837648e-3	1	8.837648e-3	1.000000e+0	20	1.754933e-2	1.000000e+0	1.000000e+0	5.673270e+1	1.762652e-2	1	159	5.000000e-1	6.289308e-3	unnamed	F5
MSigDB Perturbation	LEIN_CHOROID_PLEXUS_MARKERS	Genes enriched in choroid plexus cells in the brain identified through correlation-based searches seeded with the choroid plexus cell-type specific gene expression patterns.	11	9.611171e-3	1.000000e+0	1.000000e+0	1.040456e+2	9.611171e-3	1	9.611171e-3	1.000000e+0	12	1.083493e-2	1.000000e+0	1.000000e+0	9.204592e+1	1.086414e-2	1	98	5.000000e-1	1.020408e-2	unnamed	F5
MSigDB Perturbation	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS	Transcripts in hematopoietic stem cells (HSC) which are cis-regulated (i.e., modulated by a QTL (quantitative trait locus) in close proximity to the gene).	12	9.794996e-3	1.000000e+0	1.000000e+0	1.020929e+2	9.794996e-3	1	9.794996e-3	1.000000e+0	15	1.336928e-2	1.000000e+0	1.000000e+0	7.454959e+1	1.341389e-2	1	121	5.000000e-1	8.264463e-3	unnamed	F5
MSigDB Perturbation	ZHANG_TLX_TARGETS_DN	Genes down-regulated in neural stem cells (NSC) at both 36 h and 60 h after cre-lox knockout of TLX (NR2E1) [GeneID=7101].	13	9.917184e-3	1.000000e+0	1.000000e+0	1.008351e+2	9.917184e-3	1	9.917184e-3	1.000000e+0	13	1.226779e-2	1.000000e+0	1.000000e+0	8.126577e+1	1.230530e-2	1	111	5.000000e-1	9.009009e-3	unnamed	SLC19A2
MSigDB Perturbation	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	Genes down-regulated in invasive ductal carcinoma (IDC) relative to ductal carcinoma in situ (DCIS, non-invasive).	14	1.051289e-2	1.000000e+0	1.000000e+0	9.512129e+1	1.051289e-2	1	1.051289e-2	1.000000e+0	9	8.849269e-3	1.000000e+0	1.000000e+0	1.127562e+2	8.868688e-3	1	80	5.000000e-1	1.250000e-2	unnamed	SLC19A2
MSigDB Perturbation	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN	Genes down-regulated in brain relapse of breast cancer.	15	1.181420e-2	1.000000e+0	1.000000e+0	8.464389e+1	1.181420e-2	1	1.181420e-2	1.000000e+0	7	8.518131e-3	1.000000e+0	1.000000e+0	1.171494e+2	8.536112e-3	1	77	5.000000e-1	1.298701e-2	unnamed	SLC19A2
MSigDB Perturbation	SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP	Genes up-regulated in bone relapse of breast cancer.	16	1.216498e-2	1.000000e+0	1.000000e+0	8.220318e+1	1.216498e-2	1	1.216498e-2	1.000000e+0	10	1.006297e-2	1.000000e+0	1.000000e+0	9.912637e+1	1.008813e-2	1	91	5.000000e-1	1.098901e-2	unnamed	SLC19A2
MSigDB Perturbation	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	Genes from the blue module which are up-regulated in HAEC cells (primary aortic endothelium) after exposure to the oxidized 1-palmitoyl-2-arachidonyl-sn-3-glycerophosphorylcholine (oxPAPC).	17	1.272644e-2	1.000000e+0	1.000000e+0	7.857656e+1	1.272644e-2	1	1.272644e-2	1.000000e+0	15	1.336928e-2	1.000000e+0	1.000000e+0	7.454959e+1	1.341389e-2	1	121	5.000000e-1	8.264463e-3	unnamed	SLC19A2
MSigDB Perturbation	QI_HYPOXIA	Genes up-regulated by hypoxia in TRAMP-C cells (prostatic cancer).	18	1.553739e-2	1.000000e+0	1.000000e+0	6.436085e+1	1.553739e-2	1	1.553739e-2	1.000000e+0	18	1.513038e-2	1.000000e+0	1.000000e+0	6.584307e+1	1.518763e-2	1	137	5.000000e-1	7.299270e-3	unnamed	SLC19A2
MSigDB Perturbation	DOANE_RESPONSE_TO_ANDROGEN_UP	Genes up-regulated in MDA-MB-453 cells (class A ER(-) [GeneID=2099] breast cancer) after exposure to the androgen R1881 [PubChem=13766].	19	1.585908e-2	1.000000e+0	1.000000e+0	6.305535e+1	1.585908e-2	1	1.585908e-2	1.000000e+0	24	1.908711e-2	1.000000e+0	1.000000e+0	5.214162e+1	1.917854e-2	1	173	5.000000e-1	5.780347e-3	unnamed	SLC19A2
MSigDB Perturbation	RASHI_RESPONSE_TO_IONIZING_RADIATION_5	Cluster 5: early responding genes activated in ATM [GeneID=472] deficient but not in the wild type tissues.	20	1.683583e-2	1.000000e+0	1.000000e+0	5.939715e+1	1.683583e-2	1	1.683583e-2	1.000000e+0	19	1.579039e-2	1.000000e+0	1.000000e+0	6.308042e+1	1.585278e-2	1	143	5.000000e-1	6.993007e-3	unnamed	F5
MSigDB Perturbation	GROSS_HYPOXIA_VIA_ELK3_UP	Genes up-regulated in SEND cells (skin endothelium) at hypoxia with ELK3 [GeneID=2004] knockdown by RNAi.	21	1.692654e-2	1.000000e+0	1.000000e+0	5.907883e+1	1.692654e-2	1	1.692654e-2	1.000000e+0	27	2.292630e-2	1.000000e+0	1.000000e+0	4.336779e+1	2.305859e-2	1	208	5.000000e-1	4.807692e-3	unnamed	SLC19A2
MSigDB Perturbation	ZHANG_TLX_TARGETS_36HR_UP	Genes up-regulated in neural stem cells (NSC) at 36 h after cre-lox knockout of TLX (NR2E1) [GeneID=7101].	22	1.763612e-2	1.000000e+0	1.000000e+0	5.670181e+1	1.763612e-2	1	1.763612e-2	1.000000e+0	31	2.456936e-2	1.000000e+0	1.000000e+0	4.045067e+1	2.472147e-2	1	223	5.000000e-1	4.484305e-3	unnamed	SLC19A2
MSigDB Perturbation	CERVERA_SDHB_TARGETS_2	Genes present but differentially expressed between Hep3B cells (hepatocellular carcinoma, HCC) with RNAi knockdown of SDHB [GeneID=6390] and control cells.	23	1.783730e-2	1.000000e+0	1.000000e+0	5.606230e+1	1.783730e-2	1	1.783730e-2	1.000000e+0	14	1.248814e-2	1.000000e+0	1.000000e+0	7.982743e+1	1.252702e-2	1	113	5.000000e-1	8.849558e-3	unnamed	F5
MSigDB Perturbation	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP	Genes up-regulated in apoptotic tissues (neuroepithelium) after MDM4 [GeneID=4194] knockout.	24	1.902804e-2	1.000000e+0	1.000000e+0	5.255401e+1	1.902804e-2	1	1.902804e-2	1.000000e+0	23	1.820853e-2	1.000000e+0	1.000000e+0	5.466970e+1	1.829167e-2	1	165	5.000000e-1	6.060606e-3	unnamed	SLC19A2
MSigDB Perturbation	HSIAO_LIVER_SPECIFIC_GENES	Liver selective genes	25	1.933690e-2	1.000000e+0	1.000000e+0	5.171459e+1	1.933690e-2	1	1.933690e-2	1.000000e+0	33	2.686732e-2	1.000000e+0	1.000000e+0	3.696926e+1	2.704950e-2	1	244	5.000000e-1	4.098361e-3	unnamed	F5
MSigDB Perturbation	TIEN_INTESTINE_PROBIOTICS_6HR_DN	Genes down-regulated in Caco-2 cells (intestinal epithelium) after coculture with the probiotic bacteria L. casei for 6h.	26	2.009742e-2	1.000000e+0	1.000000e+0	4.975762e+1	2.009742e-2	1	2.009742e-2	1.000000e+0	22	1.787895e-2	1.000000e+0	1.000000e+0	5.568210e+1	1.795909e-2	1	162	5.000000e-1	6.172840e-3	unnamed	SLC19A2
MSigDB Perturbation	SMID_BREAST_CANCER_LUMINAL_B_UP	Genes up-regulated in the luminal B subtype of breast cancer.	27	2.166873e-2	1.000000e+0	1.000000e+0	4.614944e+1	2.166873e-2	1	2.166873e-2	1.000000e+0	21	1.765921e-2	1.000000e+0	1.000000e+0	5.637812e+1	1.773738e-2	1	160	5.000000e-1	6.250000e-3	unnamed	SLC19A2
MSigDB Perturbation	KIM_MYC_AMPLIFICATION_TARGETS_UP	Genes positively correlated with amplifications of MYC [GeneID=4609] in SCLC (small cell lung cancer) cell lines.	28	2.171723e-2	1.000000e+0	1.000000e+0	4.604639e+1	2.171723e-2	1	2.171723e-2	1.000000e+0	25	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	SLC19A2
MSigDB Perturbation	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN	Genes down-regulated in CD133+ [GeneID=8842] cells (hematopoietic stem cells, HSC) compared to the CD133- cells.	29	2.231905e-2	1.000000e+0	1.000000e+0	4.480478e+1	2.231905e-2	1	2.231905e-2	1.000000e+0	28	2.391230e-2	1.000000e+0	1.000000e+0	4.156912e+1	2.405632e-2	1	217	5.000000e-1	4.608295e-3	unnamed	F5
MSigDB Perturbation	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP	Genes up-regulated in MCF7 cells (breast cancer) at 6 h of estradiol [PubChemID=5757] treatment.	30	2.250191e-2	1.000000e+0	1.000000e+0	4.444068e+1	2.250191e-2	1	2.250191e-2	1.000000e+0	30	2.445986e-2	1.000000e+0	1.000000e+0	4.063288e+1	2.461061e-2	1	222	5.000000e-1	4.504505e-3	unnamed	SLC19A2
MSigDB Perturbation	LI_INDUCED_T_TO_NATURAL_KILLER_UP	Genes up-regulated in ITNK cells (T-lymphocyte progenitors (DN3 cells) reprogrammed to natural killer (NK) cells by ablation of BCL11B [GeneID=64919] gene), compared to the parental DN3 cells.	31	2.276746e-2	1.000000e+0	1.000000e+0	4.392234e+1	2.276746e-2	1	2.276746e-2	1.000000e+0	39	3.232775e-2	1.000000e+0	1.000000e+0	3.068197e+1	3.259243e-2	1	294	5.000000e-1	3.401361e-3	unnamed	SLC19A2
MSigDB Perturbation	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP	Genes up-regulated in non-apoptotic tissues (fetal liver) after MDM4 [GeneID=4194] knockout.	32	2.320298e-2	1.000000e+0	1.000000e+0	4.309791e+1	2.320298e-2	1	2.320298e-2	1.000000e+0	28	2.391230e-2	1.000000e+0	1.000000e+0	4.156912e+1	2.405632e-2	1	217	5.000000e-1	4.608295e-3	unnamed	SLC19A2
MSigDB Perturbation	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN	Genes down-regulated in CD34+ [GeneID=947] hematopoetic cells by expression of NUP98-HOXA9 fusion [GeneID=4928;3205] off a retroviral vector at 8 days after transduction.	33	2.346927e-2	1.000000e+0	1.000000e+0	4.260891e+1	2.346927e-2	1	2.346927e-2	1.000000e+0	26	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	F5
MSigDB Perturbation	HOSHIDA_LIVER_CANCER_SUBCLASS_S3	Genes from 'subtype S3' signature of hepatocellular carcinoma (HCC): hepatocyte differentiation.	34	2.431376e-2	1.000000e+0	1.000000e+0	4.112898e+1	2.431376e-2	1	2.431376e-2	1.000000e+0	35	2.970866e-2	1.000000e+0	1.000000e+0	3.340926e+1	2.993182e-2	1	270	5.000000e-1	3.703704e-3	unnamed	F5
MSigDB Perturbation	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING	Genes whose expression in optimally debulked ovarian tumors is associated with survival prognosis.	35	2.457305e-2	1.000000e+0	1.000000e+0	4.069499e+1	2.457305e-2	1	2.457305e-2	1.000000e+0	32	2.566396e-2	1.000000e+0	1.000000e+0	3.871459e+1	2.583005e-2	1	233	5.000000e-1	4.291845e-3	unnamed	SLC19A2
MSigDB Perturbation	FORTSCHEGGER_PHF8_TARGETS_UP	Genes up-regulated in HeLa cells (cervical carcinoma) upon knockdown of PHF8 [GeneID=23133] by RNAi.	36	3.047209e-2	1.000000e+0	1.000000e+0	3.281692e+1	3.047209e-2	1	3.047209e-2	1.000000e+0	34	2.785133e-2	1.000000e+0	1.000000e+0	3.565415e+1	2.804723e-2	1	253	5.000000e-1	3.952569e-3	unnamed	SLC19A2
MSigDB Perturbation	ZHANG_TLX_TARGETS_60HR_UP	Genes up-regulated in neural stem cells (NSC) at 60 h after cre-lox knockout of TLX (NR2E1) [GeneID=7101].	37	3.152082e-2	1.000000e+0	1.000000e+0	3.172507e+1	3.152082e-2	1	3.152082e-2	1.000000e+0	39	3.232775e-2	1.000000e+0	1.000000e+0	3.068197e+1	3.259243e-2	1	294	5.000000e-1	3.401361e-3	unnamed	SLC19A2
MSigDB Perturbation	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4	The 'group 4 set' of genes associated with acquired endocrine therapy resistance in breast tumors expressing ESR1 but not ERBB2 [GeneID=2099;2064].	38	3.519695e-2	1.000000e+0	1.000000e+0	2.841155e+1	3.519695e-2	1	3.519695e-2	1.000000e+0	38	3.178240e-2	1.000000e+0	1.000000e+0	3.121280e+1	3.203814e-2	1	289	5.000000e-1	3.460208e-3	unnamed	SLC19A2
MSigDB Perturbation	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP	Genes up-regulated during prostate cancer progression in the JOCK1 model due to inducible activation of FGFR1 [GeneID=2260] gene in prostate.	39	3.608544e-2	1.000000e+0	1.000000e+0	2.771201e+1	3.608544e-2	1	3.608544e-2	1.000000e+0	37	3.134601e-2	1.000000e+0	1.000000e+0	3.165088e+1	3.159470e-2	1	285	5.000000e-1	3.508772e-3	unnamed	F5
MSigDB Perturbation	MILI_PSEUDOPODIA_CHEMOTAXIS_DN	Transcripts depleted in pseudopodia of NIH/3T3 cells (fibroblast) in response to the chemotactic migration stimulus by lysophosphatidic acid (LPA) [PubChem=3988].	40	3.695199e-2	1.000000e+0	1.000000e+0	2.706214e+1	3.695199e-2	1	3.695199e-2	1.000000e+0	47	4.937365e-2	1.000000e+0	1.000000e+0	2.000111e+1	4.999723e-2	1	451	5.000000e-1	2.217295e-3	unnamed	SLC19A2
MSigDB Perturbation	WANG_MLL_TARGETS	Genes requiring MLL [GeneID=4297] for H3K4me3 and expression in MEF cells (embryonic fibroblast).	41	4.068723e-2	1.000000e+0	1.000000e+0	2.457774e+1	4.068723e-2	1	4.068723e-2	1.000000e+0	36	3.090952e-2	1.000000e+0	1.000000e+0	3.210142e+1	3.115127e-2	1	281	5.000000e-1	3.558719e-3	unnamed	F5
MSigDB Perturbation	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL	Genes which best discriminated between two groups of breast cancer according to the status of ESR1 and AR [GeneID=2099;367]: basal (ESR1- AR-) and luminal (ESR1+ AR+).	42	4.119949e-2	1.000000e+0	1.000000e+0	2.427215e+1	4.119949e-2	1	4.119949e-2	1.000000e+0	43	3.537888e-2	1.000000e+0	1.000000e+0	2.801398e+1	3.569647e-2	1	322	5.000000e-1	3.105590e-3	unnamed	SLC19A2
MSigDB Perturbation	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL	Genes which best discriminate between two groups of breast cancer according the status of ESR1 and AR [GeneID=2099;367]: apocrine (ESR1- AR+) vs basal (ESR1- AR-).	43	4.240436e-2	1.000000e+0	1.000000e+0	2.358248e+1	4.240436e-2	1	4.240436e-2	1.000000e+0	42	3.516110e-2	1.000000e+0	1.000000e+0	2.818906e+1	3.547475e-2	1	320	5.000000e-1	3.125000e-3	unnamed	SLC19A2
MSigDB Perturbation	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	Genes up-regulated in ME-A cells (breast cancer, sensitive to apoptotic stimuli) exposed to doxorubicin [PubChem=31703] in the presence of medium concentrate (MC) from ME-C cells (breast cancer, resistant to apoptotic stimuli).	44	4.262412e-2	1.000000e+0	1.000000e+0	2.346089e+1	4.262412e-2	1	4.262412e-2	1.000000e+0	49	6.519651e-2	1.000000e+0	1.000000e+0	1.508445e+1	6.629344e-2	1	598	5.000000e-1	1.672241e-3	unnamed	SLC19A2
MSigDB Perturbation	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN	Genes down-regulated in leukemic progenitor cells expressing activated fusion of ESWR1 and FLI1 [GeneID=2130, 2313] compared to normal hematopoetic progenitors.	45	4.463652e-2	1.000000e+0	1.000000e+0	2.240318e+1	4.463652e-2	1	4.463652e-2	1.000000e+0	41	3.352698e-2	1.000000e+0	1.000000e+0	2.957541e+1	3.381187e-2	1	305	5.000000e-1	3.278689e-3	unnamed	F5
MSigDB Perturbation	MILI_PSEUDOPODIA_HAPTOTAXIS_DN	Transcripts depleted from pseudopodia of NIH/3T3 cells (fibroblast) in response to haptotactic migratory stimulus by fibronectin, FN1 [GeneID=2335].	46	5.127776e-2	1.000000e+0	1.000000e+0	1.950163e+1	5.127776e-2	1	5.127776e-2	1.000000e+0	50	7.161666e-2	1.000000e+0	1.000000e+0	1.370897e+1	7.294496e-2	1	658	5.000000e-1	1.519757e-3	unnamed	SLC19A2
MSigDB Perturbation	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP	Genes up-regulated in nasopharyngeal carcinoma (NPC) positive for LMP1 [GeneID=9260], a latent gene of Epstein-Barr virus (EBV).	47	5.992122e-2	1.000000e+0	1.000000e+0	1.668858e+1	5.992122e-2	1	5.992122e-2	1.000000e+0	44	4.190080e-2	1.000000e+0	1.000000e+0	2.361387e+1	4.234799e-2	1	382	5.000000e-1	2.617801e-3	unnamed	F5
MSigDB Perturbation	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP	Genes up-regulated in liver tumor compared to the normal adjacent tissue.	48	6.025185e-2	1.000000e+0	1.000000e+0	1.659700e+1	6.025185e-2	1	6.025185e-2	1.000000e+0	56	9.169554e-2	1.000000e+0	1.000000e+0	1.064994e+1	9.389723e-2	1	847	5.000000e-1	1.180638e-3	unnamed	F5
MSigDB Perturbation	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF	Class I of genes transiently induced by EGF [GeneID =1950] in 184A1 cells (mammary epithelium).	49	6.194948e-2	1.000000e+0	1.000000e+0	1.614218e+1	6.194948e-2	1	6.194948e-2	1.000000e+0	48	5.272149e-2	1.000000e+0	1.000000e+0	1.871473e+1	5.343385e-2	1	482	5.000000e-1	2.074689e-3	unnamed	SLC19A2
MSigDB Perturbation	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D	Genes with promoters bound by both PPARG and RXRA [GeneID=5468, 6256] at 8 day time point of adipocyte differentiation of 3T3-L1 cells (preadipocyte).	50	6.300120e-2	1.000000e+0	1.000000e+0	1.587271e+1	6.300120e-2	1	6.300120e-2	1.000000e+0	58	9.496795e-2	1.000000e+0	1.000000e+0	1.027392e+1	9.733385e-2	1	878	5.000000e-1	1.138952e-3	unnamed	SLC19A2
MSigDB Perturbation	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP	Genes up-regulated in cultured stromal stem cells from adipose tissue, compared to the freshly isolated cells.	51	6.459289e-2	1.000000e+0	1.000000e+0	1.548158e+1	6.459289e-2	1	6.459289e-2	1.000000e+0	46	4.591162e-2	1.000000e+0	1.000000e+0	2.152864e+1	4.644975e-2	1	419	5.000000e-1	2.386635e-3	unnamed	SLC19A2
MSigDB Perturbation	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN	Genes down-regulated in HL-60 cells (acute promyelocytic leukemia, APL) after treatment with the aminopeptidase inhibitor tosedostat (CHR-2797) [PubChem=15547703] for 6 h.	52	6.654607e-2	1.000000e+0	1.000000e+0	1.502718e+1	6.654607e-2	1	6.654607e-2	1.000000e+0	57	9.285739e-2	1.000000e+0	1.000000e+0	1.051340e+1	9.511668e-2	1	858	5.000000e-1	1.165501e-3	unnamed	SLC19A2
MSigDB Perturbation	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	Genes up-regulated in ME-A cells (breast cancer) undergoing apoptosis in response to doxorubicin [PubChem=31703].	53	7.551862e-2	1.000000e+0	1.000000e+0	1.324177e+1	7.551862e-2	1	7.551862e-2	1.000000e+0	60	1.189586e-1	1.000000e+0	1.000000e+0	8.148600e+0	1.227205e-1	1	1107	5.000000e-1	9.033424e-4	unnamed	SLC19A2
MSigDB Perturbation	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN	Genes down-regulated in HL-60 cells (acute promyelocytic leukemia, APL) after treatment with the aminopeptidase inhibitor tosedostat (CHR-2797) [PubChem=15547703] for 24 h.	54	7.774937e-2	1.000000e+0	1.000000e+0	1.286184e+1	7.774937e-2	1	7.774937e-2	1.000000e+0	59	1.027556e-1	1.000000e+0	1.000000e+0	9.475315e+0	1.055374e-1	1	952	5.000000e-1	1.050420e-3	unnamed	SLC19A2
MSigDB Perturbation	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN	Genes down-regulated in the urogenital sinus (UGS) of day E16 females exposed to the androgen dihydrotestosterone [PubChem=10635] for 48 h.	55	7.798954e-2	1.000000e+0	1.000000e+0	1.282223e+1	7.798954e-2	1	7.798954e-2	1.000000e+0	45	4.558673e-2	1.000000e+0	1.000000e+0	2.168389e+1	4.611718e-2	1	416	5.000000e-1	2.403846e-3	unnamed	SLC19A2
MSigDB Perturbation	LEE_BMP2_TARGETS_UP	Genes up-regulated in uterus upon knockout of BMP2 [GeneID=650].	56	7.803375e-2	1.000000e+0	1.000000e+0	1.281497e+1	7.803375e-2	1	7.803375e-2	1.000000e+0	53	7.790824e-2	1.000000e+0	1.000000e+0	1.258089e+1	7.948562e-2	1	717	5.000000e-1	1.394700e-3	unnamed	F5
MSigDB Perturbation	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3	The 'group 3 set' of genes associated with acquired endocrine therapy resistance in breast tumors expressing ESR1 and ERBB2 [GeneID=2099;2064].	57	7.827498e-2	1.000000e+0	1.000000e+0	1.277547e+1	7.827498e-2	1	7.827498e-2	1.000000e+0	52	7.321825e-2	1.000000e+0	1.000000e+0	1.340342e+1	7.460784e-2	1	673	5.000000e-1	1.485884e-3	unnamed	F5
MSigDB Perturbation	SMID_BREAST_CANCER_BASAL_DN	Genes down-regulated in basal subtype of breast cancer samles.	58	8.172677e-2	1.000000e+0	1.000000e+0	1.223589e+1	8.172677e-2	1	8.172677e-2	1.000000e+0	51	7.225746e-2	1.000000e+0	1.000000e+0	1.358509e+1	7.361011e-2	1	664	5.000000e-1	1.506024e-3	unnamed	SLC19A2
MSigDB Perturbation	GEORGES_TARGETS_OF_MIR192_AND_MIR215	Genes down-regulated in HCT116 cells (colon cancer) by expression of MIR192 or MIR215 [GeneID=406967;406997] at 24 h.	59	9.671084e-2	1.000000e+0	1.000000e+0	1.034010e+1	9.671084e-2	1	9.671084e-2	1.000000e+0	55	9.137854e-2	1.000000e+0	1.000000e+0	1.068780e+1	9.356466e-2	1	844	5.000000e-1	1.184834e-3	unnamed	SLC19A2
MSigDB Perturbation	GOZGIT_ESR1_TARGETS_DN	Genes down-regulated in TMX2-28 cells (breast cancer) which do not express ESR1 [GeneID=2099]) compared to the parental MCF7 cells which do.	60	1.109780e-1	1.000000e+0	1.000000e+0	9.010794e+0	1.109780e-1	1	1.109780e-1	1.000000e+0	54	7.897249e-2	1.000000e+0	1.000000e+0	1.240784e+1	8.059420e-2	1	727	5.000000e-1	1.375516e-3	unnamed	SLC19A2
MSigDB Perturbation	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY	Genes transiently induced only by the first pulse of EGF [GeneID =1950] in 184A1 cells (mammary epithelium).	61	1.656740e-1	1.000000e+0	1.000000e+0	6.035952e+0	1.656740e-1	1	1.656740e-1	1.000000e+0	61	1.708257e-1	1.000000e+0	1.000000e+0	5.592374e+0	1.788149e-1	1	1613	5.000000e-1	6.199628e-4	unnamed	F5
MSigDB Perturbation	PILON_KLF1_TARGETS_DN	Genes down-regulated in erythroid progenitor cells from fetal livers of E13.5 embryos with KLF1 [GeneID=10661] knockout compared to those from the wild type embryos.	62	1.766774e-1	1.000000e+0	1.000000e+0	5.660033e+0	1.766774e-1	1	1.766774e-1	1.000000e+0	62	2.003385e-1	1.000000e+0	1.000000e+0	4.727725e+0	2.115182e-1	1	1908	5.000000e-1	5.241090e-4	unnamed	F5
MSigDB Predicted Promoter Motifs	V$HLF_01	Motif GTTACRYAAT matches HLF: hepatic leukemia factor	1	3.859062e-2	1.000000e+0	1.000000e+0	2.591303e+1	3.859062e-2	1	3.859062e-2	1.000000e+0	2	2.785133e-2	1.000000e+0	1.000000e+0	3.565415e+1	2.804723e-2	1	253	5.000000e-1	3.952569e-3	unnamed	F5
MSigDB Predicted Promoter Motifs	V$CEBPA_01	Motif NNATTRCNNAANNN matches CEBPA: CCAAT/enhancer binding protein (C/EBP), alpha	2	4.127006e-2	1.000000e+0	1.000000e+0	2.423064e+1	4.127006e-2	1	4.127006e-2	1.000000e+0	1	2.588281e-2	1.000000e+0	1.000000e+0	3.838511e+1	2.605177e-2	1	235	5.000000e-1	4.255319e-3	unnamed	F5
MSigDB Predicted Promoter Motifs	TGCTGAY_UNKNOWN	Motif TGCTGAY (no known TF)	3	7.174661e-2	1.000000e+0	1.000000e+0	1.393794e+1	7.174661e-2	1	7.174661e-2	1.000000e+0	3	5.692491e-2	1.000000e+0	1.000000e+0	1.731382e+1	5.775733e-2	1	521	5.000000e-1	1.919386e-3	unnamed	F5
MSigDB Predicted Promoter Motifs	GGGAGGRR_V$MAZ_Q6	Motif GGGAGGRR matches MAZ: MYC-associated zinc finger protein (purine-binding transcription factor)	4	2.285624e-1	1.000000e+0	1.000000e+0	4.375173e+0	2.285624e-1	1	2.285624e-1	1.000000e+0	5	2.271738e-1	1.000000e+0	1.000000e+0	4.135947e+0	2.417826e-1	1	2181	5.000000e-1	4.585053e-4	unnamed	F5
MSigDB Predicted Promoter Motifs	TTGTTT_V$FOXO4_01	Motif TTGTTT matches MLLT7: myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 7	5	2.767434e-1	1.000000e+0	1.000000e+0	3.613455e+0	2.767434e-1	1	2.767434e-1	1.000000e+0	4	2.050899e-1	1.000000e+0	1.000000e+0	4.611708e+0	2.168394e-1	1	1956	5.000000e-1	5.112474e-4	unnamed	SLC19A2
MSigDB miRNA Motifs	GGGACCA,MIR-133A,MIR-133B	Targets of MicroRNA GGGACCA,MIR-133A,MIR-133B	1	1.797265e-2	1.000000e+0	1.000000e+0	5.564011e+1	1.797265e-2	1	1.797265e-2	1.000000e+0	1	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	SLC19A2
MSigDB miRNA Motifs	CTGAGCC,MIR-24	Targets of MicroRNA CTGAGCC,MIR-24	2	2.419205e-2	1.000000e+0	1.000000e+0	4.133589e+1	2.419205e-2	1	2.419205e-2	1.000000e+0	2	2.489780e-2	1.000000e+0	1.000000e+0	3.991372e+1	2.505404e-2	1	226	5.000000e-1	4.424779e-3	unnamed	SLC19A2
MSigDB miRNA Motifs	GTACTGT,MIR-101	Targets of MicroRNA GTACTGT,MIR-101	3	4.071928e-2	1.000000e+0	1.000000e+0	2.455839e+1	4.071928e-2	1	4.071928e-2	1.000000e+0	3	2.719538e-2	1.000000e+0	1.000000e+0	3.652024e+1	2.738207e-2	1	247	5.000000e-1	4.048583e-3	unnamed	SLC19A2
MSigDB miRNA Motifs	ACCAAAG,MIR-9	Targets of MicroRNA ACCAAAG,MIR-9	4	7.022342e-2	1.000000e+0	1.000000e+0	1.424026e+1	7.022342e-2	1	7.022342e-2	1.000000e+0	4	5.444710e-2	1.000000e+0	1.000000e+0	1.811345e+1	5.520758e-2	1	498	5.000000e-1	2.008032e-3	unnamed	SLC19A2
InterPro	IPR028338	Thiamine transporter 1	1	4.190995e-5	3.948755e-1	3.948755e-1	2.386068e+4	4.190995e-5	1	4.190995e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	SLC19A2
InterPro	IPR024715	Coagulation factor 5/8	2	9.733276e-5	9.170693e-1	4.585346e-1	1.027403e+4	9.733276e-5	1	9.733276e-5	1.000000e+0	2	2.217111e-4	1.000000e+0	1.000000e+0	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	F5
InterPro	IPR002666	Reduced folate carrier	3	2.229109e-4	1.000000e+0	7.000888e-1	4.486097e+3	2.229109e-4	1	2.229109e-4	1.000000e+0	3	4.433975e-4	1.000000e+0	1.000000e+0	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	SLC19A2
InterPro	IPR011707	Multicopper oxidase, type 3	4	4.690134e-4	1.000000e+0	1.000000e+0	2.132135e+3	4.690134e-4	1	4.690134e-4	1.000000e+0	4	5.542315e-4	1.000000e+0	1.000000e+0	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	F5
InterPro	IPR002355	Multicopper oxidase, copper-binding site	5	4.806694e-4	1.000000e+0	9.057734e-1	2.080432e+3	4.806694e-4	1	4.806694e-4	1.000000e+0	5	6.650594e-4	1.000000e+0	1.000000e+0	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	F5
InterPro	IPR008972	Cupredoxin	6	1.980541e-3	1.000000e+0	1.000000e+0	5.049127e+2	1.980541e-3	1	1.980541e-3	1.000000e+0	6	2.216004e-3	1.000000e+0	1.000000e+0	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	F5
InterPro	IPR000421	Coagulation factor 5/8 C-terminal type domain	7	5.241064e-3	1.000000e+0	1.000000e+0	1.908010e+2	5.241064e-3	1	5.241064e-3	1.000000e+0	7	2.548193e-3	1.000000e+0	1.000000e+0	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	F5
InterPro	IPR016196	Major facilitator superfamily domain, general substrate transporter	8	1.002249e-2	1.000000e+0	1.000000e+0	9.977556e+1	1.002249e-2	1	1.002249e-2	1.000000e+0	9	1.546041e-2	1.000000e+0	1.000000e+0	6.443214e+1	1.552020e-2	1	140	5.000000e-1	7.142857e-3	unnamed	SLC19A2
InterPro	IPR008979	Galactose-binding domain-like	9	1.363827e-2	1.000000e+0	1.000000e+0	7.332306e+1	1.363827e-2	1	1.363827e-2	1.000000e+0	8	8.959636e-3	1.000000e+0	1.000000e+0	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	F5
TreeFam	TF313684	SLC19A1, SLC19A2, SLC19A3	1	1.652385e-4	1.000000e+0	1.000000e+0	6.051859e+3	1.652385e-4	1	1.652385e-4	1.000000e+0	1	3.325574e-4	1.000000e+0	1.000000e+0	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	SLC19A2
TreeFam	TF329807	CP, F5, F8, HEPH, HEPHL1	2	4.690134e-4	1.000000e+0	1.000000e+0	2.132135e+3	4.690134e-4	1	4.690134e-4	1.000000e+0	2	5.542315e-4	1.000000e+0	1.000000e+0	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	F5
HGNC Gene Families	SLC	SLC	1	3.126915e-2	1.000000e+0	1.000000e+0	3.198041e+1	3.126915e-2	1	3.126915e-2	1.000000e+0	1	4.070677e-2	1.000000e+0	1.000000e+0	2.431402e+1	4.112854e-2	1	371	5.000000e-1	2.695418e-3	unnamed	SLC19A2
Ensembl Genes	1547	SLC19A2	1	4.190995e-5	7.560974e-1	7.560974e-1	2.386068e+4	4.190995e-5	1	4.190995e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	SLC19A2
Ensembl Genes	1548	F5	2	4.826709e-5	8.707866e-1	4.353933e-1	2.071805e+4	4.826709e-5	1	4.826709e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	F5
MSigDB Oncogenic Signatures	PRC1_BMI_UP.V1_DN	Genes down-regulated in TIG3 cells (fibroblasts) upon knockdown of BMI1 [Gene ID=648] gene.	1	2.085117e-2	1.000000e+0	1.000000e+0	4.795894e+1	2.085117e-2	1	2.085117e-2	1.000000e+0	1	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	SLC19A2
MSigDB Oncogenic Signatures	RPS14_DN.V1_UP	Genes up-regulated in CD34+ hematopoietic progenitor cells after knockdown of RPS14 [Gene ID=6208] by RNAi.	2	2.328320e-2	1.000000e+0	1.000000e+0	4.294943e+1	2.328320e-2	1	2.328320e-2	1.000000e+0	3	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	F5
MSigDB Oncogenic Signatures	P53_DN.V1_DN	Genes down-regulated in NCI-60 panel of cell lines with mutated TP53 [Gene ID=7157].	3	2.437345e-2	1.000000e+0	1.000000e+0	4.102825e+1	2.437345e-2	1	2.437345e-2	1.000000e+0	4	2.062369e-2	1.000000e+0	9.641575e-1	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	SLC19A2
MSigDB Oncogenic Signatures	PRC2_EZH2_UP.V1_DN	Genes down-regulated in TIG3 cells (fibroblasts) upon knockdown of EZH2 [Gene ID=2146] gene.	4	2.665821e-2	1.000000e+0	1.000000e+0	3.751190e+1	2.665821e-2	1	2.665821e-2	1.000000e+0	2	2.040425e-2	1.000000e+0	1.000000e+0	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	SLC19A2
MSigDB Oncogenic Signatures	RAF_UP.V1_DN	Genes down-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) stably over-expressing constitutively active RAF1 [Gene ID=5894] gene.	5	3.391411e-2	1.000000e+0	1.000000e+0	2.948625e+1	3.391411e-2	1	3.391411e-2	1.000000e+0	5	2.193980e-2	1.000000e+0	8.205485e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	SLC19A2
MSigDB Oncogenic Signatures	NFE2L2.V2	Genes up-regulated in MEF cells (embryonic fibroblasts) with knockout of NFE2L2 [Gene ID=4780] gene.	6	4.485003e-2	1.000000e+0	1.000000e+0	2.229653e+1	4.485003e-2	1	4.485003e-2	1.000000e+0	6	4.645297e-2	1.000000e+0	1.000000e+0	2.127476e+1	4.700405e-2	1	424	5.000000e-1	2.358491e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_DN	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute E. coli infection versus PBMC from patients with acute S. pneumoniae infection.	1	9.386539e-3	1.000000e+0	1.000000e+0	1.065355e+2	9.386539e-3	1	9.386539e-3	1.000000e+0	1	1.732955e-2	1.000000e+0	1.000000e+0	5.745541e+1	1.740480e-2	1	157	5.000000e-1	6.369427e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE17721_LPS_VS_PAM3CSK4_4H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 4 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 4 h.	2	1.054199e-2	1.000000e+0	1.000000e+0	9.485879e+1	1.054199e-2	1	1.054199e-2	1.000000e+0	32	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE6269_E_COLI_VS_STREP_AUREUS_INF_PBMC_DN	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute E. coli infection versus PBMC from patients with acute S. aureus infection.	3	1.064443e-2	1.000000e+0	1.000000e+0	9.394584e+1	1.064443e-2	1	1.064443e-2	1.000000e+0	6	1.908711e-2	1.000000e+0	1.000000e+0	5.214162e+1	1.917854e-2	1	173	5.000000e-1	5.780347e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 4 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 4 h.	4	1.192314e-2	1.000000e+0	1.000000e+0	8.387053e+1	1.192314e-2	1	1.192314e-2	1.000000e+0	13	2.029452e-2	1.000000e+0	1.000000e+0	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 12 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 12 h.	5	1.282245e-2	1.000000e+0	1.000000e+0	7.798821e+1	1.282245e-2	1	1.282245e-2	1.000000e+0	44	2.150119e-2	1.000000e+0	9.333471e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE6269_HEALTHY_VS_STREP_PNEUMO_INF_PBMC_DN	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute S. pneumoniae infection.	6	1.296815e-2	1.000000e+0	1.000000e+0	7.711201e+1	1.296815e-2	1	1.296815e-2	1.000000e+0	2	1.875769e-2	1.000000e+0	1.000000e+0	5.306176e+1	1.884596e-2	1	170	5.000000e-1	5.882353e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN	Genes down-regulated in comparison of naive CD8 T cells versus effector CD8 IL2RA [GeneID=3559] high T cells at.	7	1.300812e-2	1.000000e+0	1.000000e+0	7.687506e+1	1.300812e-2	1	1.300812e-2	1.000000e+0	44	2.150119e-2	1.000000e+0	9.333471e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 2 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 2 h.	8	1.369577e-2	1.000000e+0	1.000000e+0	7.301524e+1	1.369577e-2	1	1.369577e-2	1.000000e+0	44	2.150119e-2	1.000000e+0	9.333471e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 8 h.	9	1.374471e-2	1.000000e+0	1.000000e+0	7.275528e+1	1.374471e-2	1	1.374471e-2	1.000000e+0	16	2.062369e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 10 h.	10	1.394933e-2	1.000000e+0	1.000000e+0	7.168801e+1	1.394933e-2	1	1.394933e-2	1.000000e+0	14	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_UP	Genes up-regulated in comparison of unstimulated macrophage cells versus macrophage cells stimulated with LPS (TLR4 agonist) for 240 min.	11	1.407297e-2	1.000000e+0	1.000000e+0	7.105820e+1	1.407297e-2	1	1.407297e-2	1.000000e+0	21	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_DN	Genes down-regulated in comparison of untreated peripheral blood mononuclear cells (PBMC) versus PBMCs treated with CSF3 [GeneID=1440].	12	1.412300e-2	1.000000e+0	1.000000e+0	7.080647e+1	1.412300e-2	1	1.412300e-2	1.000000e+0	16	2.062369e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 6 h versus cDCs infected with Newcastle disease virus (NDV) at 6 h.	13	1.417033e-2	1.000000e+0	1.000000e+0	7.056996e+1	1.417033e-2	1	1.417033e-2	1.000000e+0	14	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 10 h versus cDCs infected with Newcastle disease virus (NDV) at 10 h.	14	1.435409e-2	1.000000e+0	1.000000e+0	6.966657e+1	1.435409e-2	1	1.435409e-2	1.000000e+0	16	2.062369e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE360_L_MAJOR_VS_T_GONDII_MAC_DN	Genes down-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to M. tuberculosis.	15	1.439255e-2	1.000000e+0	1.000000e+0	6.948041e+1	1.439255e-2	1	1.439255e-2	1.000000e+0	67	2.314545e-2	1.000000e+0	6.598181e-1	4.295476e+1	2.328031e-2	1	210	5.000000e-1	4.761905e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_24H_GARDIQUIMOD_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with Gardiquimod (TLR7 agonist) at 0.5 h versus those stimulated with Gardiquimod (TLR7 agonist) at 24 h.	16	1.466399e-2	1.000000e+0	1.000000e+0	6.819427e+1	1.466399e-2	1	1.466399e-2	1.000000e+0	27	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 14 h.	17	1.480092e-2	1.000000e+0	1.000000e+0	6.756336e+1	1.480092e-2	1	1.480092e-2	1.000000e+0	26	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE22886_CD8_VS_CD4_NAIVE_TCELL_DN	Genes down-regulated in comparison of naive CD8 T cells versus naive CD4 [GeneID=920] T cells.	18	1.485682e-2	1.000000e+0	1.000000e+0	6.730914e+1	1.485682e-2	1	1.485682e-2	1.000000e+0	11	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE14308_TH1_VS_NATURAL_TREG_UP	Genes up-regulated in comparison of Th1 cells versus natural regulatory T cell (Treg).	19	1.502918e-2	1.000000e+0	1.000000e+0	6.653722e+1	1.502918e-2	1	1.502918e-2	1.000000e+0	20	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with Gardiquimod (TLR7 agonist) at 0.5 h versus those stimulated with Gardiquimod (TLR7 agonist) at 8 h.	20	1.520813e-2	1.000000e+0	1.000000e+0	6.575428e+1	1.520813e-2	1	1.520813e-2	1.000000e+0	61	2.183015e-2	1.000000e+0	6.835342e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE19825_CD24LOW_VS_IL2RA_HIGH_DAY3_EFF_CD8_TCELL_DN	Genes down-regulated in comparison of effector CD8 IL2RA [GeneID=3559] low T cells versus effector CD8 IL2RA [GeneID=3559] high cells.	21	1.526239e-2	1.000000e+0	1.000000e+0	6.552055e+1	1.526239e-2	1	1.526239e-2	1.000000e+0	27	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_CPG_4H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 4 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 4 h.	22	1.561088e-2	1.000000e+0	1.000000e+0	6.405788e+1	1.561088e-2	1	1.561088e-2	1.000000e+0	44	2.150119e-2	1.000000e+0	9.333471e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_DN	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 1 h.	23	1.581142e-2	1.000000e+0	1.000000e+0	6.324544e+1	1.581142e-2	1	1.581142e-2	1.000000e+0	2	1.875769e-2	1.000000e+0	1.000000e+0	5.306176e+1	1.884596e-2	1	170	5.000000e-1	5.882353e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE10325_MYELOID_VS_LUPUS_MYELOID_DN	Genes down-regulated in comparison of healthy myeloid cells versus systemic lupus erythematosus myeloid cells.	24	1.581373e-2	1.000000e+0	1.000000e+0	6.323618e+1	1.581373e-2	1	1.581373e-2	1.000000e+0	32	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_UP	Genes up-regulated in comparison of CD25+ T effector cells treated with IL4 [GeneID=3565] at day 3 versus untreated CD25- T cells at day 3.	25	1.593468e-2	1.000000e+0	1.000000e+0	6.275622e+1	1.593468e-2	1	1.593468e-2	1.000000e+0	37	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP	Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 12 h versus PMN treated with F. tularensis vaccine at 48 h.	26	1.596829e-2	1.000000e+0	1.000000e+0	6.262410e+1	1.596829e-2	1	1.596829e-2	1.000000e+0	37	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_UP	Genes up-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] versus macrophages cultured with M-CSF [GeneID=1435] and IFNG [GeneID=3458].	27	1.661274e-2	1.000000e+0	1.000000e+0	6.019476e+1	1.661274e-2	1	1.661274e-2	1.000000e+0	9	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 2 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 2 h.	28	1.695553e-2	1.000000e+0	1.000000e+0	5.897780e+1	1.695553e-2	1	1.695553e-2	1.000000e+0	52	2.161085e-2	1.000000e+0	7.937831e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_UP	Genes up-regulated in comparison of untreated CD25+ T effector cells at day 5 versus untreated CD25- T cells at day 5.	29	1.714712e-2	1.000000e+0	1.000000e+0	5.831884e+1	1.714712e-2	1	1.714712e-2	1.000000e+0	44	2.150119e-2	1.000000e+0	9.333471e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 0.5 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 0.5 h.	30	1.715947e-2	1.000000e+0	1.000000e+0	5.827685e+1	1.715947e-2	1	1.715947e-2	1.000000e+0	52	2.161085e-2	1.000000e+0	7.937831e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_UP	Genes up-regulated in comparsion of WTActCD4 versus WTActCD4TGF (see Fig. 1 in the paper for details).	31	1.734409e-2	1.000000e+0	1.000000e+0	5.765653e+1	1.734409e-2	1	1.734409e-2	1.000000e+0	44	2.150119e-2	1.000000e+0	9.333471e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_DN	Genes down-regulated in comparison of monocytes treated with 5000 ng/ml LPS (TLR4 agonist) versus monocytes treated with anti-TREM1 [GeneID=54210].	32	1.734844e-2	1.000000e+0	1.000000e+0	5.764208e+1	1.734844e-2	1	1.734844e-2	1.000000e+0	8	1.974579e-2	1.000000e+0	1.000000e+0	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_DN	Genes down-regulated in comparison of CTRLrv versus FOXP3rv (see Fig. 1 for details).	33	1.783889e-2	1.000000e+0	1.000000e+0	5.605731e+1	1.783889e-2	1	1.783889e-2	1.000000e+0	11	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_UP	Genes up-regulated in comparison of monocytes cultured for 0 days versus those cultured for 1 day.	34	1.791649e-2	1.000000e+0	1.000000e+0	5.581452e+1	1.791649e-2	1	1.791649e-2	1.000000e+0	56	2.172051e-2	1.000000e+0	7.408245e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_CPG_16H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 16 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 16 h.	35	1.794138e-2	1.000000e+0	9.790867e-1	5.573706e+1	1.794138e-2	1	1.794138e-2	1.000000e+0	37	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 0.5 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 0.5 h.	36	1.805545e-2	1.000000e+0	9.579419e-1	5.538494e+1	1.805545e-2	1	1.805545e-2	1.000000e+0	27	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_CPG_24H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 24 h versus those stimulated with CpG DNA (TLR9 agonist) at 24 h.	37	1.825466e-2	1.000000e+0	9.423352e-1	5.478054e+1	1.825466e-2	1	1.825466e-2	1.000000e+0	61	2.183015e-2	1.000000e+0	6.835342e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_UP	Genes up-regulated in comparison of CD4 [GeneID=920] T cells from bone marrow versus those from spleen.	38	1.831336e-2	1.000000e+0	9.204873e-1	5.460495e+1	1.831336e-2	1	1.831336e-2	1.000000e+0	22	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_POLYIC_0.5H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 0 h versus those stimulated with poly(I:C) (TLR3 agonist) at 0.5 h.	39	1.853963e-2	1.000000e+0	9.079665e-1	5.393852e+1	1.853963e-2	1	1.853963e-2	1.000000e+0	32	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE17721_LPS_VS_PAM3CSK4_16H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 16 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 16 h.	40	1.859484e-2	1.000000e+0	8.879036e-1	5.377836e+1	1.859484e-2	1	1.859484e-2	1.000000e+0	61	2.183015e-2	1.000000e+0	6.835342e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_UP	Genes up-regulated in comparison of CD4 [GeneID=920] effector memory T cells versus CD4 [GeneID=920] central memory T cells.	41	1.872494e-2	1.000000e+0	8.723082e-1	5.340471e+1	1.872494e-2	1	1.872494e-2	1.000000e+0	7	1.930669e-2	1.000000e+0	1.000000e+0	5.154571e+1	1.940025e-2	1	175	5.000000e-1	5.714286e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP	Genes up-regulated in comparison of monocytes cultured for 0 days versus those cultured for 7 days.	42	1.877942e-2	1.000000e+0	8.540165e-1	5.324979e+1	1.877942e-2	1	1.877942e-2	1.000000e+0	27	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_UP	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) cultured with YF17D vaccine for 12 h versus PBMC cultured for 3 h.	43	1.880536e-2	1.000000e+0	8.353079e-1	5.317633e+1	1.880536e-2	1	1.880536e-2	1.000000e+0	32	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 24 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 24 h.	44	1.901723e-2	1.000000e+0	8.255207e-1	5.258390e+1	1.901723e-2	1	1.901723e-2	1.000000e+0	44	2.150119e-2	1.000000e+0	9.333471e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 24 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 24 h.	45	1.905614e-2	1.000000e+0	8.088273e-1	5.247653e+1	1.905614e-2	1	1.905614e-2	1.000000e+0	56	2.172051e-2	1.000000e+0	7.408245e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE27786_BCELL_VS_NKCELL_DN	Genes down-regulated in comparison of B cells versus NK cells.	46	1.937323e-2	1.000000e+0	8.044102e-1	5.161761e+1	1.937323e-2	1	1.937323e-2	1.000000e+0	44	2.150119e-2	1.000000e+0	9.333471e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_LPS_0.5H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 0 h versus those stimulated with LPS (TLR4 agonist) at 0.5 h.	47	1.943415e-2	1.000000e+0	7.897708e-1	5.145581e+1	1.943415e-2	1	1.943415e-2	1.000000e+0	37	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE29618_MONOCYTE_VS_MDC_UP	Genes up-regulated in comparison of monocytes versus myeloid dendritic cells (mDC).	48	1.956328e-2	1.000000e+0	7.784555e-1	5.111619e+1	1.956328e-2	1	1.956328e-2	1.000000e+0	61	2.183015e-2	1.000000e+0	6.835342e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_UP	Genes up-regulated in comparison of memory CD8 T cells treated with IL7 [GeneID=3574] versus those treated with IL4 [GeneID=3565].	49	1.961059e-2	1.000000e+0	7.644128e-1	5.099287e+1	1.961059e-2	1	1.961059e-2	1.000000e+0	22	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP	Genes up-regulated in comparison of monocytes from influenza vaccinee at day 7 post-vaccination versus myeloid dendritic cells at day 7 post-vaccination.	50	1.962886e-2	1.000000e+0	7.498225e-1	5.094539e+1	1.962886e-2	1	1.962886e-2	1.000000e+0	56	2.172051e-2	1.000000e+0	7.408245e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 12 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 12 h.	51	2.041558e-2	1.000000e+0	7.645835e-1	4.898221e+1	2.041558e-2	1	2.041558e-2	1.000000e+0	65	2.193980e-2	1.000000e+0	6.446926e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_UP	Genes up-regulated in comparison of untreated eosinophils versus eosinophils treated with PMA [PubChem=4792] at 2 h.	52	2.049593e-2	1.000000e+0	7.528313e-1	4.879017e+1	2.049593e-2	1	2.049593e-2	1.000000e+0	66	2.303588e-2	1.000000e+0	6.666444e-1	4.316029e+1	2.316945e-2	1	209	5.000000e-1	4.784689e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE22886_DC_VS_MONOCYTE_DN	Genes down-regulated in comparison of dendritic cells (DC) versus monocytes.	53	2.073068e-2	1.000000e+0	7.470868e-1	4.823769e+1	2.073068e-2	1	2.073068e-2	1.000000e+0	27	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE27786_NKCELL_VS_NKTCELL_UP	Genes up-regulated in comparison of NK cells versus NKT cells.	54	2.076640e-2	1.000000e+0	7.345153e-1	4.815471e+1	2.076640e-2	1	2.076640e-2	1.000000e+0	56	2.172051e-2	1.000000e+0	7.408245e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_UP	Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist) versus monocytes treated with control IgG.	55	2.100856e-2	1.000000e+0	7.295700e-1	4.759964e+1	2.100856e-2	1	2.100856e-2	1.000000e+0	10	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_DN	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 1 h versus cDCs infected with Newcastle disease virus (NDV) at 1 h.	56	2.116845e-2	1.000000e+0	7.219953e-1	4.724012e+1	2.116845e-2	1	2.116845e-2	1.000000e+0	2	1.875769e-2	1.000000e+0	1.000000e+0	5.306176e+1	1.884596e-2	1	170	5.000000e-1	5.882353e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells versus those treated with IL6 [GeneID=3569]  and IL23A [GeneID=51561].	57	2.140237e-2	1.000000e+0	7.171671e-1	4.672379e+1	2.140237e-2	1	2.140237e-2	1.000000e+0	16	2.062369e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE29618_MONOCYTE_VS_PDC_UP	Genes up-regulated in comparison of monocytes versus plasmacytoid dendritic cells (pDC).	58	2.157771e-2	1.000000e+0	7.105763e-1	4.634411e+1	2.157771e-2	1	2.157771e-2	1.000000e+0	52	2.161085e-2	1.000000e+0	7.937831e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_UP	Genes up-regulated in comparison of regulatory T cell (Treg) versus conventional T cells activated with lamina propria dendritic cells.	59	2.171087e-2	1.000000e+0	7.028434e-1	4.605987e+1	2.171087e-2	1	2.171087e-2	1.000000e+0	32	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN	Genes down-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus thymic stromal cells.	60	2.172671e-2	1.000000e+0	6.916336e-1	4.602630e+1	2.172671e-2	1	2.172671e-2	1.000000e+0	22	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN	Genes down-regulated in comparison of effector memory T cells versus central memory T cells from peripheral blood mononuclear cells (PBMC).	61	2.175578e-2	1.000000e+0	6.812056e-1	4.596480e+1	2.175578e-2	1	2.175578e-2	1.000000e+0	5	1.886750e-2	1.000000e+0	1.000000e+0	5.275146e+1	1.895682e-2	1	171	5.000000e-1	5.847953e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_UP	Genes up-regulated in comparison of untreated CD25+ T effector cells at day 10 versus untreated CD25- T cells at day 10.	62	2.178263e-2	1.000000e+0	6.710455e-1	4.590815e+1	2.178263e-2	1	2.178263e-2	1.000000e+0	52	2.161085e-2	1.000000e+0	7.937831e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_DN	Genes down-regulated in naive CD4 [GeneID=920] T cells from cord blood versus thymic stromal cells.	63	2.190623e-2	1.000000e+0	6.641413e-1	4.564912e+1	2.190623e-2	1	2.190623e-2	1.000000e+0	37	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_DN	Genes down-regulated in comparison of resting CD4 [GeneID=920] T cells versus directly activated CD4 [GeneID=920] T cells.	64	2.242666e-2	1.000000e+0	6.692956e-1	4.458979e+1	2.242666e-2	1	2.242666e-2	1.000000e+0	37	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_DN	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells versus those treated with IL1B [GeneID=3553] and IL6 [GeneID=3569].	65	2.254917e-2	1.000000e+0	6.625987e-1	4.434753e+1	2.254917e-2	1	2.254917e-2	1.000000e+0	22	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN	Genes down-regulated in comparison of naive T cells versus central memory T cells.	66	2.437598e-2	1.000000e+0	7.054261e-1	4.102399e+1	2.437598e-2	1	2.437598e-2	1.000000e+0	37	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	F5
MSigDB Immunologic Signatures	GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP	Genes up-regulated in comparison of microglia cells 1 h after stimulation with IFNG [GeneID=3458] versus microglia cells 24 h after the stimulation.	67	2.438851e-2	1.000000e+0	6.952545e-1	4.100291e+1	2.438851e-2	1	2.438851e-2	1.000000e+0	56	2.172051e-2	1.000000e+0	7.408245e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	SLC19A2
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
